Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
217135160173123463769-739523-----191191Designated Individual60%11%74%zr50%54%2%100%100%98%zp96%zp100%zp-60%g56%42%-----100%zbce53%bcepr(DI)
33-450-50---2--151821----54-54Organ Donation &9%-9%16%-35%zklm---4%--12%10%38%zhi----100%zace-15%acehklmTransplant (ODT) named
contact or corporatelicence holder contact
577544-43------16277---49--49Independent Assessor16%77%11%14%-30%zklm------13%16%13%---100%zabe--14%abeklm(IA)
171-18131--1---414---19---19Accredited Assessor (AA)5%12%-6%42%1%--2%---4%8%zg---100%---5%akp
37-346-47-----1314164-47----47Living donor coordinator10%-5%14%-33%zklm-----91%11%10%7%-100%zabc----13%abcklm
1--11------1---1-----1Stem cell coordinator*--*4%------9%---100%-----*
----------------------Other----------------------
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 1Q.1 Please specify your relationship with the HTA:
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
217512424193814171015826191Designated Individual60%53%51%21%66%g56%46%71%55%55%48%68%55%53%(DI)
33-5725162543-554Organ Donation &9%-22%34%5%14%20%i9%16%24%11%-11%15%Transplant (ODT) named
contact or corporatelicence holder contact
571154413-4333949Independent Assessor16%9%4%27%12%12%16%-14%14%9%22%19%14%(IA)
17111-24-4-2-219Accredited Assessor (AA)5%12%5%6%-6%6%-14%-7%-5%5%
373436494-181547Living donor coordinator10%26%18%13%17%11%11%20%-7%25%11%11%13%
1-----1------1Stem cell coordinator*-----2%------*
--------------Other--------------
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 2Q.1 Please specify your relationship with the HTA:
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
21711231886220167191Designated Individual60%54%61%54%62%z56%53%53%(DI)
333012212374654Organ Donation &9%14%22%13%23%zf18%14%15%Transplant (ODT) named
contact or corporatelicence holder contact
5724320534549Independent Assessor16%12%5%12%5%9%14%14%e(IA)
1711111-21419Accredited Assessor (AA)5%5%2%7%e-6%5%5%e
3728523934547Living donor coordinator10%14%10%14%9%7%14%13%
1---11-1Stem cell coordinator*---1%3%zc-*
--------Other--------
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 3Q.1 Please specify your relationship with the HTA:
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
494123932911465---55-4-7212355Less than 1 year14%40%26%zr12%10%20%k11%33%8%16%8%---100%zhi-8%-14%39%zace12%15%ahikr
176523150195952262132--171--1614271895171Between 1 and 5 years49%51%49%47%60%41%39%67%56%53%46%--100%zgi--35%76%54%33%50%47%gi
1261111158436-171232-122---144161573122Between 6 and 10 years35%10%23%36%z26%30%50%-36%31%46%zp-100%zgh---29%24%32%28%38%z34%gh
11-114113-----14---113----14More than 10 years3%-3%4%4%9%zkm-----100%---100%28%zabc----4%ahi
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 4Q.2 How long have you been working in this role?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
49237531715322655Less than 1 year14%19%12%34%14%8%21%5%17%15%8%14%12%15%
1767962418349151212421171Between 1 and 5 years49%67%41%31%66%zag51%42%47%47%69%40%34%44%47%
12619561225911313620122Between 6 and 10 years35%13%40%28%16%34%31%48%36%17%44%53%43%i34%i
11-21135---3--14More than 10 years3%-7%6%3%7%6%---8%--4%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 5Q.2 How long have you been working in this role?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
492610221774455Less than 1 year14%13%20%14%17%20%14%15%
1769918844019148171Between 1 and 5 years49%48%36%51%39%51%47%47%
1267521523910110122Between 6 and 10 years35%37%40%32%39%26%35%34%
11435511314More than 10 years3%2%5%3%5%3%4%4%h
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 6Q.2 How long have you been working in this role?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
78-268------69-32325-----6969Post mortem22%-4%21%zs------100%zlmp-26%zg19%10%-----36%zbce19%bcelmp
s
38-1923-----39--12216----23739Human application10%-40%zr7%-----100%zkmp--10%12%11%----3%20%zbce11%cekmpr(tissue for treatment
sector)
59-1235----47---17264--1--4647Research16%-25%zr11%----100%zklp---14%15%7%--6%--24%zbce13%bceklp
r
3--3---3-----21-----33Public display1%--1%---100%-----1%2%-----1%1%
18-112--12-----651-----1212Anatomy5%-1%4%--100%-----5%3%3%-----7%zc3%p
11959136-144-----13435929-47143503144Transplants - solid33%57%18%43%zs-100%zklm-----91%35%34%53%hi-100%zac5%86%za92%za2%40%ahklmsorgan donation
30123032------181931-13--1732Transplants - bone8%11%4%9%100%------9%7%11%6%100%-72%--9%c9%ckmpmarrow or stem cell
donation
173412--------485--373316Other5%32%8%4%--------3%4%10%--18%14%zae5%2%5%apr
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 7Q.3 In which sector do you primarily work?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
7813-781468284969Post mortem22%9%12%-19%23%17%32%26%10%26%29%19%19%
38-536481441-339Human application10%-22%15%17%12%9%5%13%22%3%-7%11%(tissue for treatment
sector)
5922-841042242947Research16%16%7%-22%11%12%21%5%13%14%13%19%13%
3---1-1-1----3Public display1%---2%-1%-3%----1%
1811-1121-111112Anatomy5%7%6%-2%4%3%7%-4%5%12%3%3%
1193101312123359714619144Transplants - solid33%35%44%65%34%35%40%29%30%40%45%46%40%40%organ donation
30322-310-511-432Transplants - bone8%32%9%11%-9%12%i-17%6%3%-9%9%marrow or stem cell
donation
17--22251211-216Other5%--9%5%6%6%5%6%6%3%-4%5%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 8Q.3 In which sector do you primarily work?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
783316262286069Post mortem22%16%31%zh16%22%22%19%19%
38246181533539Human application10%12%12%11%15%8%11%11%(tissue for treatment
sector)
59286211663947Research16%14%12%13%16%15%12%13%
32-2--33Public display1%1%-1%--1%1%
181018321012Anatomy5%5%1%5%3%6%3%3%
1197521593712129144Transplants - solid33%37%40%36%37%32%41%40%organ donation
3023-21652632Transplants - bone8%11%g-13%z6%12%8%9%gmarrow or stem cell
donation
17929221416Other5%4%4%6%2%5%4%5%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 9Q.3 In which sector do you primarily work?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
5--4-1--3---22----1-34Post mortem1%--1%-1%--7%zkp---1%1%----2%-2%1%
18121645--2-5-5113---231318Human application5%11%4%5%13%4%--5%-8%-4%6%5%---4%6%7%5%(tissue for treatment
sector)
50175212221-1413-19297---3183355Research14%10%14%16%3%15%m17%33%-35%zmp19%m-16%17%13%---7%33%zace17%e15%em
2--2----1-1--11-----22Public display1%--1%----2%-1%--*2%-----1%*
6--5----2-4-14------55Anatomy2%--2%----3%p-5%zp-1%2%------3%z1%
8-261---133-44----1258Transplants - solid2%-4%2%3%---2%7%p4%p-4%2%----2%3%3%2%organ donation
10-39-2--18--543--1-3711Transplants - bone3%-6%3%-1%--2%20%zkmp--4%2%5%--6%-6%4%3%marrow or stem cell
donation
8-17-2--121-3-5-112138Other2%-2%2%-1%--2%5%1%-2%h-9%zh-3%6%4%2%2%2%
27773723827117102392248148913140146174333135274I do not work in any77%79%78%75%84%81%l83%67%82%l57%69%100%73%77%72%100%97%zab88%86%zab62%70%76%alother sectors
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 10Q.3b Which other sectors, if any, do you work in?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
5---1-21----14Post mortem1%---2%-2%4%----2%1%
18-1-3-851----18Human application5%-3%-7%-10%za28%3%----5%(tissue for treatment
sector)
50142541339232855Research14%9%19%10%12%10%17%18%28%10%9%14%17%15%
21---1-------2Public display1%9%---2%-------*
6-----1-1121-5Anatomy2%-----1%-3%4%6%7%-1%
8-2---32--1-18Transplants - solid2%-8%---3%9%--3%-2%2%organ donation
10-112-41-1--111Transplants - bone3%-4%5%6%-5%4%-6%--2%3%marrow or stem cell
donation
8-111-2--11-18Other2%-4%4%3%-2%--6%4%-3%2%
27791716303055102214241037274I do not work in any77%91%74%81%82%87%g67%54%72%80%81%80%79%76%other sectors
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 11Q.3b Which other sectors, if any, do you work in?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
51213134Post mortem1%*3%*3%2%1%1%
187451021518Human application5%4%7%3%10%zf5%5%5%(tissue for treatment
sector)
502216162584455Research14%11%32%zh10%25%zf22%14%15%fh
21111-22Public display1%*2%*1%-1%*
63122145Anatomy2%2%2%1%2%2%1%1%
86144-88Transplants - solid2%3%2%2%4%-3%2%organ donation
107247-1011Transplants - bone3%4%4%3%7%z-3%3%marrow or stem cell
donation
811-2178Other2%*2%-2%2%2%2%h
277168321376226244274I do not work in any77%82%zg61%84%ze62%71%77%76%egother sectors
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 12Q.3b Which other sectors, if any, do you work in?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
316311319301361233523681411515039146184450160319Public sector87%29%24%100%zs94%95%zlm94%100%75%60%99%zlm100%95%zgh88%g72%100%97%a94%89%92%84%88%aglms
5024711291-121921112312-3-543547Private sector14%19%100%zr4%6%6%6%-25%zkp48%zkmp3%9%9%14%22%i-5%-11%8%18%ze13%kpr
1092315------154--17-19Voluntary sector3%100%4%1%3%4%------1%3%7%i--6%14%zabe-1%3%ar
1-----1-------1-----11Don't know*-----6%-------1%-----**
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 13Q.3c Do you work in the public, private or voluntary sector(s)?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
316101818243471162814301243319Public sector87%100%80%90%66%98%i87%i83%90%80%100%100%93%i88%i
50-32111124342-547Private sector14%-13%10%31%zagh3%15%21%9%20%6%-11%13%
10111113-1---19Voluntary sector3%9%4%4%2%2%3%-4%---2%3%
1-1----------1Don't know*-3%----------*
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 14Q.3c Do you work in the public, private or voluntary sector(s)?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
316179491449132279319Public sector87%87%95%88%90%87%88%88%
50255201454147Private sector14%12%10%12%14%14%13%13%
104-21189Voluntary sector3%2%-1%1%2%3%3%
11-1-1-1Don't know**-*-2%c-*
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 15Q.3c Do you work in the public, private or voluntary sector(s)?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
4815434191-939-20216-52952647North West13%10%11%14%13%13%11%-19%8%13%-17%12%10%-11%12%18%9%13%13%
13--12-61-2-4-642-1-3-812North East4%--4%-4%11%-3%-5%-5%2%3%-3%-5%-4%3%
30-2301141-418313122-82331530Yorkshire & Humber8%-4%9%3%9%11%-9%3%12%18%11%7%4%-16%11%5%6%8%8%
18-414171-242-3123-1-341018East Midlands5%-8%5%3%5%6%-5%10%3%-2%7%5%-3%-5%8%5%5%
31132859-1248-11155--4451731West Midlands9%12%6%9%17%7%-33%3%10%12%-9%8%10%--24%9%e9%9%9%
20-416-51-416-991-4--21419East of England6%-9%5%-4%11%-8%3%9%-8%5%2%-8%--3%7%c5%
803127110332110814525341719413163882London22%30%26%22%30%23%17%33%20%20%21%35%21%20%31%100%19%24%26%30%20%23%
3511343121-448312183-42451935South West10%10%2%11%10%9%11%-8%10%12%18%10%10%5%-8%12%9%9%10%10%s
3911124-121186716245-6-422437South East11%10%24%zr8%-9%6%33%17%16%10%9%5%14%zi9%-13%-9%3%13%z10%ir
171218213---3-1567-3157420Scotland5%10%4%6%7%9%km---8%km-9%4%4%12%zh-5%6%11%a12%a2%5%ak
2113182101-2532993-41151223Wales6%10%6%6%7%7%11%-3%13%4%12%7%6%5%-9%6%2%9%6%6%
101-10331-2-1-172-311-510Northern Ireland3%10%-3%10%2%6%-3%-1%-1%4%3%-5%6%2%-3%3%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 16Q.4 In which of the following geographical areas are you mainly based?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
48-----------4747North West13%-----------100%zghi13%ghi
13----------12-12North East4%----------100%-3%
30---------30--30Yorkshire & Humber8%---------100%--8%ag
18--------18---18East Midlands5%--------100%---5%g
31-------31----31West Midlands9%-------100%----9%ag
20------19-----19East of England6%------100%-----5%g
80-----82------82London22%-----100%zahi------23%ahi
35----35-------35South West10%----100%zagi-------10%agi
39---37--------37South East11%---100%zagh--------10%ag
17--20---------20Scotland5%--100%---------5%g
21-23----------23Wales6%-100%----------6%g
1010-----------10Northern Ireland3%100%-----------3%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 17Q.4 In which of the following geographical areas are you mainly based?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
48255191144247North West13%12%11%12%11%11%13%13%
138255-1212North East4%4%3%3%5%-4%3%
3019313842630Yorkshire & Humber8%9%7%8%8%10%8%8%
1813210221518East Midlands5%6%3%6%2%7%5%5%
31127111042531West Midlands9%6%13%7%10%12%8%9%h
2010378-1919East of England6%5%6%4%8%-6%5%
8041133324156482London22%20%25%20%24%41%zc20%23%c
35187161213135South West10%9%14%10%12%2%10%10%
3923220723537South East11%11%3%12%7%6%11%10%
1713310521820Scotland5%6%6%6%5%5%6%5%
211649832023Wales6%8%7%6%8%7%6%6%
109191-1010Northern Ireland3%4%2%5%z1%-3%3%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 18Q.4 In which of the following geographical areas are you mainly based?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1412231181343512423268536317-153102388140Very well39%21%49%37%42%30%39%33%51%zp59%zkp38%53%43%37%31%-32%18%21%43%c46%zc39%cp
206721188179482221541567983512811382997206A fair amount57%79%45%59%z54%65%zlm61%67%47%39%59%l38%55%57%64%100%60%60%77%zab54%51%57%al
14-31217--1111293-4412415Just a little4%-6%4%4%5%--2%3%1%9%2%5%5%-8%22%2%3%2%4%a
1--1------1--1------11Not very well*--*------1%--1%------**
----------------------Heard of HTA, but know----------------------nothing about it
----------------------Don't know----------------------
347945305311361234738671312016152143154952186346Very well/A fair amount96%100%94%96%96%95%100%100%98%97%97%91%98%z94%95%100%92%78%98%97%97%z96%
1--1------1--1------11Not very well/Heard of*--*------1%--1%------**HTA,but know nothing
about it
346945305311361234738661312016052143154952185345Net96%100%94%96%96%95%100%100%98%97%96%91%98%94%95%100%92%78%98%97%97%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 19Q.5 How well do you think you know what the HTA does?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
141487201228910817412140Very well39%45%35%38%54%a35%34%47%32%45%57%36%26%39%
206515121521489181011834206A fair amount57%55%65%62%40%60%59%48%59%55%36%64%74%zi57%i
14---31613-2--15Just a little4%---7%3%7%5%9%-7%--4%
1----1-------1Not very well*----3%z-------*
--------------Heard of HTA, but know--------------nothing about it
--------------Don't know--------------
347102320343376182818281247346Very well/A fair amount96%100%100%100%93%94%93%95%91%100%93%100%100%96%
1----1-------1Not very well/Heard of*----3%z-------*HTA,but know nothing
about it
346102320343276182818281247345Net96%100%100%100%93%92%93%95%91%100%93%100%100%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 20Q.5 How well do you think you know what the HTA does?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1419217724011129140Very well39%45%z33%44%40%30%41%z39%
20610832865421178206A fair amount57%53%62%53%54%58%56%57%
1453564915Just a little4%2%5%3%6%10%c3%4%ch
1---11-1Not very well*---1%2%zc-*
--------Heard of HTA, but know--------nothing about it
--------Don't know--------
347200491599432307346Very well/A fair amount96%98%z95%97%94%88%97%zd96%d
1---11-1Not very well/Heard of*---1%2%zc-*HTA,but know nothing
about it
346200491599431307345Net96%98%95%97%93%85%97%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 21Q.5 How well do you think you know what the HTA does?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
13031511312576-1711198366321-196251564128Very favourable36%29%32%35%39%40%44%-36%28%28%53%30%37%39%-40%30%51%zab28%33%35%
1916251691575722921365768427-26102034103193Mainly favourable53%71%53%53%46%52%56%67%61%53%53%38%62%zh49%50%-54%52%40%63%c54%53%c
33-63059-1161018185133331933Neither favourable nor9%-12%10%15%7%-33%2%16%m14%m9%7%11%10%100%5%18%7%6%10%9%munfavourable
5-14-2---13--5-----245Mainly unfavourable1%-2%1%-1%---3%4%--3%z-----3%2%1%
1--1----1---1-------11Very unfavourable*--*----2%z---1%-------**
1--1------1-1-------11No opinion*--*------1%-1%-------**
1--1----------1---1--1Don't know*--*----------2%---2%--*
321941281271331224632561311214749-45154549167321Favourable89%100%86%88%85%92%k100%67%97%zkl82%81%91%92%86%88%-95%82%91%91%87%89%k
6-15-2--113-15-----246Unfavourable2%-2%2%-1%--2%3%4%-1%3%-----3%2%2%
315940276271311224531531311114249045154547162315Net87%100%84%87%85%91%100%67%95%79%77%91%91%83%88%0%95%82%91%88%85%87%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 22Q.6 How favourable or unfavourable is your overall opinion of the HTA?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
13046916131789814815128Very favourable36%45%28%47%42%g39%21%43%30%44%47%67%32%35%g
1915158191750915814428193Mainly favourable53%55%64%43%52%49%62%46%48%47%47%33%60%53%
33-1224112522-333Neither favourable nor9%-4%10%5%13%13%12%15%9%6%-7%9%unfavourable
5-1---2-3----5Mainly unfavourable1%-4%---2%-8%----1%
1-----------11Very unfavourable*-----------2%*
1-----1------1No opinion*-----1%------*
1-----1------1Don't know*-----1%------*
321102118353067172416281243321Favourable89%100%92%90%95%87%83%88%77%91%94%100%92%89%
6-1---2-3---16Unfavourable2%-4%---2%-8%---2%2%
315102018353066172116281242315Net87%100%88%90%95%87%80%88%69%91%94%100%90%87%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 23Q.6 How favourable or unfavourable is your overall opinion of the HTA?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
13094672242126128Very favourable36%46%zg12%44%ze24%7%40%zd35%deg
19110728855316172193Mainly favourable53%52%54%52%53%43%54%53%
33313520151433Neither favourable nor9%1%24%zh3%19%zf41%zc4%9%cfhunfavourable
51413245Mainly unfavourable1%*8%zh1%3%5%1%1%
1-1-11-1Very unfavourable*-2%-1%2%c-*
1----1-1No opinion*----2%zc-*
1-----11Don't know*-----**
321201341577718298321Favourable89%98%zg66%96%ze76%50%94%zd89%deg
61514346Unfavourable2%*10%zh1%4%7%zc1%2%ch
315200291567316295315Net87%98%56%96%72%43%93%87%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 24Q.6 How favourable or unfavourable is your overall opinion of the HTA?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
71111608294-81193174011-9310103971Speak highly of HTA,20%10%23%19%26%20%33%-17%28%k13%18%14%24%20%-19%18%21%18%20%20%without being asked
1945221741483723315296718529-277322898192Speak highly of HTA, if54%60%46%54%45%58%kl56%67%70%zkl39%42%44%58%50%53%-56%36%65%z53%51%53%kasked
82313727301151225530351411266134584Be neutral about HTA, if23%30%27%23%21%21%11%33%10%30%m36%zmp38%24%21%25%100%25%34%12%25%24%23%cmasked
8-251---114-251--1-157Be critical of HTA, if2%-4%2%4%---2%3%5%p-1%3%2%--6%-2%3%2%asked
2--3-2----1--3-----213Be critical of HTA,1%--1%-1%----1%--1%-----3%*1%without being asked
5--51---1-2-23---11-35No opinion1%--1%4%---2%-3%-1%2%---6%2%-1%1%
----------------------Don't know----------------------
2656322342311211241263898912540-35104338137263Speak highly73%70%68%73%72%78%k89%67%87%zkl67%55%62%73%73%73%-75%54%86%za70%72%73%k
10-2812--114-271--1-3610Critical3%-4%3%4%1%--2%3%6%zp-1%4%2%--6%-5%3%3%
255630226221111124025339871183903594335131253Net70%70%64%71%68%77%89%67%85%65%49%62%71%69%71%0%75%48%86%65%68%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 25Q.7 Which of these comes closest to describing how you would speak about the HTA? Would you...
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
71234971378444671Speak highly of HTA,20%18%15%20%26%19%16%38%24%23%14%33%13%20%without being asked
19461214221839610822629192Speak highly of HTA, if54%58%55%70%60%52%48%32%32%43%73%46%63%53%asked
82262482669542984Be neutral about HTA, if23%25%27%10%12%24%31%i30%29%29%13%20%20%23%asked
8-----4-21--17Be critical of HTA, if2%-----5%-6%6%--2%2%asked
2-1-----2----3Be critical of HTA,1%-4%-----5%----1%without being asked
5---12--1---15No opinion1%---2%5%--4%---2%1%
--------------Don't know--------------
26571618312552131812261035263Speak highly73%75%70%90%85%g71%64%70%56%66%87%80%76%73%
10-1---4-31--110Critical3%-4%---5%-11%6%--2%3%
25571518312548131411261035253Net70%75%66%90%85%71%59%70%45%60%87%80%75%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 26Q.7 Which of these comes closest to describing how you would speak about the HTA? Would you...
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
71554441317071Speak highly of HTA,20%27%zg8%27%ze13%4%22%zd20%dgwithout being asked
19411821934511178192Speak highly of HTA, if54%57%g40%57%44%31%56%zd53%deasked
8231212437186284Be neutral about HTA, if23%15%40%zh15%37%zf50%zc19%23%cfhasked
81312537Be critical of HTA, if2%*5%h1%2%12%zc1%2%chasked
2-3-3-33Be critical of HTA,1%-5%zh-3%-1%1%without being asked
51122125No opinion1%*2%1%2%2%1%1%c
--------Don't know--------
265172251375813248263Speak highly73%84%zg48%84%ze57%35%78%zd73%deg
1015145510Critical3%*10%zh1%4%12%zc2%3%cfh
25517120136538242253Net70%84%39%83%53%23%77%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 27Q.7 Which of these comes closest to describing how you would speak about the HTA? Would you...
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
17422115421727-19222510509023-2310312188172Strongly agree48%19%45%48%66%50%56%-41%57%k36%71%41%52%42%-48%52%63%zab38%46%48%k
153724131859412514363666519-238152384153Tend to agree42%81%50%41%26%41%33%33%52%35%53%z20%54%zgh38%35%-49%42%30%43%44%42%c
23-1231111221413101111-381125Neither agree nor6%-3%7%4%8%6%67%3%3%6%9%2%6%20%zhi100%3%-5%15%6%7%idisagree
6-151---122-33---1--56Tend to disagree2%-2%1%4%---2%5%p3%-2%2%---6%--2%2%
----------------------Strongly disagree----------------------
3--3-2--1-1-121----223No opinion1%--1%-1%--2%-1%-1%1%1%----3%1%1%
3--2--1---1--21---1-22Don't know1%--1%--6%---1%--1%2%---2%-1%1%
327945285291311114436611311615542-46184644172326Agree90%100%95%90%92%91%89%33%93%92%88%91%95%zg91%g77%-97%b94%93%81%90%90%g
6-151---122-33---1--56Disagree2%-2%1%4%---2%5%p3%-2%2%---6%--2%2%
321944281281311114334591311315242046174644168320Net agree89%100%93%88%89%91%89%33%92%87%86%91%93%89%77%0%97%88%93%81%88%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 28Q.8a In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Accessible -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
174691219143510161018520172Strongly agree48%57%39%64%51%41%42%51%51%52%61%41%42%48%
153412517173181379723153Tend to agree42%43%54%23%47%49%38%44%41%38%31%59%49%42%
23-13121213-2-225Neither agree nor6%-3%13%2%5%15%z5%9%-6%-4%7%disagree
6-1--12-----26Tend to disagree2%-4%--3%3%-----4%2%
--------------Strongly disagree--------------
3-----1--21--3No opinion1%-----1%--9%3%--1%
3----11-----12Don't know1%----3%1%-----1%1%
327102117363166182816281242326Agree90%100%93%87%98%g90%81%95%91%91%92%100%91%90%g
6-1--12-----26Disagree2%-4%--3%3%-----4%2%
321102017363064182816281241320Net agree89%100%89%87%98%87%78%95%91%91%92%100%88%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 29Q.8a In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Accessible -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1741141196305165172Strongly agree48%55%zg21%59%ze29%13%52%zd48%deg
1537930605316134153Tend to agree42%39%58%zh37%52%zf44%42%42%f
2388414101325Neither agree nor6%4%16%zh2%14%zf27%zc4%7%cfhdisagree
62323246Tend to disagree2%1%5%1%3%5%1%2%
--------Strongly disagree--------
32-2-3-3No opinion1%1%-1%-7%zc-1%
31--2212Don't know1%*--2%4%zc*1%c
327193411568321299326Agree90%94%zg79%96%ze82%56%94%zd90%deg
62323246Disagree2%1%5%1%3%5%1%2%
321191381548019295320Net agree89%93%74%94%79%51%93%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 30Q.8a In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Accessible -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1262171121556511614175436316-237181862127Strongly agree35%19%36%35%46%39%k39%33%34%36%24%35%35%37%30%-48%36%37%33%32%35%k
15441714010626222133185669211196202483154Tend to agree43%48%36%44%30%43%44%67%47%34%45%53%46%40%38%100%40%34%40%45%43%42%
4718407131-6811214249-44382848Neither agree nor13%11%18%12%23%9%6%-12%20%17%12%11%14%17%-9%24%5%15%15%13%cdisagree
8-17-3---14-252---1258Tend to disagree2%-2%2%-2%---3%6%z-1%3%3%---2%3%3%2%
4-13----112-22------44Strongly disagree1%-2%1%----2%3%3%-1%1%------2%1%
61-5-31-1----42--12216No opinion2%12%-2%-2%6%-2%----2%4%i--6%4%3%1%2%
171312-61-224-554-1-6-815Don't know5%10%6%4%-4%6%-3%5%5%-5%3%8%-3%-12%zab-4%4%
28063425324119103392748139913237142133842144281Agree77%67%72%79%77%83%k83%100%81%70%69%88%82%77%68%100%88%70%77%78%76%78%k
12-29-3--126-362---12912Disagree3%-4%3%-2%--2%5%9%zp-3%4%3%---2%3%5%3%
26863224324116103382541139612536142133741135270Net agree74%67%68%76%77%81%83%100%80%65%60%88%79%73%65%100%88%70%75%75%71%74%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 31Q.8b In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Accountable -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
12659914131978912318127Strongly agree35%49%41%45%37%39%23%37%27%52%41%27%39%35%g
154457181537913615718154Tend to agree43%38%23%36%49%43%45%45%43%34%48%61%39%42%
47171341536211448Neither agree nor13%13%29%4%9%11%18%18%21%9%3%7%9%13%disagree
8---1-3-112--8Tend to disagree2%---3%-4%-3%5%6%--2%
4-1---1-1---14Strongly disagree1%-4%---1%-3%---2%1%
6----2--1-1126No opinion2%----5%--4%-3%6%4%2%
17-13117-----315Don't know5%-3%14%2%3%8%-----7%4%
28081516312856162216271136281Agree77%87%64%82%86%82%68%82%70%86%89%88%78%78%g
12-1-1-4-212-112Disagree3%-4%-3%-5%-6%5%6%-2%3%
26881416302851162015251135270Net agree74%87%60%82%83%82%63%82%64%81%83%88%76%74%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 32Q.8b In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Accountable -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
12694674242124127Strongly agree35%46%zg11%45%ze24%7%39%zd35%deg
1548624694211141154Tend to agree43%42%47%42%42%29%45%z42%
4716111322123248Neither agree nor13%8%22%h8%22%zf34%zc10%13%cfhdisagree
81315448Tend to disagree2%*7%zh1%5%zf12%zc1%2%cfh
41313224Strongly disagree1%*5%zh1%3%5%c1%1%c
62212-46No opinion2%1%3%*2%-1%2%c
17636451015Don't know5%3%5%3%4%14%zc3%4%c
280179301436613265281Agree77%87%zg58%87%ze65%36%84%zd78%deg
1226286612Disagree3%1%12%zh1%8%zf16%zc2%3%cfh
26817724141587260270Net agree74%87%47%86%57%20%82%74%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 33Q.8b In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Accountable -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1403161281756521811264457220-206202173140Strongly agree39%29%34%40%52%39%39%67%38%28%37%27%37%42%36%-43%30%40%39%38%39%
14942312811596122212595165231216201981149Tend to agree41%49%48%40%34%41%44%33%45%53%36%65%42%38%42%100%44%34%40%36%42%41%
5218444191-7511119247-66672752Neither agree nor14%10%16%14%14%13%11%-15%13%17%9%16%14%13%-13%30%12%12%14%14%disagree
12-110-51--24-453---23712Tend to disagree3%-2%3%-4%6%--5%6%-4%3%6%---4%6%4%3%
1--1------1-1-------11Strongly disagree*--*------1%-1%-------**
41-3-3--1----41--11214No opinion1%12%-1%-2%--2%----2%1%--6%2%3%*1%a
4--4-2----2-221---1224Don't know1%--1%-1%----3%-1%1%2%---2%3%1%1%
28973925627115103393250139613743141124041154289Agree80%78%82%80%86%80%83%100%83%82%73%91%79%80%78%100%87%64%81%75%80%80%
13-111-51--25-553---23813Disagree4%-2%4%-4%6%--5%8%zm-4%3%6%---4%6%4%4%
27673824427110103393045139113240141123837146276Net agree76%78%79%77%86%77%78%100%83%77%65%91%74%77%72%100%87%64%77%69%76%76%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 34Q.8c In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Authoritative -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
140495151824814712519140Strongly agree39%45%38%28%42%51%g30%42%44%38%38%41%41%39%
1494710141242810812417149Tend to agree41%42%31%54%39%34%51%z43%31%44%39%34%37%41%
52143531235263552Neither agree nor14%13%20%14%14%7%15%14%15%9%20%24%11%14%disagree
12-31213-1---312Tend to disagree3%-11%4%5%2%3%-3%---6%3%
1-------1----1Strongly disagree*-------3%----*
4-------121-14No opinion1%-------4%9%3%-2%1%
4----21-----24Don't know1%----5%1%-----4%1%
2898161630306616231523936289Agree80%87%69%82%81%85%81%86%75%82%77%76%78%80%
13-31213-2---313Disagree4%-11%4%5%2%3%-6%---6%4%
2768131528296416211523934276Net agree76%87%58%77%76%83%78%86%69%82%77%76%72%76%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 35Q.8c In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Authoritative -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
140951170333135140Strongly agree39%46%zg22%43%33%9%43%zd39%dg
1497929694414131149Tend to agree41%38%57%zh42%44%40%41%41%
522081617113752Neither agree nor14%10%15%10%17%30%zc12%14%cfhdisagree
1263444812Tend to disagree3%3%5%3%4%12%zc3%3%c
1-1-11-1Strongly disagree*-2%-1%2%zc-*
43-2-224No opinion1%1%-1%-5%c1%1%c
42-31134Don't know1%1%-2%1%2%1%1%
289174411397718266289Agree80%85%z79%85%z77%49%84%zd80%d
1363455813Disagree4%3%7%3%5%14%zc3%4%c
276168371347213258276Net agree76%82%72%82%72%35%81%76%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 36Q.8c In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Authoritative -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
962138684851107136304812-22217134397Strongly agree27%19%27%27%26%34%zk39%33%20%18%19%44%24%28%22%-46%za12%35%a24%22%27%a
1655181461367622718275587625-239202390165Tend to agree46%60%38%46%40%47%44%67%58%zk47%40%35%48%44%46%-48%46%40%42%47%45%
55211476161-471611823121127103355Neither agree nor15%21%22%15%20%11%6%-8%18%23%zmp9%15%14%21%100%3%12%14%19%e17%e15%edisagree
27-42438--466212142-24271429Tend to disagree7%-9%8%11%5%--8%15%9%12%10%8%3%-4%24%4%12%7%8%
4-13-----13-13------44Strongly disagree1%-2%1%-----3%4%zp-1%2%------2%1%
5--5-31-2----31---1225No opinion1%--2%-2%6%-3%----2%3%---2%3%1%1%
10-18121-1-4-333--13-59Don't know3%-2%2%4%1%6%-2%-5%-2%2%5%--6%5%-3%2%
26173123221115103372541118812437-44113736133261Agree72%79%65%73%66%80%zk83%100%78%k65%59%80%72%73%68%-94%zabc58%75%66%70%72%k
31-52738--479213162-24271832Disagree9%-11%9%11%5%--8%17%p13%12%10%10%3%-4%24%4%12%9%9%
2307252051710810333193210751083604363629115229Net agree64%79%54%64%55%75%83%100%70%47%46%68%62%63%65%0%90%34%72%54%60%63%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 37Q.8d In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Consistent -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
96-481011128861341497Strongly agree27%-16%39%29%31%15%40%24%31%44%33%30%27%g
165810718133969814825165Tend to agree46%85%44%38%48%37%48%32%29%45%45%67%53%45%
55-43551441311-555Neither agree nor15%-19%14%12%15%18%23%41%5%3%-10%15%disagree
27-4133101222-229Tend to disagree7%-16%5%7%10%13%4%6%9%6%-4%8%
4-----4------4Strongly disagree1%-----4%z------1%
51--1----21-15No opinion1%8%--2%----9%3%-2%1%
10111132-----19Don't know3%7%5%4%2%7%2%-----2%2%
26181415282451141714271238261Agree72%85%60%76%76%68%63%72%53%77%89%100%83%g72%g
31-4133141222-232Disagree9%-16%5%7%10%17%za4%6%9%6%-4%9%
23081014252037131512251237229Net agree64%85%45%71%69%58%46%68%47%67%83%100%79%63%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 38Q.8d In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Consistent -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
96743571429497Strongly agree27%36%zg6%35%ze14%5%30%zd27%deg
165972277448155165Tend to agree46%47%42%47%44%21%49%zd45%d
5514141224153755Neither agree nor15%7%28%zh7%24%zf40%zc12%15%cfhdisagree
271310101572029Tend to disagree7%6%20%zh6%15%zf18%zc6%8%c
41211314Strongly disagree1%*3%1%1%7%zc*1%c
53-3-225No opinion1%2%-2%-5%c1%1%c
103123279Don't know3%2%2%1%3%5%2%2%
26117125134589249261Agree72%83%zg47%82%ze57%26%79%zd72%deg
311412111692132Disagree9%7%23%zh7%16%zf25%zc7%9%c
2301571312342*228229Net agree64%77%24%75%41%*72%63%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 39Q.8d In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Consistent -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
11331410013535-1312145366012-204191555113Strongly agree31%29%29%31%42%37%k39%-27%31%21%35%29%35%22%-43%22%39%27%29%31%k
1655201461068622816284617230-239222885167Tend to agree46%51%43%46%30%48%44%67%60%zk40%41%27%50%42%54%-48%48%44%53%44%46%
602752514114820523236143743858Neither agree nor17%21%16%16%17%10%6%33%8%21%29%zmp38%19%13%12%100%9%18%14%8%20%z16%pdisagree
8-37-3--222-252----359Tend to disagree2%-6%2%-2%--3%5%3%-1%3%3%----6%3%2%
4-1412---11-14---1-225Strongly disagree1%-2%1%4%1%---3%1%-1%2%---6%-3%1%1%
3--412--1----12--1-214No opinion1%--1%4%1%--2%----1%4%zi--6%-3%*1%
9-26111---4--52---2-68Don't know2%-4%2%3%1%11%---5%p--3%4%i---4%-3%2%
2787342462312210241284299613242-43134143140280Agree77%79%72%77%73%85%zk83%67%87%k72%62%62%79%77%76%-91%za70%82%80%73%77%ak
12-41115--233-392--1-5713Disagree3%-8%3%4%3%--3%8%4%-2%5%3%--6%-9%4%4%
2667302362211710239254099412340043124138132266Net agree73%79%64%74%69%81%83%67%83%64%58%62%77%72%73%0%91%64%82%70%69%74%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 40Q.8e In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Effective -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
113368141119710713311113Strongly agree31%32%28%43%37%31%24%38%33%37%43%28%24%31%
165788151440911814824167Tend to agree46%68%36%43%42%41%49%48%34%43%47%65%52%46%
60-62451538321958Neither agree nor17%-28%9%12%15%19%14%24%15%7%7%19%16%disagree
8-112-3-11--19Tend to disagree2%-4%5%5%-3%-3%4%--2%2%
4-----3-2----5Strongly disagree1%-----4%-5%----1%
3----21---1--4No opinion1%----5%z1%---3%--1%
9-1-231-----28Don't know2%-3%-5%8%z1%-----3%2%
278101517292559162115271135280Agree77%100%64%86%79%72%72%86%68%80%90%93%76%77%
12-112-6-31--113Disagree3%-4%5%5%-7%-8%4%--2%4%
266101416272553161814271135266Net agree73%100%60%81%74%72%65%86%59%76%90%93%74%74%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 41Q.8e In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Effective -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1137986317-111113Strongly agree31%39%zg15%39%ze17%-35%zd31%deg
16510519804315151167Tend to agree46%51%z37%49%43%42%48%46%
6014151328114258Neither agree nor17%7%29%zh8%28%zf29%zc13%16%cfhdisagree
82626549Tend to disagree2%1%12%zh1%6%zf14%zc1%2%ch
41212235Strongly disagree1%*3%1%2%5%zc1%1%c
312121-4No opinion1%1%3%1%2%3%c-1%
93133258Don't know2%2%2%2%3%6%2%2%
278184271436015263280Agree77%90%zg51%88%ze59%42%83%zd77%deg
1238387613Disagree3%1%15%zh2%8%zf20%zc2%4%cfh
26618119141528256266Net agree73%88%37%86%52%22%81%74%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 42Q.8e In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Effective -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
10731295135441129119295812-236221144107Strongly agree30%29%25%30%40%38%zk33%33%25%22%17%62%23%34%21%-48%zab34%44%zab21%23%29%ak
16052114512736125152355773291238223278164Tend to agree44%51%45%45%38%51%k50%33%54%k39%33%38%47%42%53%100%49%42%44%59%41%45%ak
581852514-171019-252410-14393958Neither agree nor16%10%16%16%17%10%-33%14%26%p27%zp-20%14%18%-3%24%7%17%21%zce16%cepdisagree
121291---144-551---1-1011Tend to disagree3%11%4%3%3%---2%10%zp6%p-4%3%2%---2%-5%z3%
7-16-2--114-34-----257Strongly disagree2%-2%2%-1%--2%3%5%z-2%3%-----3%3%2%
5--4-11-1-1-211---1-34No opinion1%--1%-1%11%-2%-1%-2%1%1%---2%-2%1%
13-381-1-1-7-362---1-1011Don't know4%-7%3%3%-6%-2%-10%zlp-2%4%4%---2%-5%z3%
26773324025127102372434148513041146144343123271Agree74%79%70%75%77%89%zkl83%67%79%k61%50%100%70%76%75%100%97%zab76%88%za80%64%75%akl
19131512--258-7101---121618Disagree5%11%6%5%3%1%--3%13%zp12%zp-6%6%2%---2%3%8%z5%p
24863022423126102361926147812040146144341107253Net agree69%68%64%70%74%87%83%67%76%48%38%100%64%70%73%100%97%76%86%77%56%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 43Q.8f In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Efficient -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
10726912101669814313107Strongly agree30%18%26%46%33%28%20%33%27%42%47%27%27%29%g
1605891814461113612814164Tend to agree44%50%36%45%50%41%56%za58%41%33%41%67%30%45%a
5826156102633-1458Neither agree nor16%25%28%4%12%18%12%9%20%15%10%-30%zg16%disagree
121-1-15--2--211Tend to disagree3%8%-5%-3%6%--10%--4%3%
7-2---1-3---17Strongly disagree2%-8%---1%-11%---2%2%
5-----2---1114No opinion1%-----2%---3%6%2%1%
13-1-243-----311Don't know4%-3%-5%11%z3%-----5%3%
26771418302462172114261127271Agree74%67%61%90%83%a69%76%a91%69%75%87%94%57%75%a
19121-16-32--318Disagree5%8%8%5%-3%7%-11%10%--5%5%
24861217302356171812261124253Net agree69%59%54%85%83%66%69%91%58%64%87%94%52%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 44Q.8f In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Efficient -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
10777659182102107Strongly agree30%37%zg12%36%ze17%4%32%zd29%deg
1609920784514149164Tend to agree44%48%39%48%45%38%47%45%
5818131423134058Neither agree nor16%9%25%h8%22%f36%zc13%16%cfhdisagree
1255562911Tend to disagree3%3%9%zh3%6%5%3%3%
71616347Strongly disagree2%*12%zh1%6%zf7%zc1%2%ch
51-1-124No opinion1%*-*-2%1%1%
1342542911Don't know4%2%3%3%4%7%3%3%
267176271376316251271Agree74%86%zg51%84%ze62%43%79%zd75%deg
1961161241418Disagree5%3%21%zh4%12%zf12%4%5%
248170161315111238253Net agree69%83%31%80%51%30%75%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 45Q.8f In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Efficient -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
893108411492-71010630479-16516163893Strongly agree25%29%22%27%36%34%zkm17%-15%26%14%44%25%28%16%-35%a28%33%a30%20%26%akm
1633271361159522221345547426-223221895160Tend to agree45%30%58%zr43%36%41%39%67%47%54%50%38%45%43%48%-46%18%44%34%50%z44%
7226707283-1451632731161873183875Neither agree nor20%19%13%22%21%19%22%-29%l12%23%18%22%18%28%100%16%36%7%34%c20%c21%cdisagree
15-21221-1125-491--2111014Tend to disagree4%-4%4%7%1%-33%2%5%8%p-4%5%2%--12%2%2%5%4%p
7-25----213-34----1-56Strongly disagree2%-4%2%----3%p3%4%p-2%2%----2%-3%2%
102-7-51-1-1-351-113-39No opinion3%22%-2%-3%11%-2%-1%-2%3%3%-3%6%7%za-2%2%
6--4-21-1---122---3-25Don't know2%--1%-1%11%-2%---1%1%3%---5%za-1%1%
2525372202310972293144128512135-3893835133253Agree70%59%79%69%72%76%56%67%62%80%64%82%70%71%64%-81%46%77%64%69%70%
22-41721-1238-7121--2211520Disagree6%-8%5%7%1%-33%5%p8%p12%zp-6%7%2%--12%4%2%8%z6%p
230534203211087127283612781093403863634118233Net agree64%59%71%64%65%75%56%33%57%72%53%82%64%64%62%0%81%34%74%62%62%64%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 46Q.8g In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Engaging -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
8936969165961121093Strongly agree25%28%28%46%17%27%20%28%27%32%38%14%21%26%
16331142611321015811920160Tend to agree45%33%49%23%70%zagh33%39%53%49%44%35%72%43%44%
722454824442721275Neither agree nor20%25%16%26%11%22%29%i19%12%9%24%13%25%21%disagree
151---46-12--114Tend to disagree4%8%---10%7%-3%10%--2%4%
7--1--1-21--26Strongly disagree2%--5%--1%-6%4%--4%2%
10-1-122-1-1-29No opinion3%-4%-2%6%2%-4%-3%-4%2%
611--12-----15Don't know2%7%3%--2%2%-----2%1%
25261813322148152414221030253Agree70%60%77%69%87%zagh59%59%81%76%76%73%87%64%70%g
221-1-47-33--320Disagree6%8%-5%-10%8%-8%15%--5%6%
23051812321741152111221027233Net agree64%52%77%64%87%49%51%81%68%61%73%87%59%64%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 47Q.8g In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Engaging -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
89666481718993Strongly agree25%32%zg11%30%e17%3%28%zd26%deg
16310014804413147160Tend to agree45%49%g27%49%43%34%46%z44%g
7226212528145775Neither agree nor20%13%41%zh15%28%f40%zc18%21%cfhdisagree
15646531114Tend to disagree4%3%9%4%5%8%4%4%
71515426Strongly disagree2%*10%zh1%5%zf12%zc1%2%ch
104-11179No opinion3%2%-1%1%2%2%2%
62121135Don't know2%1%2%1%1%2%1%1%
252166201286114236253Agree70%81%zg38%78%ze60%37%75%zd70%deg
2271071171320Disagree6%3%19%zh4%10%z19%zc4%6%ch
23015910121506223233Net agree64%78%20%74%50%18%71%64%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 48Q.8g In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Engaging -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
73210657374-6107622359-1431683273Strongly agree20%19%20%20%23%26%km33%-12%26%k10%44%18%21%16%-29%17%32%za15%17%20%ak
12611711111473-2314224436415-187122070126Tend to agree35%10%36%35%33%33%28%-50%zkp36%32%27%36%38%27%-38%36%25%37%36%35%
984108893733134244334021113612125498Neither agree nor27%49%22%28%28%26%22%100%27%l10%35%l29%27%23%38%h100%28%30%25%22%28%27%ldisagree
33-728412--377-14173-11491834Tend to disagree9%-15%9%13%9%--7%17%10%-12%10%5%-3%6%9%17%10%9%
9-27----144-261-----88Strongly disagree2%-4%2%----2%10%zp5%p-1%3%2%-----4%z2%
101-9-51-1-2-344-1113411No opinion3%12%-3%-4%11%-2%-3%-2%2%7%-3%6%2%6%2%3%
131210151-1-4-453--142512Don't know4%10%4%3%4%4%6%-2%-5%-4%3%5%--6%9%zae3%3%3%
19932617618848-292429106610024-32102828102199Agree55%29%56%55%56%58%k61%-61%k62%k42%71%54%58%43%-67%52%56%52%53%55%k
42-936412--41111-16234-11492743Disagree12%-19%11%13%9%--8%28%zmp15%-13%14%7%-3%6%9%17%14%12%
157317140147280251319105076200309231975156Net agree43%29%37%44%43%50%61%0%53%35%27%71%41%45%37%0%64%46%47%34%39%43%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 49Q.8h In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Flexible -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
73146651359691973Strongly agree20%7%16%31%16%15%16%24%27%30%31%7%19%20%
126611716122375515615126Tend to agree35%58%48%38%43%35%28%39%15%26%49%51%31%35%
98234139276124441298Neither agree nor27%17%11%22%34%25%33%33%37%20%12%36%25%27%disagree
3311-14121432-634Tend to disagree9%8%4%-3%11%14%4%14%15%6%-14%9%
9-31--3-1---18Strongly disagree2%-12%5%--4%-3%---2%2%
101--131-1211111No opinion3%9%--2%8%1%-4%9%3%6%2%3%
13-21123-----312Don't know4%-9%4%2%5%4%-----7%3%
1996151321183612131024724199Agree55%66%64%69%59%50%44%63%42%56%79%58%51%55%g
4214114141532-743Disagree12%8%17%5%3%11%18%i4%17%15%6%-16%12%
15761112201421118822716156Net agree43%57%47%63%56%40%26%59%25%41%74%58%35%43%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 50Q.8h In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Flexible -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
73582458-7273Strongly agree20%28%zg4%28%ze8%-23%zd20%deg
126831167284119126Tend to agree35%40%zg21%41%ze28%11%38%zd35%dg
9845163833187898Neither agree nor27%22%30%23%33%48%zc25%27%chdisagree
3381371862734Tend to disagree9%4%25%zh4%18%zf17%9%9%fh
91716458Strongly disagree2%*14%zh1%6%zf10%zc2%2%cfh
1033233611No opinion3%2%5%1%3%7%2%3%c
13613521012Don't know4%3%2%2%5%7%3%3%
19914113113364191199Agree55%69%zg25%69%ze36%11%60%zd55%deg
42920824103243Disagree12%4%39%zh5%24%zf27%zc10%12%cfh
157132-710512-6159156Net agree43%64%-14%64%12%-15%50%43%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 51Q.8h In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Flexible -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1293181131552611415195367115-185221667128Strongly agree36%38%37%35%49%36%44%33%29%39%27%35%30%41%zi28%-38%28%44%30%35%35%
15041913210615-25173085563251246172379150Tend to agree41%40%40%41%30%43%39%-53%43%44%53%45%37%45%100%51%30%35%42%42%42%
5927556241265122232512-476133162Neither agree nor16%22%15%17%17%17%6%67%13%13%18%12%19%15%22%-9%36%12%25%16%17%disagree
8-35----124-35----1-67Tend to disagree2%-6%2%----2%5%p5%zp-2%3%----2%-3%z2%
1--1------1-1-------11Strongly disagree*--*------1%-1%-------**
8--8151-1-1-351-112228No opinion2%--3%4%3%6%-2%-1%-2%3%1%-3%6%4%3%1%2%
7-14-11-1-3-132---2-46Don't know2%-2%1%-1%6%-2%-4%-1%2%4%---4%-2%2%
27973624525114101393248139113440142113939146278Agree77%78%77%77%79%79%83%33%81%82%71%88%75%79%72%100%88%58%79%72%76%77%
9-36----124-45----1-78Disagree2%-6%2%----2%5%p6%zp-3%3%----2%-4%z2%
27073423825114101383044138813040142113839139270Net agree75%78%71%75%79%79%83%33%80%77%64%88%72%76%72%100%88%58%77%72%73%75%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 52Q.8i In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Focused -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
12937918142448713616128Strongly agree36%28%30%44%48%42%29%21%25%40%43%48%34%35%
1507841313351314615319150Tend to agree41%72%35%21%36%38%42%69%46%32%49%24%41%42%
59-55531928323762Neither agree nor16%-23%26%13%9%23%9%26%14%6%28%16%17%disagree
8-21--1--1--37Tend to disagree2%-8%5%--1%--4%--6%2%
1-----1------1Strongly disagree*-----1%------*
8----22-121-18No opinion2%----6%2%-3%9%3%-2%2%
7-11121-----16Don't know2%-3%4%2%5%1%-----2%2%
27910151331285917221327935278Agree77%100%65%65%84%80%72%91%71%72%91%72%75%77%
9-21--2--1--38Disagree2%-8%5%--2%--4%--6%2%
27010131231285717221227932270Net agree75%100%57%59%84%80%70%91%71%68%91%72%69%75%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 53Q.8i In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Focused -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
12990772193122128Strongly agree36%44%zg13%44%ze19%9%39%zd35%deg
1508025624812137150Tend to agree41%39%48%38%48%34%43%42%
5927132125114562Neither agree nor16%13%24%13%25%zf30%zc14%17%chdisagree
81514357Tend to disagree2%*10%zh1%4%f7%zc1%2%cfh
1----1-1Strongly disagree*----2%zc-*
84132448No opinion2%2%2%2%2%10%zc1%2%c
73132236Don't know2%2%2%2%2%7%zc1%2%c
279170321346816260278Agree77%83%zg62%82%ze67%43%82%zd77%deg
91514458Disagree2%*10%zh1%4%f10%zc1%2%cfh
270169271336312255270Net agree75%82%52%82%63%33%81%75%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 54Q.8i In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Focused -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1402171231656811812246446919-207212071138Strongly agree39%19%36%39%49%39%61%33%37%30%35%44%36%41%34%-43%36%42%36%37%38%
17562414810665127213585982231245222199173Tend to agree48%71%51%46%33%46%39%33%58%54%51%56%49%48%42%100%52%28%44%39%52%48%
361538617-1257-161410-374101640Neither agree nor10%10%11%12%18%12%-33%3%13%10%-13%8%18%-5%36%9%19%8%11%amdisagree
3--3-3----1--22---1213Tend to disagree1%--1%-2%----1%--1%3%---2%3%*1%
3-12-----11-21------33Strongly disagree1%-2%1%-----3%1%-1%1%------1%1%
4--4-3--1-1-131---1224No opinion1%--1%-2%--2%-1%-1%1%1%---2%3%1%1%
1--1----------1---1--1Don't know*--*----------2%---2%--*
315841271261221224533591410315242145124341170311Agree87%90%87%85%82%85%100%67%95%z84%86%100%85%89%g76%100%95%b64%86%75%89%zb86%
6-15-3---12-232---1246Disagree2%-2%2%-2%---3%3%-1%2%3%---2%3%2%2%
309840266261191224532571410214940145124239166305Net agree85%90%85%83%82%83%100%67%95%82%83%100%83%87%73%100%95%64%84%72%87%84%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 55Q.8j In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Informative -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
1406891617266111012512138Strongly agree39%57%37%45%43%49%a32%32%36%56%40%40%26%38%
17541091913411214614527173Tend to agree48%43%44%46%51%36%50%63%44%34%45%38%59%48%
36-42241015-33640Neither agree nor10%-19%10%6%12%12%5%15%-9%21%14%11%disagree
3----12---1--3Tend to disagree1%----3%2%---3%--1%
3-----1-2----3Strongly disagree1%-----1%-5%----1%
4-----1--21-14No opinion1%-----1%--9%3%-2%1%
1-----1------1Don't know*-----1%------*
31510191834306718251626939311Agree87%100%81%90%94%85%82%95%80%91%86%79%85%86%
6----13-2-1--6Disagree2%----3%3%-5%-3%--2%
30910191834296418231625939305Net agree85%100%81%90%94%83%79%95%74%91%83%79%85%84%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 56Q.8j In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Informative -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
14097878242136138Strongly agree39%48%zg16%48%ze23%5%43%zd38%deg
1759025695317152173Tend to agree48%44%49%42%53%46%48%48%
3615151420102640Neither agree nor10%7%29%zh8%20%zf28%zc8%11%chdisagree
3-2-33-3Tend to disagree1%-3%h-3%9%zc-1%
31212213Strongly disagree1%*3%1%2%5%zc*1%c
42-2-314No opinion1%1%-1%-7%zc*1%c
1-----11Don't know*-----**
315188341477719288311Agree87%92%zg65%90%ze76%51%91%zd86%deg
61314516Disagree2%*6%zh1%4%14%zc*2%ch
309187301467314287305Net agree85%91%58%89%72%37%91%84%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 57Q.8j In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Informative -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
94278513375114611435449-1561784591Strongly agree26%19%14%27%40%26%39%33%29%16%17%27%29%25%16%-32%30%35%b15%23%25%k
136423118757212115306516020-193172374137Tend to agree38%48%48%37%23%40%17%33%44%39%44%44%42%35%36%-40%18%35%43%39%38%
9531385942311010194274722113891950100Neither agree nor26%33%27%27%28%29%22%33%20%25%28%29%22%28%39%i100%28%40%18%36%26%28%disagree
11-210-3--234-551---12811Tend to disagree3%-4%3%-2%--3%8%5%-4%3%2%---2%3%4%3%
1-1------1---1------11Strongly disagree*-2%zr------3%z---1%------1%*
16-114242-123-2111--232815No opinion4%-2%4%7%3%17%-2%5%4%-2%6%3%--12%7%3%4%4%
9-17111-122-242---2-68Don't know2%-2%2%3%1%6%-2%5%3%-1%2%4%---4%-3%2%
230630203209472352141108610328-3493531119228Agree64%67%62%64%62%66%56%67%73%54%60%71%70%zg61%52%-72%48%70%58%62%63%
12-310-3--244-561---12912Disagree3%-6%3%-2%--3%10%zp5%-4%3%2%---2%3%5%3%
2186261932092723317381081982703493430109216Net agree60%67%56%61%62%64%56%67%70%44%55%71%66%57%50%0%72%48%68%55%57%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 58Q.8k In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Modern -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
942697916487841191Strongly agree26%26%27%48%19%26%19%22%26%37%27%33%23%25%
13655719103599412615137Tend to agree38%52%22%38%53%zh28%43%49%29%24%41%46%32%38%
9519210132461049311100Neither agree nor26%13%40%10%26%37%29%29%32%20%29%21%24%28%disagree
11-21--2-----611Tend to disagree3%-9%5%--2%-----13%zghi3%
1-----1------1Strongly disagree*-----1%------*
16---124-231-315No opinion4%---2%5%5%-6%15%3%-7%4%
911--21-21--18Don't know2%9%3%--5%1%-6%5%--2%2%
2308111726195013171120925228Agree64%78%48%85%72%53%62%71%56%61%68%79%54%63%
12-21--3-----612Disagree3%-9%5%--3%-----13%zhi3%
218891626194813171120919216Net agree60%78%40%80%72%53%58%71%56%61%68%79%42%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 59Q.8k In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Modern -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
947145611-8991Strongly agree26%35%zg8%34%ze11%-28%zd25%deg
136821264367129137Tend to agree38%40%g23%39%36%20%41%zd38%dg
95382732411974100Neither agree nor26%18%52%zh19%41%zf53%zc23%28%cfhdisagree
1136352911Tend to disagree3%1%12%zh2%5%5%3%3%h
11-1--11Strongly disagree**-1%--**
1672557715No opinion4%3%3%3%5%20%zc2%4%c
94133178Don't know2%2%2%2%3%2%2%2%
23015316119477218228Agree64%75%zg31%73%ze47%20%69%zd63%deg
12464521012Disagree3%2%12%zh2%5%5%3%3%
21814910116436209216Net agree60%73%19%71%42%15%66%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 60Q.8k In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Modern -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1934231752184822322269659525-258313199194Strongly agree53%48%49%55%65%59%k61%67%49%57%k37%62%53%56%46%-54%40%63%58%52%54%k
144519123105251211336551642312210151976143Tend to agree40%52%40%39%32%36%39%33%44%33%53%zlp38%42%37%42%100%46%54%30%36%40%40%
18-31615--226-665--1221318Neither agree nor5%-6%5%4%4%--5%5%9%-5%4%9%--6%4%3%7%z5%disagree
2-2------2---2------22Tend to disagree1%-4%zr------5%zp---1%------1%1%
----------------------Strongly disagree----------------------
3--3-3--1----31---1213No opinion1%--1%-2%--2%----1%1%---2%3%*1%
2--2------1--11---1-12Don't know1%--1%------1%--1%2%---2%-**
337943298311361234435621411615948147184651174337Agree93%100%90%93%96%95%100%100%93%90%90%100%95%93%88%100%100%94%93%94%91%93%
2-2------2---2------22Disagree1%-4%zr------5%zp---1%------1%1%
335940298311361234433621411615748147184651172335Net agree93%100%86%93%96%95%100%100%93%84%90%100%95%92%88%100%100%94%93%94%90%93%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 61Q.8l In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Professional -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
1935121523163411161120625194Strongly agree53%54%52%77%62%g47%42%57%50%62%67%48%54%54%g
14448312174181539519143Tend to agree40%46%36%13%33%48%51%z43%47%14%30%38%41%40%
18-22214-13-2218Neither agree nor5%-8%10%5%2%5%-3%14%-14%4%5%disagree
2-1---1------2Tend to disagree1%-4%---1%------1%
--------------Strongly disagree--------------
3--------21-13No opinion1%--------9%3%-2%1%
2----11------2Don't know1%----3%1%------*
337102018353375193014291044337Agree93%100%87%90%95%95%92%100%97%77%97%86%95%93%
2-1---1------2Disagree1%-4%---1%------1%
335101918353374193014291044335Net agree93%100%83%90%95%95%91%100%97%77%97%86%95%93%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 62Q.8l In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Professional -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
19313217104455186194Strongly agree53%64%zg33%64%ze45%14%59%zd54%dg
1446925554521118143Tend to agree40%34%49%34%44%57%zc37%40%cfh
18191107918Neither agree nor5%*18%zh1%10%zf19%zc3%5%cfhdisagree
21-1-112Tend to disagree1%*-1%-3%*1%
--------Strongly disagree--------
32-2-213No opinion1%1%-1%-5%zc*1%c
2---1112Don't know1%---1%2%**
337201431609026305337Agree93%98%zg82%98%ze89%71%96%zd93%dg
21-1-112Disagree1%*-1%-3%*1%
335200431599025304335Net agree93%98%82%97%89%69%96%93%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 63Q.8l In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Professional -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
9229801333611310123354013-10312125290Strongly agree25%19%19%25%42%23%44%33%27%26%18%18%29%23%23%-21%18%25%22%27%25%
140516128960422312258516320-246162174141Tend to agree39%59%34%40%30%42%33%67%50%31%36%56%42%37%36%-52%30%33%39%38%39%
79-14718341-6919427391311188163983Neither agree nor22%-30%22%25%24%11%-13%22%28%m27%22%23%24%100%24%40%16%30%20%23%disagree
11--11-3--1-6-56----13711Tend to disagree3%--4%-2%--2%-9%zp-4%3%----2%6%4%3%
7-26-----43-151-----77Strongly disagree2%-4%2%-----10%zmp4%p-1%3%2%-----3%z2%
121-10131-221-281--23-511No opinion3%12%-3%4%2%6%-3%5%1%-1%5%3%--12%7%-3%3%
211613-111-223-2117-1-92819Don't know6%10%13%zr4%-7%6%-5%5%4%-1%6%i13%zi-3%-18%zabe3%4%5%ir
2327252082393103362237118610332-3592933126231Agree64%78%53%65%72%65%78%100%76%zkl57%54%73%70%60%59%-73%48%58%61%66%64%k
18-217-3--149-6111---131418Disagree5%-4%5%-2%--2%10%p13%zmp-5%6%2%---2%6%7%z5%
21472319123891033518281180923103592830112213Net agree59%78%49%60%72%62%78%100%75%47%41%73%65%54%57%0%73%48%56%55%59%59%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 64Q.8m In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Proportionate -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
92366111013576841190Strongly agree25%29%24%30%31%29%16%27%24%30%28%35%23%25%g
14059914834810616418141Tend to agree39%55%40%48%39%23%42%43%31%31%54%30%38%39%h
7914381122510344883Neither agree nor22%9%18%13%21%31%26%25%33%19%13%35%18%23%disagree
11----13-211-411Tend to disagree3%----3%3%-5%5%3%-9%z3%
7-21-12-1----7Strongly disagree2%-8%5%-3%2%-3%----2%
12---1221111-311No opinion3%---2%5%3%5%4%6%3%-5%3%
21121336--2--319Don't know6%7%9%4%7%7%8%--9%--6%5%
2328151526184713171124829231Agree64%84%64%77%70%51%58%70%55%61%81%65%62%64%
18-21-25-311-418Disagree5%-8%5%-5%6%-8%5%3%-9%5%
2148131426164313151024824213Net agree59%84%56%72%70%46%52%70%47%56%79%65%52%59%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 65Q.8m In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Proportionate -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
92743581318890Strongly agree25%36%zg5%35%ze13%4%28%zd25%deg
1408316644311127141Tend to agree39%40%32%39%42%31%40%39%
7930192630156383Neither agree nor22%15%36%zh16%30%f40%zc20%23%cfhdisagree
1126263811Tend to disagree3%1%11%zh1%6%f9%zc2%3%fh
72524257Strongly disagree2%1%9%zh1%4%5%2%2%
1251321911No opinion3%2%2%2%2%3%3%3%
2110310331619Don't know6%5%5%6%3%8%5%5%
232157191215613215231Agree64%77%zg37%74%ze56%35%68%zd64%dg
1841141051318Disagree5%2%20%zh2%10%zf14%zc4%5%cfh
2141539118468202213Net agree59%75%16%72%46%21%64%59%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 66Q.8m In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Proportionate -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1323151181757611412178426813-236231167130Strongly agree36%29%31%37%55%40%k50%33%30%31%24%53%34%40%g23%-48%b30%47%b21%35%36%k
169628145127352232031758743412310223384173Tend to agree47%71%59%46%38%51%39%67%49%51%45%47%48%43%61%h100%49%52%44%61%44%48%r
47-2452111-8614-18236-13383046Neither agree nor13%-4%14%zs7%8%6%-18%16%21%zp-15%13%11%-3%18%7%15%16%e13%epsdisagree
3-12-----12-21------33Tend to disagree1%-2%1%-----3%3%-1%1%------1%1%
----------------------Strongly disagree----------------------
5--5-2--1-3-131----235No opinion1%--2%-1%--2%-4%-1%2%1%----3%2%1%
6-23--1-1-3-222---1-45Don't know2%-4%1%--6%-2%-4%p-1%1%3%---2%-2%1%
301943263301311133732481410014246146154544151303Agree83%100%91%83%93%91%zkm89%100%79%82%69%100%82%83%85%100%97%zab82%91%a81%79%84%ak
3-12-----12-21------33Disagree1%-2%1%-----3%3%-1%1%------1%1%
29894226130131113373146149814146146154544148300Net agree82%100%88%82%93%91%89%100%79%79%67%100%80%83%85%100%97%82%91%81%78%83%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 67Q.8n In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Reliable -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
132477141524711813615130Strongly agree36%36%29%35%38%44%29%37%36%43%43%48%32%36%
1695149181442913613623173Tend to agree47%51%60%46%49%40%51%49%41%34%44%52%50%48%
4711444133733-546Neither agree nor13%13%3%18%10%11%16%14%23%14%10%-11%13%disagree
3-1---1-----13Tend to disagree1%-4%---1%-----2%1%
--------------Strongly disagree--------------
5-1--11--21--5No opinion1%-4%--3%1%--9%3%--1%
6---111-----25Don't know2%---2%3%1%-----5%z1%
30182016322966162414261238303Agree83%87%89%82%88%84%81%86%77%77%88%100%82%84%
3-1---1-----13Disagree1%-4%---1%-----2%1%
29881916322965162414261237300Net agree82%87%85%82%88%84%80%86%77%77%88%100%80%83%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 68Q.8n In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Reliable -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
13292675212125130Strongly agree36%45%zg11%46%ze21%5%39%zd36%deg
1699629735319152173Tend to agree47%47%55%45%52%51%48%48%
4711151022123246Neither agree nor13%6%29%zh6%22%zf33%zc10%13%cfhdisagree
32121-33Tend to disagree1%1%2%1%1%-1%1%
--------Strongly disagree--------
52122315No opinion1%1%2%1%2%9%zc*1%c
61122145Don't know2%1%2%1%2%2%1%1%
301188341487420276303Agree83%92%zg66%91%ze73%56%87%zd84%deg
32121-33Disagree1%1%2%1%1%-1%1%
298187341467320274300Net agree82%91%65%89%72%56%86%83%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 69Q.8n In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Reliable -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1393151221856611714186387319-197261570136Strongly agree38%38%32%38%55%39%50%33%35%36%26%44%31%42%34%-40%36%53%zab27%36%38%k
1695251489696223173676581171249212689170Tend to agree47%51%53%46%28%48%50%67%50%43%53%47%53%g47%g31%100%52%46%42%48%46%47%g
431541418--67101131517-422132546Neither agree nor12%11%11%13%13%13%--12%18%14%9%11%9%30%zhi-8%12%4%25%zc13%c13%chdisagree
4-13-----13-31------44Tend to disagree1%-2%1%-----3%4%zp-2%1%------2%1%
2--2------2-2-------22Strongly disagree1%--1%------3%z-1%-------1%*
2--2----1-1--11-----22No opinion1%--1%----2%-1%--1%1%-----1%*
3-121---1---1-2--11-13Don't know1%-2%1%4%---2%---1%-3%h--6%2%-*1%
308840270271261234031541310315436143154741158306Agree85%89%85%85%83%87%100%100%85%79%78%91%85%g90%zg65%100%92%82%95%zab75%83%85%g
6-14-----14-41------55Disagree2%-2%1%-----3%6%zp-4%z1%------3%z1%
30283926527126123403049139915336143154741153301Net agree83%89%83%83%83%87%100%100%85%77%72%91%81%89%65%100%92%82%95%75%80%83%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 70Q.8o In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Responsive -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
1394513141429714610417136Strongly agree38%37%21%65%38%39%35%36%46%32%35%35%37%38%
169414319193711101016820170Tend to agree47%41%63%17%53%53%45%55%32%53%53%65%42%47%
4323432131633-846Neither agree nor12%22%12%18%7%5%16%4%19%15%10%-17%13%disagree
4-----11----24Tend to disagree1%-----1%5%----4%1%
2-----1-1----2Strongly disagree1%-----1%-3%----*
2----1----1--2No opinion1%----3%----3%--*
3-1-1-1------3Don't know1%-5%-2%-1%------1%
30881916333266172415261237306Agree85%78%83%82%90%93%81%91%78%85%88%100%79%85%
6-----211---25Disagree2%-----2%5%3%---4%1%
30281916333264162315261235301Net agree83%78%83%82%90%93%78%87%75%85%88%100%75%83%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 71Q.8o In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Responsive -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
139931076263128136Strongly agree38%46%zg18%46%ze26%9%41%zd38%deg
1699124724518150170Tend to agree47%44%45%44%45%49%47%47%
4318161426133246Neither agree nor12%9%31%zh8%25%zf35%zc10%13%cfhdisagree
42222-44Tend to disagree1%1%3%1%2%-1%1%
2-1-12-2Strongly disagree1%-2%-1%5%zc-*
2---11-2No opinion1%---1%2%c-*
31----33Don't know1%1%----1%1%
308184331487221278306Agree85%90%zg64%90%ze71%58%88%zd85%deg
62323245Disagree2%1%5%1%3%5%1%1%
302182301466919275301Net agree83%89%59%89%68%53%87%83%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 72Q.8o In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Responsive -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
15741913414601011818238497420-245291280150Strongly agree43%48%40%42%46%42%78%33%39%46%33%53%40%43%36%-51%b28%58%zab23%42%b42%b
137417126962322113264566319-198142873143Tend to agree38%41%35%39%30%43%22%67%44%34%37%29%46%37%35%-41%42%28%53%c38%39%
471840516--55153132310142582747Neither agree nor13%11%16%12%14%11%--10%13%22%zp18%10%13%18%100%8%12%11%15%14%13%disagree
8-1922---23--72--2-259Tend to disagree2%-2%3%7%1%---5%4%--4%i3%--12%-3%2%2%
4-13----112-31------44Strongly disagree1%-2%1%----2%3%3%-2%1%------2%1%
5--6-4--1-1--32---1326No opinion1%--2%-3%--2%-1%--2%4%i---2%6%a1%2%
4-221---2---2-2--11-24Don't know1%-3%1%4%---3%p---2%-3%h--6%2%-1%1%
294836260241221233931481210513739-43134341153293Agree81%89%76%82%75%85%k100%100%83%79%71%82%86%g80%71%-92%70%86%75%80%81%k
12-21122--134-382--2-2812Disagree3%-4%3%7%1%--2%8%p6%p-2%5%3%--12%-3%4%3%
282834249221201233928441210212938043114339145281Net agree78%89%72%78%68%84%100%100%81%72%64%82%84%76%68%0%92%58%86%72%76%78%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 73Q.8p In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Supportive -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
15738121515289121117416150Strongly agree43%26%37%59%41%44%34%47%39%58%58%33%35%42%
137710616133481338716143Tend to agree38%74%42%31%44%38%42%44%41%18%27%59%35%39%
47-415312253411047Neither agree nor13%-16%4%12%8%15%9%17%14%13%7%21%13%disagree
8--1-15-1---19Tend to disagree2%--5%-3%6%z-3%---2%2%
4-----2-----24Strongly disagree1%-----2%-----4%1%
5----3---21-16No opinion1%----7%zg---9%3%-2%2%
4-1-1-1-----14Don't know1%-5%-2%-1%-----2%1%
294101818312862172514251133293Agree81%100%79%90%85%82%76%91%80%77%85%93%70%81%
12--1-17-1---312Disagree3%--5%-3%8%z-3%---5%3%
282101817312756172414251130281Net agree78%100%79%85%85%79%68%91%77%77%85%93%65%78%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 74Q.8p In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Supportive -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1571051084274143150Strongly agree43%51%zg20%51%ze27%12%45%zd42%deg
1378420654612129143Tend to agree38%41%39%40%46%32%41%39%
479131019123447Neither agree nor13%5%26%zh6%19%f32%zc11%13%cfhdisagree
82525549Tend to disagree2%1%9%zh1%5%13%zc1%2%ch
41212224Strongly disagree1%*3%1%2%5%c1%1%c
52223316No opinion1%1%3%1%3%7%zc*2%c
42-1--44Don't know1%1%-*--1%1%
294189311487316273293Agree81%92%zg59%91%ze73%43%86%zd81%deg
1236366612Disagree3%1%12%zh2%6%18%zc2%3%ch
28218624145679267281Net agree78%91%47%89%67%26%84%78%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 75Q.8p In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Supportive -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
11131596154541148185345613-164171358109Strongly agree31%38%31%30%49%31%33%33%30%21%26%35%28%33%24%-35%24%35%24%30%30%
15142013411574223213085664251198162681152Tend to agree42%40%43%42%34%39%33%67%50%53%44%56%46%37%45%100%41%40%33%48%42%42%
5815583292-6611-232910-937123061Neither agree nor16%10%11%18%10%20%17%-12%16%15%-19%17%18%-19%18%14%22%16%17%disagree
10-36----126-54------99Tend to disagree3%-6%2%----2%5%p9%zp-4%3%------5%z2%
----------------------Strongly disagree----------------------
161113161-2-2-3111-1242615No opinion4%12%2%4%4%4%6%-5%-3%-2%6%3%-3%12%9%3%3%4%
16-412161-1231175-1142715Don't know4%-8%4%4%4%11%-2%5%4%9%1%4%10%i-3%6%9%3%4%4%i
2627352302610283382948139012038136123439139261Agree72%78%74%72%83%71%67%100%80%74%69%91%74%70%69%100%76%64%68%72%73%72%
10-36----126-54------99Disagree3%-6%2%----2%5%p9%zp-4%3%------5%z2%
2527322232610283372741138611638136123439130252Net agree70%78%68%70%83%71%67%100%78%69%60%91%70%68%69%100%76%64%68%72%68%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 76Q.8q In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Targeted in its actions -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
11145712112078712215109Strongly agree31%39%21%35%34%31%25%37%25%37%41%13%33%30%
151510916940813714614152Tend to agree42%52%46%46%43%26%49%ah44%43%40%47%52%30%42%h
58-634914451231161Neither agree nor16%-26%14%12%25%17%19%17%5%6%28%24%17%disagree
10-2-1-2-22--19Tend to disagree3%-8%-3%-2%-6%9%--2%2%
--------------Strongly disagree--------------
161--142-1211315No opinion4%8%--4%11%z2%-4%9%3%7%5%4%
16--1234-2-1-315Don't know4%--4%5%7%5%-7%-4%-6%4%
2629151628206015211426829261Agree72%92%66%82%77%57%73%81%67%77%87%65%63%72%h
10-2-1-2-22--19Disagree3%-8%-3%-2%-6%9%--2%2%
2529131627205815191226828252Net agree70%92%58%82%74%57%71%81%62%67%87%65%61%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 77Q.8q In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Targeted in its actions -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
11182666212106109Strongly agree31%40%zg12%40%ze20%5%33%zd30%deg
151882371479142152Tend to agree42%43%44%43%46%26%45%zd42%d
5821151522144361Neither agree nor16%10%29%zh9%22%f38%zc14%17%cfhdisagree
10-7-7459Tend to disagree3%-13%zh-7%zf12%zc1%2%cfh
--------Strongly disagree--------
168-5351015No opinion4%4%-3%3%12%zc3%4%c
16717231215Don't know4%3%2%4%2%7%4%4%
262169291366711247261Agree72%83%zg56%83%ze67%31%78%zd72%dg
10-7-7459Disagree3%-13%zh-7%zf12%zc1%2%cfh
25216922136607243252Net agree70%83%42%83%60%19%77%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 78Q.8q In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Targeted in its actions -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
103214911242411412126325213-155151553103Strongly agree28%19%29%29%39%29%33%33%29%31%18%44%26%30%23%-32%28%30%27%28%28%k
146419128959612417264526624-214152581146Tend to agree40%40%39%40%30%41%50%33%51%44%38%29%43%38%44%-44%24%30%46%43%40%
7441165629119619429291419610133876Neither agree nor20%41%24%20%17%20%6%33%19%15%27%27%24%17%26%100%19%30%19%23%20%21%disagree
14-11311---29-48---11-1113Tend to disagree4%-2%4%4%1%---5%13%zmp-4%5%---6%2%-6%z4%p
2-11-1---1---2----1-12Strongly disagree1%-2%*-1%---3%---1%----2%-1%1%
11--11181-11--281-3132211No opinion3%--4%4%5%6%-2%3%--2%4%3%-5%6%7%a3%1%3%a
12-210241---3-263--15-411Don't know3%-4%3%7%3%6%---4%-1%4%5%--6%11%zabe-2%3%
24953221922101102382939118411837-36103040134249Agree69%59%68%69%69%70%83%67%80%zk75%56%73%69%69%67%-76%52%60%73%70%69%k
16-21412---39-410---12-1215Disagree4%-4%4%4%1%---8%mp13%zmp-4%6%---6%4%-6%z4%p
233530206219910238263011801073703692840123235Net agree64%59%64%65%65%69%83%67%80%67%44%73%66%63%67%0%76%46%56%73%64%65%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 79Q.8r In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Transparent -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
10346101181768710215103Strongly agree28%36%28%50%31%24%20%33%25%37%34%13%31%28%
1465126161625817712615146Tend to agree40%52%52%31%45%47%31%42%54%39%41%52%32%40%
741327430553431076Neither agree nor20%12%12%9%18%12%37%zhi25%15%15%13%28%22%21%disagree
14-11-25-1-1-313Tend to disagree4%-4%5%-5%6%-3%-3%-6%4%
2-----1---1--2Strongly disagree1%-----1%---3%--1%
11-1-121--221211No opinion3%-4%-2%6%1%--9%7%7%4%3%
12--1223-1---211Don't know3%--4%5%5%3%-4%---5%3%
2499181628254214251422830249Agree69%88%80%82%75%g71%51%75%79%76%74%65%64%69%g
16-11-26-1-2-315Disagree4%-4%5%-5%7%-3%-6%-6%4%
2339171528233614241421827235Net agree64%88%76%76%75%65%44%75%76%76%68%65%58%65%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 80Q.8r In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Transparent -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
10377761181100103Strongly agree28%38%zg13%37%ze18%2%32%zd28%deg
146872067428136146Tend to agree40%42%39%41%41%22%43%zd40%d
7427182129175676Neither agree nor20%13%35%zh13%29%zf47%zc18%21%cfhdisagree
1456575813Tend to disagree4%2%11%zh3%7%z13%zc3%4%c
21-1-112Strongly disagree1%*-1%-2%*1%
116-523811No opinion3%3%-3%2%8%2%3%c
1221532711Don't know3%1%2%3%3%7%2%3%ch
24916427128609236249Agree69%80%zg52%78%ze60%24%75%zd69%deg
1666676915Disagree4%3%11%zh3%7%15%zc3%4%c
23315822122533227235Net agree64%77%42%75%52%9%72%65%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 81Q.8r In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Transparent -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
Targeted inTransparentits actionsSupportiveResponsiveReliableProportionateProfessionalModernInformativeFocusedFlexibleEngagingEfficientEffectiveConsistentAuthoritativeAccountableAccessible
362362362362362362362362362362362362362362362362362362Unweighted total
362362362362362362362362362362362362362362362362362362Weighted total
1031091501361309019491138128739310711397140127172Strongly agree28%30%42%38%36%25%54%25%38%35%20%26%29%31%27%39%35%48%
146152143170173141143137173150126160164167165149154153Tend to agree40%42%39%47%48%39%40%38%48%42%35%44%45%46%45%41%42%42%
7661474646831810040629875585855524825Neither agree nor21%17%13%13%13%23%5%28%11%17%27%21%16%16%15%14%13%7%disagree
13994311211373414119291286Tend to disagree4%2%2%1%1%3%1%3%1%2%9%4%3%2%8%3%2%2%
2-42-7-1318675414-Strongly disagree1%-1%*-2%-*1%*2%2%2%1%1%*1%-
11156251131548119445463No opinion3%4%2%*1%3%1%4%1%2%3%2%1%1%1%1%2%1%
111543519281612511894152Don't know3%4%1%1%1%5%*2%*2%3%1%3%2%2%1%4%1%
249261293306303231337228311278199253271280261289281326Agree69%72%81%85%84%64%93%63%86%77%55%70%75%77%72%80%78%90%
15912531821268432018133213126Disagree4%2%3%1%1%5%1%3%2%2%12%6%5%4%9%4%3%2%
235252281301300213335216305270156233253266229276270320Net agree65%70%78%83%83%59%93%60%84%75%43%64%70%74%63%76%74%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 82Q.8 In your experience, please indicate the extent to which you agree or disagree with each of the following descriptions about the HTA.
- Summary -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
27963324925115123392351138913739-42143641144278Very Important77%68%70%78%79%80%l100%100%81%l60%74%91%73%80%71%-89%76%74%77%75%77%l
6011052522--6151312323141416123862Fairly Important17%10%22%16%17%15%--13%38%zkmp19%9%19%14%25%100%8%6%12%22%20%17%
121310-4--212-74---14-511Not Very Important3%10%6%3%-3%--5%3%3%-6%z2%---6%9%zae-3%3%
----------------------Not at all Important----------------------
1111913----3-272-1231411Don't know3%12%2%3%4%2%----4%-2%4%3%-3%12%5%2%2%3%
339744300311361234538641411316153146154353182341Important94%78%92%94%96%95%100%100%95%97%94%100%92%94%97%100%97%82%86%98%c95%c94%c
121310-4--212-74---14-511Not important3%10%6%3%-3%--5%3%3%-6%z2%---6%9%zae-3%3%
327641291311321234337631410615753146143853177330Net90%68%86%91%96%92%100%100%90%95%91%100%87%92%97%100%97%76%77%98%93%91%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 83Q.9a How important, if at all, do you think each of the following activities are for the HTA?
- Improving public confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
27910171632245917241424735278Very Important77%100%75%81%87%69%73%90%76%78%80%55%75%77%
60-54481913345762Fairly Important17%-22%19%10%22%24%5%11%16%14%38%14%17%
12---122-1-11311Not Very Important3%---3%5%2%-3%-3%7%7%3%
--------------Not at all Important--------------
11-1--111311-211Don't know3%-4%--4%1%5%10%6%3%-4%3%
339102220363279182717281141341Important94%100%96%100%97%92%96%95%87%94%94%93%89%94%
12---122-1-11311Not important3%---3%5%2%-3%-3%7%7%3%
327102220353077182617271038330Net90%100%96%100%94%87%94%95%84%94%91%86%82%91%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 84Q.9a How important, if at all, do you think each of the following activities are for the HTA?
- Improving public confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
279176291406528248278Very Important77%86%zg56%86%ze65%75%78%77%eg
602518202855362Fairly Important17%12%35%zh12%28%zf13%17%17%fh
1223253711Not Very Important3%1%6%h1%5%7%2%3%ch
--------Not at all Important--------
1122232811Don't know3%1%3%1%3%5%3%3%h
339201471599332301341Important94%98%zg90%98%ze92%88%95%z94%
1223253711Not important3%1%6%h1%5%7%2%3%ch
327199431578830295330Net90%97%84%96%87%81%93%91%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 85Q.9a How important, if at all, do you think each of the following activities are for the HTA?
- Improving public confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
24853521624100123312941128112727-38143432129247Very Important69%59%74%68%76%70%94%100%66%74%59%82%66%g74%zg49%-81%b76%68%59%67%68%gk
90211838401-13920330362419210224894Fairly Important25%19%22%26%24%28%6%-27%23%29%18%25%21%44%zhi100%19%12%21%41%ze25%26%
151113-3--314-832--13-913Not Very Important4%10%2%4%-2%--7%3%6%-6%2%3%--6%5%-5%4%
4-13-1----2-211---2-23Not at all Important1%-2%1%-1%----3%-1%1%2%---4%-1%1%
51-4------2-131--11-35Don't know1%12%-1%------3%-1%2%2%--6%2%-1%1%
338746298321401234438611411116451147174454177341Important93%78%96%94%100%98%zk100%100%93%97%88%100%91%96%94%100%100%c88%89%100%c93%94%k
191217-3--316-1043--14-1117Not important5%10%4%5%-2%--7%3%9%zp-8%h3%5%--6%9%e-6%5%
319644282321371234137551410215949147154054166324Net88%68%93%88%100%95%100%100%87%95%79%100%83%93%89%100%100%82%81%100%87%89%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 86Q.9b How important, if at all, do you think each of the following activities are for the HTA?
- Improving professional confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2489181331235116191223725247Very Important69%91%78%67%86%zag66%62%83%62%69%76%55%55%68%a
90-3651026285551794Fairly Important25%-14%33%14%29%32%i11%26%26%18%38%36%i26%
15-1--24-1-21313Not Very Important4%-4%--5%5%-3%-6%7%7%4%
41------11--13Not at all Important1%9%------3%5%--2%1%
5-1---112----5Don't know1%-4%---1%5%6%----1%
33892120373377182717281142341Important93%91%92%100%100%95%94%95%88%95%94%93%91%94%
1911--24-2121417Not important5%9%4%--5%5%-5%5%6%7%9%5%
31982020373173182616271038324Net88%82%87%100%100%90%90%95%83%90%89%86%82%89%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 87Q.9b How important, if at all, do you think each of the following activities are for the HTA?
- Improving professional confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
248157241245824222247Very Important69%76%zg45%76%ze58%65%70%68%eg
904320353298094Fairly Important25%21%38%h22%32%24%25%26%h
1534353813Not Very Important4%1%8%h2%5%9%c2%4%ch
41313-33Not at all Important1%*5%zh1%3%-1%1%
512-3145Don't know1%1%3%-3%f2%1%1%
338200431609032301341Important93%98%zg83%98%ze90%88%95%z94%eg
19474831117Not important5%2%13%zh2%8%f9%4%5%cfh
319196361568329290324Net88%96%70%95%82%79%92%89%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 88Q.9b How important, if at all, do you think each of the following activities are for the HTA?
- Improving professional confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
222429197218983292933116911329137133028114223Very Important61%48%62%62%68%62%67%100%61%74%k49%80%57%66%53%100%78%zab70%60%53%60%62%k
1143131018484-168273444522-113152263114Fairly Important31%30%28%32%26%34%33%-34%21%40%l20%36%26%39%-22%18%30%41%33%31%h
17141516--216-853---331117Not Very Important5%10%8%5%3%4%--5%3%9%z-6%3%6%---5%6%6%5%
2-11-----11-11------22Not at all Important1%-2%*-----3%1%-1%1%------1%1%
71-611----1--61--23-27Don't know2%12%-2%4%1%----1%--3%i2%--12%5%a-1%2%
336743298301371234537611411315951147174451177337Important93%78%90%93%93%95%100%100%95%95%88%100%93%93%92%100%100%c88%89%94%92%93%
19151516--227-963---331218Not important5%10%10%5%3%4%--5%5%10%z-7%4%6%---5%6%7%5%
317638282291311234335541410515247147174247164318Net88%68%80%89%90%91%100%100%90%90%78%100%86%89%86%100%100%88%84%88%86%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 89Q.9c How important, if at all, do you think each of the following activities are for the HTA?
- Providing licences -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2228131025225111171121530223Very Important61%79%57%51%67%63%62%57%55%61%70%40%65%62%
11426101062771069713114Fairly Important31%21%27%49%28%17%33%38%33%34%30%60%28%31%
17-3-161-31--317Not Very Important5%-12%-2%18%zgi1%-8%5%--5%5%
2---1-1------2Not at all Important1%---3%-1%------1%
7-1--1211---17Don't know2%-4%--2%2%5%4%---2%2%
336101920352878182717301243337Important93%100%84%100%95%80%96%h95%88%95%100%100%93%93%h
19-3-262-31--318Not important5%-12%-5%18%zg2%-8%5%--5%5%
317101620332276182516301241318Net88%100%72%100%90%62%93%95%80%90%100%100%87%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 90Q.9c How important, if at all, do you think each of the following activities are for the HTA?
- Providing licences -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
222139251114716202223Very Important61%68%zg49%68%ze47%44%64%zd62%de
114621649391497114Fairly Important31%30%30%30%38%39%31%31%
172921151017Not Very Important5%1%18%zh1%11%zf15%zc3%5%cfh
2-1-2-22Not at all Important1%-2%-2%-1%1%
72112167Don't know2%1%2%1%2%3%2%2%
336201411618630299337Important93%98%zg79%98%ze85%82%95%zd93%deg
1921021351118Not important5%1%20%zh1%13%zf15%zc4%5%cfh
317199311597325288318Net88%97%59%97%72%68%91%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 91Q.9c How important, if at all, do you think each of the following activities are for the HTA?
- Providing licences -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
24352921625958235244298412028-35173231126242Very Important67%60%60%68%79%66%67%67%73%61%62%62%69%g71%g51%-75%88%65%58%66%67%g
109417937434113152453548211112151961110Fairly Important30%40%37%29%21%30%33%33%27%39%35%38%29%28%39%100%22%12%30%36%32%30%
7-17-6----2-315-1-2328Not Very Important2%-3%2%-4%----3%-2%1%8%zh-3%-4%6%1%2%ah
----------------------Not at all Important----------------------
3--3------1--21---1-23Don't know1%--1%------1%--1%2%---2%-1%1%
352946309321371234739661411916849146194751188351Important97%100%97%97%100%96%100%100%100%100%96%100%98%g98%g90%100%97%100%95%94%98%97%g
7-17-6----2-315-1-2328Not important2%-3%2%-4%----3%-2%1%8%zh-3%-4%6%1%2%ah
345945302321311234739641411716745145194547186343Net95%100%95%95%100%91%100%100%100%100%94%100%96%98%82%100%95%100%91%88%97%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 92Q.9d How important, if at all, do you think each of the following activities are for the HTA?
- Producing codes of practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2436101331255113211421731242Very Important67%61%46%67%84%zg73%62%67%66%75%70%55%67%67%
1094117692551148515110Fairly Important30%39%50%33%16%25%30%28%34%25%27%45%32%30%i
7----15---1-18Not Very Important2%----2%7%z---3%-2%2%
--------------Not at all Important--------------
3-1---11-----3Don't know1%-4%---1%5%-----1%
352102220373475183118291246351Important97%100%96%100%100%98%92%95%100%100%97%100%98%97%g
7----15---1-18Not important2%----2%7%z---3%-2%2%
345102220373370183118281245343Net95%100%96%100%100%95%86%95%100%100%94%100%96%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 93Q.9d How important, if at all, do you think each of the following activities are for the HTA?
- Producing codes of practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
243159221254916220242Very Important67%78%zg43%76%ze49%44%70%zd67%deg
109432637441988110Fairly Important30%21%51%zh23%44%zf51%zc28%30%cfh
73316258Not Very Important2%1%5%1%6%zf6%2%2%c
--------Not at all Important--------
3-1-2-33Don't know1%-2%-2%-1%1%
352202481629334309351Important97%99%zg93%99%ze92%94%98%97%e
73316258Not important2%1%5%1%6%zf6%2%2%c
345199461618732303343Net95%97%88%98%86%88%96%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 94Q.9d How important, if at all, do you think each of the following activities are for the HTA?
- Producing codes of practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
2716322392510812335274799213039-39183836138270Very Important75%70%67%75%80%75%94%100%73%70%68%62%76%76%70%-83%95%77%67%72%74%
78315666321-131017525361218110144579Fairly Important22%30%31%21%20%22%6%-27%25%24%38%20%21%22%100%17%5%19%27%24%22%
7-17-3---23-422---1257Not Very Important2%-2%2%-2%---5%4%-3%1%3%---2%3%2%2%
1--2-2--------2----2-2Not at all Important*--1%-1%--------3%zh----3%a-*
5--5------3-131---1-45Don't know1%--1%------4%zp-1%2%2%---2%-2%1%
349946305321391234737631411716651147194851183349Important96%100%98%96%100%97%100%100%100%k95%92%100%96%97%92%100%100%100%96%94%96%96%k
8-19-4---23-423---1359Not important2%-2%3%-3%---5%4%-3%1%6%---2%6%2%2%
341945296321351234735611411416447147194747178340Net94%100%96%93%100%94%100%100%100%90%88%100%93%96%86%100%100%100%95%88%93%94%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 95Q.9e How important, if at all, do you think each of the following activities are for the HTA?
- Overseeing the consent requirements of the Human Tissue Act -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2717121829285815241224835270Very Important75%72%53%90%79%80%71%79%78%66%81%67%75%74%
7831018617366541179Fairly Important22%28%43%4%21%17%21%15%20%34%16%33%23%22%
7--1-13-1-1--7Not Very Important2%--5%-3%4%-3%-3%--2%
1-----2------2Not at all Important*-----2%------*
5-1---21----15Don't know1%-4%---2%5%----2%1%
349102219373475183018291246349Important96%100%96%95%100%97%92%95%97%100%97%100%98%96%g
8--1-15-1-1--9Not important2%--5%-3%6%z-3%-3%--2%
341102218373370182918281246340Net94%100%96%90%100%94%85%95%94%100%94%100%98%94%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 96Q.9e How important, if at all, do you think each of the following activities are for the HTA?
- Overseeing the consent requirements of the Human Tissue Act -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
271174301376121244270Very Important75%85%zg58%84%ze60%57%77%zd74%deg
7829162332136379Fairly Important22%14%31%h14%32%zf36%zc20%22%cfh
71335257Not Very Important2%*5%h2%4%5%1%2%ch
1-2-2-22Not at all Important*-3%zh-2%-1%*
51112145Don't know1%*2%1%2%2%1%1%
349203471609334306349Important96%99%zg90%98%e92%93%97%96%eg
81436269Not important2%*9%zh2%6%z5%2%2%h
341202421578732300340Net94%99%81%96%86%88%95%94%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 97Q.9e How important, if at all, do you think each of the following activities are for the HTA?
- Overseeing the consent requirements of the Human Tissue Act -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
23073120126949228273797610938133173233116232Very Important64%79%66%63%81%66%72%67%60%69%54%62%62%64%69%100%70%88%65%62%60%64%k
117216103544311712284405615-13-161967115Fairly Important32%21%34%32%15%31%28%33%35%31%41%z29%33%33%26%-28%-32%35%35%32%
8--9-5--2-21422-1--269Not Very Important2%--3%-3%--5%-3%9%3%1%3%-3%--3%3%2%
1--1------1-1-------11Not at all Important*--*------1%-1%-------**
6--611----1-141--22-26Don't know2%--2%4%1%----1%-1%2%2%--12%4%-1%2%
347947303311381234539651311616552146174852183346Important96%100%100%95%96%96%100%100%95%100%95%91%95%97%95%100%97%88%96%97%96%96%
9--10-5--2-31522-1--2710Not important2%--3%-3%--5%-4%9%4%1%3%-3%--3%4%3%h
338947294311341234339631211116451145174851176337Net93%100%100%92%96%93%100%100%90%100%91%82%91%96%92%100%95%88%96%94%92%93%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 98Q.9f How important, if at all, do you think each of the following activities are for the HTA?
- Inspecting organisations to ensure good standards and appropriate procedures -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2301015142623469211023729232Very Important64%100%66%73%72%65%57%46%66%55%76%58%61%64%
117-7510102991086316115Fairly Important32%-30%27%28%28%36%48%31%45%21%28%35%32%
8----32-1-1219Not Very Important2%----7%3%-3%-3%14%2%2%
1-----1------1Not at all Important*-----1%------*
6-1---31----16Don't know2%-4%---4%5%----2%2%
347102220373276183018291045346Important96%100%96%100%100%93%93%95%97%100%97%86%96%96%
9----33-1-12110Not important2%----7%4%-3%-3%14%2%3%
33810222037307318291828944337Net93%100%96%100%100%85%89%95%95%100%94%72%95%93%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 99Q.9f How important, if at all, do you think each of the following activities are for the HTA?
- Inspecting organisations to ensure good standards and appropriate procedures -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
230147241155020207232Very Important64%72%zg47%71%ze50%54%66%64%eg
117562246421398115Fairly Important32%27%42%h28%42%zf36%31%32%h
8-5-7369Not Very Important2%-9%zh-7%zf7%2%2%h
11-1--11Not at all Important**-1%--**
61112146Don't know2%1%2%1%2%3%1%2%h
347203461619233306346Important96%99%zg89%99%ze92%90%97%z96%eg
915173710Not important2%*9%zh1%7%zf7%2%3%fh
338202411608630299337Net93%99%79%98%85%83%94%93%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 100Q.9f How important, if at all, do you think each of the following activities are for the HTA?
- Inspecting organisations to ensure good standards and appropriate procedures -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
26473622826100102372847128713132-41153332140262Very Important73%79%76%71%83%70%83%67%78%72%68%82%72%77%g58%-87%zbc82%67%60%73%72%g
88298063821101020132371915314184789Fairly Important24%21%20%25%17%27%17%33%22%26%29%9%26%22%34%100%11%18%28%e34%e25%25%e
7-28-5---111313-1-2328Not Very Important2%-4%3%-4%---3%1%9%2%1%6%h-3%-4%6%1%2%ah
----------------------Not at all Important----------------------
3--3------1--21---1-23Don't know1%--1%------1%--1%2%---2%-1%1%
352945308321381234738671311916851146194751187351Important97%100%96%97%100%96%100%100%100%97%97%91%98%98%g92%100%97%100%95%94%98%97%
7-28-5---111313-1-2328Not important2%-4%3%-4%---3%1%9%2%1%6%h-3%-4%6%1%2%ah
345944300321331234737661211716747145194547186343Net95%100%92%94%100%92%100%100%100%95%96%82%96%98%86%100%95%100%91%88%97%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 101Q.9g How important, if at all, do you think each of the following activities are for the HTA?
- Giving advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
264101815322356132213211029262Very Important73%100%77%76%88%zagh67%68%70%72%72%69%80%63%72%
88-4441022585821689Fairly Important24%-19%18%12%28%27%24%25%28%28%20%35%i25%
7--1-23-1-1-18Not Very Important2%--5%-5%4%-3%-3%-2%2%
--------------Not at all Important--------------
3-1---11-----3Don't know1%-4%---1%5%-----1%
352102219373378183018291246351Important97%100%96%95%100%95%95%95%97%100%97%100%98%97%
7--1-23-1-1-18Not important2%--5%-5%4%-3%-3%-2%2%
345102218373175182918281245343Net95%100%96%90%100%90%92%95%94%100%94%100%96%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 102Q.9g How important, if at all, do you think each of the following activities are for the HTA?
- Giving advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
264161291235821237262Very Important73%79%zg55%75%e58%58%75%zd72%eg
8843173935147189Fairly Important24%21%33%24%34%z40%zc23%25%c
71516168Not Very Important2%*10%zh1%6%zf2%2%2%fh
--------Not at all Important--------
3-1-2-33Don't know1%-2%-2%-1%1%
352204461629336308351Important97%100%zg88%99%ze92%98%97%97%eg
71516168Not important2%*10%zh1%6%zf2%2%2%fh
345203411628735302343Net95%99%78%99%86%95%96%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 103Q.9g How important, if at all, do you think each of the following activities are for the HTA?
- Giving advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
28984025429114103403548139913742145183542150291Very Important80%89%84%80%91%79%83%100%85%k90%k69%91%82%80%76%100%95%zac94%70%78%79%80%ck
5017432221-6412114258-3-10102749Fairly Important14%11%14%14%6%15%11%-13%10%18%9%12%15%15%-5%-19%19%14%14%
7-1815--1-1-233---2248Not Very Important2%-2%2%3%4%--2%-1%-1%2%6%---4%3%2%2%
1--1------1--1------11Not at all Important*--*------1%--1%------**
15--13-31---7-652--13-913Don't know4%--4%-2%6%---10%zlmp-5%3%3%--6%7%-5%4%
339946298311361234739601411416250147184452177340Important94%100%98%93%97%95%94%100%98%k100%k87%100%93%95%91%100%100%c94%89%97%93%94%k
8-1915--1-2-243---2259Not important2%-2%3%3%4%--2%-3%-1%2%6%---4%3%3%2%
331946289301311234639581411215847147184351172332Net91%100%96%91%94%91%94%100%97%100%85%100%92%93%85%100%100%94%86%94%90%92%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 104Q.9h How important, if at all, do you think each of the following activities are for the HTA?
- Ensuring the safety and quality of human tissue, cells and organs used for patient treatment -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2899211930256316241626935291Very Important80%91%90%95%81%71%77%86%78%87%85%72%76%80%
50121791126221649Fairly Important14%9%7%5%19%27%z13%8%19%13%6%7%13%14%
7----12-1-1228Not Very Important2%----3%2%-3%-3%14%4%2%
1-----1------1Not at all Important*-----1%------*
15-1---61--21313Don't know4%-3%---7%5%--6%7%8%4%
339102220373474183018271041340Important94%100%97%100%100%a97%90%95%97%100%91%79%89%94%
8----13-1-1229Not important2%----3%3%-3%-3%14%4%2%
33110222037337118291827840332Net91%100%97%100%100%95%87%95%94%100%88%65%85%92%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 105Q.9h How important, if at all, do you think each of the following activities are for the HTA?
- Ensuring the safety and quality of human tissue, cells and organs used for patient treatment -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
289186321427027259291Very Important80%91%zg62%87%ze69%73%82%80%eg
501511181944349Fairly Important14%7%22%h11%18%10%13%14%h
7-5-7358Not Very Important2%-10%zh-7%zf7%c2%2%h
1-1-11-1Not at all Important*-2%-1%2%zc-*
15433521013Don't know4%2%5%2%4%7%3%4%fh
339201431618931301340Important94%98%zg84%98%ze88%84%95%zd94%deg
8-6-8359Not important2%-11%zh-8%zf9%zc2%2%ch
331201371618127296332Net91%98%72%98%80%75%94%92%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 106Q.9h How important, if at all, do you think each of the following activities are for the HTA?
- Ensuring the safety and quality of human tissue, cells and organs used for patient treatment -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
26083522527101123302648128013037141173632132259Very Important72%89%75%70%84%70%94%100%64%66%69%82%66%76%68%100%87%zab88%72%60%69%71%
7118664321-138141273014-519184073Fairly Important20%11%17%21%13%22%6%-28%21%21%9%23%17%26%-11%6%18%34%ze21%20%
21-321-8--24611262-1-231521Not Very Important6%-6%6%-6%--5%10%9%9%10%zh4%3%-3%-4%6%8%6%
2--2----1-1--11-----22Not at all Important1%--1%----2%-1%--1%1%-----1%*
8-1613--11--341--13-37Don't know2%-2%2%4%2%--2%3%--2%2%2%--6%7%za-1%2%
331944290311331234334621310716052146184451172332Important91%100%92%91%96%93%100%100%92%87%90%91%88%93%94%100%97%94%89%94%90%92%
23-322-8--34711272-1-231723Not important6%-6%7%-6%--7%10%10%9%10%4%4%-3%-4%6%9%z6%
30894126831125123403055129515249145184347155308Net85%100%86%84%96%87%100%100%85%77%79%82%78%89%89%100%95%94%86%88%81%85%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 107Q.9i How important, if at all, do you think each of the following activities are for the HTA?
- Ensuring dignity and respect for the deceased -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2609131532265717231219828259Very Important72%91%59%75%86%za75%70%88%76%67%63%67%60%71%
711845615165811373Fairly Important20%9%33%20%14%18%19%7%19%28%26%12%27%20%
21-21-36-2132321Not Very Important6%-8%5%-7%7%-5%5%8%14%7%6%
2-----1---1--2Not at all Important1%-----1%---3%--*
8-----31---137Don't know2%-----4%5%---7%5%2%
331102119373272182917271041332Important91%100%92%95%100%ag93%88%95%95%95%89%79%87%92%
23-21-37-2132323Not important6%-8%5%-7%8%-5%5%11%14%7%6%
30810191837306518281623837308Net85%100%83%90%100%85%80%95%89%90%78%65%80%85%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 108Q.9i How important, if at all, do you think each of the following activities are for the HTA?
- Ensuring dignity and respect for the deceased -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
260168191325824230259Very Important72%82%zg37%81%ze58%66%73%71%eg
713121262666373Fairly Important20%15%41%zh16%26%16%20%20%h
2161041441721Not Very Important6%3%20%zh3%14%zf12%5%6%fh
2-1-11-2Not at all Important1%-2%-1%2%c-*
8--12167Don't know2%--1%2%3%2%2%fh
331199411588430293332Important91%97%zg78%97%ze83%83%93%d92%eg
2361141551723Not important6%3%22%zh3%15%zf14%c5%6%cfh
308193291546925276308Net85%94%56%94%68%68%87%85%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 109Q.9i How important, if at all, do you think each of the following activities are for the HTA?
- Ensuring dignity and respect for the deceased -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
27183724026120101313044138613739143194341127274Very Important75%89%77%75%81%84%zkm78%33%65%77%64%91%71%80%70%100%92%za100%88%za75%66%76%akm
59175362131116101242311-4-5133759Fairly Important16%11%15%17%19%15%22%33%24%16%14%9%20%13%20%-8%-11%25%19%16%
15-312-2--524-553-----1414Not Very Important4%-6%4%-1%--10%zp5%6%p-4%3%6%-----7%zc4%
----------------------Not at all Important----------------------
17-114---11111-762---1-1415Don't know5%-2%4%---33%2%3%15%zlmp-6%4%3%---2%-7%z4%p
330944293321421224236541411015950147194954163333Important91%100%92%92%100%99%zklm100%67%88%92%78%100%90%93%90%100%100%a100%98%za100%a85%92%ak
15-312-2--524-553-----1414Not important4%-6%4%-1%--10%zp5%6%p-4%3%6%-----7%zc4%
315941281321401223734491410515446147194954150320Net87%100%87%88%100%98%100%67%78%87%72%100%86%90%84%100%100%100%98%100%78%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 110Q.9j How important, if at all, do you think each of the following activities are for the HTA?
- Regulation to ensure that living donors are not coerced and understand the risks of organ or bone marrow donation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
27110171931275916211420932274Very Important75%100%75%96%84%78%72%86%67%76%66%72%69%76%
59-514413284721059Fairly Important16%-21%4%12%12%16%8%25%24%23%14%21%16%
15---124-2-22314Not Very Important4%---2%5%4%-5%-5%14%6%4%
--------------Not at all Important--------------
17-1-12611-2-215Don't know5%-4%-2%5%8%5%3%-6%-4%4%
330102220353172182918271042333Important91%100%96%100%95%90%88%95%92%100%89%86%91%92%
15---124-2-22314Not important4%---2%5%4%-5%-5%14%6%4%
31510222034306818271825940320Net87%100%96%100%93%86%84%95%87%100%84%72%85%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 111Q.9j How important, if at all, do you think each of the following activities are for the HTA?
- Regulation to ensure that living donors are not coerced and understand the risks of organ or bone marrow donation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
271171271346420250274Very Important75%83%zg52%82%ze63%56%79%zd76%deg
592515232284759Fairly Important16%12%28%zh14%22%23%15%16%h
15292105714Not Very Important4%1%16%zh1%10%zf14%zc2%4%cfh
--------Not at all Important--------
17724531215Don't know5%3%3%3%4%7%4%4%
330196421578629297333Important91%96%zg80%96%ze85%79%94%zd92%deg
15292105714Not important4%1%16%zh1%10%zf14%zc2%4%cfh
315194331557624290320Net87%95%64%95%75%65%92%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 112Q.9j How important, if at all, do you think each of the following activities are for the HTA?
- Regulation to ensure that living donors are not coerced and understand the risks of organ or bone marrow donation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1312131171354521614217446514-2610191164130Very Important36%19%27%37%41%38%39%67%34%36%31%47%36%38%25%-54%zab52%39%21%33%36%
191626170147871252139663923212082637101193Fairly Important53%70%54%53%44%54%56%33%52%53%56%44%52%54%59%100%43%42%53%68%e53%53%
3318265111-546113136-11362133Not Very Important9%11%18%zr8%16%8%6%-10%10%9%9%11%7%12%-3%6%7%11%11%9%
1--1------1-1-------11Not at all Important*--*------1%-1%-------**
6-14----2-2-122---1-45Don't know2%-2%1%----3%p-3%-1%1%4%---2%-2%1%
322838288271321234135601310715646146184548165323Important89%89%81%90%s84%92%94%100%87%90%87%91%88%92%84%100%97%94%91%89%86%89%a
3418275111-547114136-11362234Not important9%11%18%zr8%16%8%6%-10%10%10%9%11%7%12%-3%6%7%11%12%9%
28873026122121113363153129414440145174242143289Net80%78%63%82%68%84%89%100%76%79%77%82%77%84%72%100%95%88%84%78%75%80%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 113Q.9k How important, if at all, do you think each of the following activities are for the HTA?
- Providing an effective website -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
131497141325711815514130Very Important36%42%37%33%38%37%31%35%36%43%49%37%29%36%
191612112221411115915527193Fairly Important53%58%51%57%60%61%50%55%49%48%49%41%58%53%
33-22-11314213633Not Very Important9%-8%10%-2%16%zi5%11%10%2%21%13%i9%
1-------1----1Not at all Important*-------3%----*
6-1-1-31-----5Don't know2%-4%-2%-3%5%-----1%
32210201836346617271629941323Important89%100%88%90%98%g98%g81%90%86%90%98%79%87%89%g
34-22-11314213634Not important9%-8%10%-2%16%zi5%14%10%2%21%13%i9%
28810181636335316221429735289Net80%100%80%81%98%95%65%85%72%80%95%58%74%80%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 114Q.9k How important, if at all, do you think each of the following activities are for the HTA?
- Providing an effective website -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
131831465259120130Very Important36%41%z27%40%e24%25%38%z36%e
19111227915919167193Fairly Important53%55%52%55%58%53%53%53%
3310981472533Not Very Important9%5%18%zh5%14%f20%zc8%9%cfh
1-1-11-1Not at all Important*-2%-1%2%zc-*
6-1-3-45Don't know2%-2%-3%f-1%1%
322195411558329287323Important89%95%zg79%95%ze83%78%91%zd89%deg
34101081582534Not important9%5%20%zh5%15%f22%zc8%9%cfh
288185311476821262289Net80%90%59%90%68%56%83%80%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 115Q.9k How important, if at all, do you think each of the following activities are for the HTA?
- Providing an effective website -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1285111121456511214206367014-239231260126Very Important35%59%22%35%44%39%39%33%25%36%29%44%29%41%zi26%-48%ab46%47%zab22%31%35%s
192429170178071311936869843612482039104196Fairly Important53%41%61%53%53%56%56%33%65%48%53%56%56%49%65%100%52%42%40%72%zc54%54%c
34-73017115510-15143--2332332Not Very Important9%-14%9%3%5%6%33%10%13%14%p-12%8%5%--12%7%6%12%ze9%p
3-12-----11-2-1---1-23Not at all Important1%-2%1%-----3%1%-1%-2%---2%-1%1%
5--5-1----2-131---2-35Don't know1%--1%-1%----3%-1%2%2%---4%-1%1%
320940282311361224333561410415450147174351164323Important88%100%84%89%97%95%zkl94%67%90%84%82%100%86%90%92%100%100%zac88%88%94%86%89%ak
37-83217115611-17144--2432535Not important10%-16%10%3%5%6%33%10%16%p15%p-14%8%7%--12%9%e6%13%ze10%ep
28393225030129111382746148813947147143947139288Net78%100%67%79%94%90%89%33%80%69%67%100%72%82%85%100%100%76%79%88%73%80%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 116Q.9l How important, if at all, do you think each of the following activities are for the HTA?
- Providing training events and workshops -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
1284991712285989514126Very Important35%38%38%44%48%34%34%24%28%43%29%41%30%35%
192612817193912221018726196Fairly Important53%62%54%42%46%55%48%62%70%57%60%59%56%54%
34-13241321-2-432Not Very Important9%-4%14%7%11%16%z9%3%-8%-8%9%
3---------1-23Not at all Important1%---------3%-4%z1%
5-1---21----15Don't know1%-4%---2%5%----2%1%
320102117343167163018271240323Important88%100%92%86%93%89%82%85%97%100%89%100%86%89%g
37-13241321-3-535Not important10%-4%14%7%11%16%z9%3%-11%-12%10%
283102014322753142918231235288Net78%100%88%72%87%78%65%76%94%100%78%100%75%80%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 117Q.9l How important, if at all, do you think each of the following activities are for the HTA?
- Providing training events and workshops -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1287911662110115126Very Important35%39%g21%40%e21%28%36%35%eg
19211328866220170196Fairly Important53%55%53%53%61%55%54%54%
34101291532732Not Very Important9%5%24%zh6%15%zf9%8%9%fh
32-21213Not at all Important1%1%-1%1%5%zc*1%c
5-1-2145Don't know1%-2%-2%2%1%1%
320193391528330285323Important88%94%zg74%93%ze82%83%90%89%eg
371212111652735Not important10%6%24%zh7%16%zf15%9%10%h
283180261416725258288Net78%88%50%86%67%69%81%80%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 118Q.9l How important, if at all, do you think each of the following activities are for the HTA?
- Providing training events and workshops -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
20742817823817124273896111125-32112925110206Very Important57%48%60%56%73%57%56%33%50%69%55%62%50%65%zgi46%-67%58%58%46%58%57%
130315118754512382645550211146172467130Fairly Important36%32%32%37%21%38%39%33%48%zl21%37%29%45%zh29%38%100%30%30%35%45%35%36%hl
1613161811-331376-1125817Not Very Important4%11%6%5%3%6%6%33%-8%m4%9%2%4%11%i-3%6%4%9%4%5%
----------------------Not at all Important----------------------
91161---113-333--12-58Don't know2%10%2%2%4%---2%3%4%p-2%2%5%--6%4%-3%2%
337743297301361224735631311616146146174649178336Important93%79%92%93%93%94%94%67%98%90%92%91%96%g94%g84%100%97%88%93%91%93%93%g
1613161811-331376-1125817Not important4%11%6%5%3%6%6%33%-8%m4%9%2%4%11%i-3%6%4%9%4%5%
321641281291281114732611211415340145154444169319Net89%68%86%88%90%89%89%33%98%82%88%82%93%90%74%100%95%82%89%81%89%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 119Q.9m How important, if at all, do you think each of the following activities are for the HTA?
- Working with other organisations to ensure joined up regulation, advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2078141225224213161016624206Very Important57%78%61%64%67%64%51%66%51%52%52%48%51%57%
130286121029511712621130Fairly Important36%22%36%31%33%28%36%29%37%38%40%52%44%36%
16-11-27-321-117Not Very Important4%-3%5%-5%9%-8%10%4%-2%5%
--------------Not at all Important--------------
9----1311-1-18Don't know2%----2%4%5%4%-3%-2%2%
337102219373271182716281245336Important93%100%97%95%100%g93%87%95%88%90%93%100%96%93%g
16-11-27-321-117Not important4%-3%5%-5%9%-8%10%4%-2%5%
321102118373163182515271244319Net89%100%94%90%100%88%77%95%80%81%89%100%93%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 120Q.9m How important, if at all, do you think each of the following activities are for the HTA?
- Working with other organisations to ensure joined up regulation, advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
20713219995113192206Very Important57%64%zg37%60%50%34%61%zd57%dg
1306623573720106130Fairly Important36%32%45%35%36%56%zc34%36%c
164941121317Not Very Important4%2%17%zh3%11%zf5%4%5%h
--------Not at all Important--------
93133258Don't know2%1%2%2%3%5%2%2%c
337198421568733298336Important93%97%zg81%95%e87%90%94%z93%eg
164941121317Not important4%2%17%zh3%11%zf5%4%5%h
321193331517731285319Net89%94%65%93%76%86%90%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 121Q.9m How important, if at all, do you think each of the following activities are for the HTA?
- Working with other organisations to ensure joined up regulation, advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
15232213211615-1421331577024-198212580152Very Important42%29%46%41%34%43%39%-30%54%m49%m9%47%41%43%-40%40%42%46%42%42%m
1454151341863622292594871181237182276147Fairly Important40%49%31%42%56%44%l50%67%46%l22%36%65%40%42%33%100%49%36%37%40%40%41%l
38-6341171187349178-51572038Not Very Important10%-13%11%3%12%6%33%17%k18%k4%27%8%10%14%-11%6%11%12%11%11%k
8-26-1----4-421---2147Not at all Important2%-4%2%-1%----6%zp-4%1%2%---4%2%2%2%
192312221-324-2104--33-1017Don't know5%22%6%4%7%1%6%-7%p5%5%-2%6%8%--18%7%-5%5%pr
297736266291241123630581110614142142143946156299Important82%78%77%83%90%86%89%67%76%77%85%73%87%83%76%100%89%76%79%86%82%83%
46-84011811877414199-51782545Not important13%-17%13%3%12%6%33%17%18%10%27%11%11%16%-11%6%14%14%13%13%
2517282262810610128235179212233137133239131254Net69%78%60%71%87%74%83%33%60%59%74%47%76%71%60%100%79%70%65%72%69%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 122Q.9n How important, if at all, do you think each of the following activities are for the HTA?
- Providing value for money for the tax payer -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
15251071717311014910418152Very Important42%47%46%34%47%49%38%53%44%52%33%35%39%42%
1454913151431811415717147Fairly Important40%46%38%66%40%40%37%42%34%19%51%58%37%41%
38-3-4212-3231838Not Very Important10%-13%-11%7%14%-9%14%10%7%18%11%
8-1---2-121-17Not at all Important2%-4%---2%-3%10%3%-2%2%
191--1261311-217Don't know5%7%--2%5%8%5%10%5%3%-4%5%
29791920323162182413251135299Important82%93%83%100%87%88%76%95%78%71%84%93%76%83%
46-4-4213-4441945Not important13%-17%-11%7%16%-11%24%13%7%20%13%
2519152028284818219211026254Net69%93%67%100%76%81%59%95%67%47%71%87%56%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 123Q.9n How important, if at all, do you think each of the following activities are for the HTA?
- Providing value for money for the tax payer -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1529220684111139152Very Important42%45%38%41%41%31%44%42%
1459016713916130147Fairly Important40%44%31%43%39%44%41%41%
381511171153238Not Very Important10%7%21%zh11%11%13%10%11%h
82424357Not at all Important2%1%7%zh1%4%7%zc1%2%c
19626421117Don't know5%3%3%3%4%6%4%5%c
297182361398127268299Important82%89%zg69%85%80%74%85%z83%g
461714191673745Not important13%8%28%zh12%16%20%12%13%h
251165211196520232254Net69%80%41%73%64%54%73%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 124Q.9n How important, if at all, do you think each of the following activities are for the HTA?
- Providing value for money for the tax payer -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1361171181141411918333486814-164121584132Very Important38%10%35%37%36%29%33%33%40%47%p49%zp18%39%40%26%-35%24%25%27%44%zc36%cp
13941912814696214172184955351199183367147Fairly Important38%48%41%40%44%48%zkm44%67%29%43%31%56%40%32%63%zhi100%41%46%37%61%zac35%41%ahk
5418465202-10210317302-63952851Not Very Important15%11%16%14%17%14%17%-22%l5%14%18%14%17%g3%-13%18%18%9%15%14%g
11139-3--223-541---32611Not at all Important3%10%6%3%-2%--3%5%4%-4%3%1%---5%3%3%3%
222118191-2-213133-528-621Don't know6%22%2%6%4%7%6%-5%-3%9%2%8%i6%-11%ab12%16%zab-3%6%ai
27553624625111103333555119712349136133047151279Important76%57%76%77%80%77%78%100%70%90%zm79%73%79%72%89%zh100%76%70%61%88%c79%c77%ch
65211545232-12412322343-631173462Not important18%21%22%17%17%16%17%-25%10%18%18%18%g20%g5%-13%18%23%12%18%17%g
2103251922087832131428748946130101941117217Net58%37%54%60%63%61%61%100%44%79%62%56%61%52%84%100%62%52%39%75%61%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 125Q.9o How important, if at all, do you think each of the following activities are for the HTA?
- Reducing the burden on your sector -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
13648715153071597313132Very Important38%44%35%34%40%42%37%35%48%50%22%28%28%36%
1393121315113498611618147Fairly Important38%32%53%66%40%33%42%45%26%36%37%51%39%41%
5422-63103411021051Not Very Important15%16%9%-15%8%12%15%14%5%35%14%21%14%
11-1-112-312-111Not at all Important3%-4%-3%2%2%-8%5%6%-2%3%
221--156111-1521Don't know6%7%--2%15%z7%5%4%5%-7%10%6%
27572020292664152315181031279Important76%76%87%100%80%74%79%80%74%85%59%79%68%77%
6523-74113721221062Not important18%16%13%-18%11%14%15%22%10%41%14%22%17%
210617202322531216146821217Net58%60%75%100%62%64%65%65%52%76%18%65%45%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 126Q.9o How important, if at all, do you think each of the following activities are for the HTA?
- Reducing the burden on your sector -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1368123574013117132Very Important38%39%45%35%40%35%37%36%
1398815733515129147Fairly Important38%43%28%45%35%40%41%41%
542510251684351Not Very Important15%12%19%15%16%22%13%14%
113435-1011Not at all Important3%2%9%zh2%5%-3%3%
227-6411821Don't know6%4%-4%4%3%6%6%h
275169381307628246279Important76%82%z73%80%75%75%78%77%
652814272285262Not important18%14%27%h17%22%22%17%17%
210141241025420194217Net58%69%46%63%53%54%61%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 127Q.9o How important, if at all, do you think each of the following activities are for the HTA?
- Reducing the burden on your sector -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
62112506222-101110322308-104583462Very Important17%10%26%16%17%16%17%-20%28%14%18%18%18%14%-21%24%11%15%18%17%r
1083101039522-1510205305226-163132457113Fairly Important30%29%22%32%29%36%17%-33%26%29%38%24%30%48%zhi-33%18%26%45%30%31%i
12021910814476317121944857111146152063119Not Very Important33%19%40%34%43%33%44%100%35%30%27%27%39%g34%20%100%29%34%30%37%33%33%g
332326191-3311311123-3-8-1930Not at all Important9%21%6%8%3%7%6%-7%8%17%zp18%9%7%6%-5%-16%zb-10%b8%
3923322132-239-12197-54921737Don't know11%22%6%10%7%9%17%-5%8%13%-9%11%13%-11%24%18%b3%9%10%
17032315215744-2521308518234-268183291176Important47%38%48%48%47%52%33%-53%54%44%56%42%48%62%i-54%42%37%60%c48%48%
15342213415566320153065970141166232082149Not important42%40%46%42%46%39%50%100%42%38%44%44%48%zg41%26%100%35%34%46%37%43%41%g
17*118*18-2-35602-81320-191-412926Net5%-2%2%6%*12%-17%-100%11%16%0%12%-6%7%36%-100%20%7%-9%23%5%7%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 128Q.9p How important, if at all, do you think each of the following activities are for the HTA?
- Supporting business and innovation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
6216286122656-962Very Important17%12%25%10%21%18%14%12%19%28%19%-19%17%
1085712141524488648113Fairly Important30%51%30%61%38%a42%a29%20%25%44%20%36%16%31%a
120163121027911312520119Not Very Important33%8%27%15%32%28%33%48%37%19%40%41%43%33%
3313211922151330Not at all Important9%9%15%10%3%3%11%9%6%5%16%7%5%8%
39211331024122837Don't know11%20%4%4%7%8%12%11%13%5%6%16%16%10%
170612142121356141312416176Important47%63%54%71%58%a60%a43%32%45%72%39%36%35%48%
15321051311361113417623149Not important42%17%42%25%35%31%44%57%42%23%55%48%49%41%
17439910-1-519-5-2-626Net5%45%13%46%24%29%-1%-25%2%48%-16%-13%-14%7%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 129Q.9p How important, if at all, do you think each of the following activities are for the HTA?
- Supporting business and innovation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
62417281835762Very Important17%20%14%17%18%9%18%17%
108691557268105113Fairly Important30%34%29%35%25%21%33%31%
1206717583514105119Not Very Important33%33%33%36%35%39%33%33%
3310941572130Not at all Important9%5%17%zh3%15%zf18%zc7%8%cfh
3918315752837Don't know11%9%6%9%7%13%9%10%c
17011022854411162176Important47%54%z43%52%43%30%51%zd48%d
1537726635021127149Not important42%37%51%38%50%57%z40%41%
1733-423-7-103526Net5%16%-8%14%-7%-26%11%7%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 130Q.9p How important, if at all, do you think each of the following activities are for the HTA?
- Supporting business and innovation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
15032013718675-2018199527714-3013221869153Very Important41%29%43%43%57%46%k39%-43%46%k27%62%43%45%g26%-64%zab70%44%33%36%42%agk
16442214313676221173535672351144213392165Fairly Important45%40%47%45%40%46%50%67%44%44%51%20%46%42%63%zh100%30%24%42%61%e48%e46%e
271224191161535144-3-431525Not Very Important7%10%3%7%3%7%6%33%12%3%8%18%4%8%8%-5%-9%6%8%7%
8-26----124-43------77Not at all Important2%-4%2%----2%5%p6%zp-4%2%------4%z2%
13219-11--15-462--13-812Don't know4%22%2%3%-1%6%--3%8%zmp-4%3%3%--6%5%-4%3%p
314643280311331124135541210814949145184351161318Important87%68%90%88%97%93%zk89%67%87%90%78%82%89%87%89%100%95%94%86%94%84%88%ak
3514301911631039174-3-432233Not important10%10%8%9%3%7%6%33%13%8%14%18%8%10%8%-5%-9%6%12%z9%
2795392503012410135324499913245142183847139285Net77%59%83%78%94%86%83%33%73%82%64%65%81%77%82%100%89%94%77%88%72%79%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 131Q.9q How important, if at all, do you think each of the following activities are for the HTA?
- Working with Government and Europe to implement legislation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
150559191433813815419153Very Important41%56%24%48%52%41%40%42%40%43%48%33%41%42%
1642169161838811712722165Fairly Important45%19%69%46%43%51%47%44%37%39%39%60%46%46%
272--13613331325Not Very Important7%17%--2%8%8%4%10%14%10%7%7%7%
8-211-111---17Not at all Important2%-8%5%3%-1%5%3%---2%2%
131----31311-212Don't know4%7%----4%5%10%5%3%-4%3%
31472119353271162415261141318Important87%76%92%95%95%92%87%86%77%81%87%93%87%88%
3522123724331433Not important10%17%8%5%5%8%9%9%13%14%10%7%9%9%
27961918332964152012231036285Net77%59%85%90%90%85%78%77%64%67%77%87%78%79%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 132Q.9q How important, if at all, do you think each of the following activities are for the HTA?
- Working with Government and Europe to implement legislation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
150971878358141153Very Important41%48%z35%48%35%22%45%zd42%d
1649322724618143165Fairly Important45%45%42%44%46%49%45%46%
27107101061925Not Very Important7%5%13%h6%10%16%zc6%7%
815-6357Not at all Important2%*9%zh-6%zf7%zc1%2%ch
1341332812Don't know4%2%2%2%3%5%3%3%c
314190401508126284318Important87%93%zg76%92%ze81%71%90%zd88%deg
351111101792433Not important10%5%22%zh6%17%zf24%zc8%9%ch
279179281406517261285Net77%88%55%86%64%48%82%79%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 133Q.9q How important, if at all, do you think each of the following activities are for the HTA?
- Working with Government and Europe to implement legislation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
240428213229792302447118111731-40143330123239Very Important66%48%60%67%70%68%72%67%63%61%68%73%66%69%56%-84%zab76%67%55%64%66%
933147863231161217330411815211185491Fairly Important26%32%30%24%20%22%28%33%34%31%24%18%24%24%33%100%11%12%23%33%e28%e25%e
181418311--2321784-11271021Not Very Important5%11%8%6%10%8%--3%8%3%9%6%5%8%-3%6%4%12%5%6%
3-13-2----1-21----2-13Not at all Important1%-2%1%-1%----1%-1%1%----4%z-*1%
81-7-1----3-242-112-48Don't know2%10%-2%-1%----4%-2%2%3%-3%6%4%-2%2%
333743291291291234636631311015849145174447177331Important92%79%91%91%90%90%100%100%97%92%92%91%91%93%89%100%95%88%89%88%92%91%
211421313--2331994-11371123Not important6%11%9%7%10%9%--3%8%4%9%7%5%8%-3%6%7%12%6%6%
312638270261161234433611210115044143154141166307Net86%68%81%85%80%81%100%100%93%84%88%82%83%88%81%100%92%82%82%75%87%85%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 134Q.9r How important, if at all, do you think each of the following activities are for the HTA?
- Sharing best practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2406141526264714201225827239Very Important66%61%60%76%72%75%58%75%63%66%82%62%59%66%
933747925475431591Fairly Important26%26%31%19%18%25%31%20%24%29%12%24%31%25%
18-113-7-3--2421Not Very Important5%-5%5%9%-8%-11%--14%8%6%
3-------1-2--3Not at all Important1%-------3%-6%--1%
811---31-1--18Don't know2%13%4%---4%5%-5%--2%2%
33382119333572182717281042331Important92%87%91%95%91%100%g88%95%86%95%94%86%90%91%
21-113-7-4-22423Not important6%-5%5%9%-8%-14%-6%14%8%6%
3128201830356618231727938307Net86%87%86%90%81%100%80%95%73%95%88%72%82%85%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 135Q.9r How important, if at all, do you think each of the following activities are for the HTA?
- Sharing best practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
240155261205615221239Very Important66%76%zg49%74%ze55%41%70%zd66%deg
9339183132196991Fairly Important26%19%34%h19%32%f52%zc22%25%cfh
18879911921Not Very Important5%4%13%zh5%9%2%6%6%
3-1-2213Not at all Important1%-2%-2%5%zc*1%c
83132-68Don't know2%2%2%2%2%-2%2%
333194431518834291331Important92%94%zg83%93%88%93%92%91%g
218891132023Not important6%4%15%zh5%11%7%6%6%h
312185361437831271307Net86%90%68%87%77%86%86%85%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 136Q.9r How important, if at all, do you think each of the following activities are for the HTA?
- Sharing best practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
Regulation toensure that
Working withliving donorsEnsuring theotherare notsafety andInspecting
organisationscoerced andquality oforganisationsWorking withto ensureunderstandhuman tissue,to ensureOverseeingGovernmentProvidingjoined upProvidingthe risks ofEnsuringcells andgoodthe consent
and Europe toSupportingReducing thevalue forregulation,trainingProviding anorgan or bonedignity andorgans usedstandards andrequirementsProducingImprovingImprovingSharing bestimplementbusiness andburden onmoney for theadvice andevents andeffectivemarrowrespect forfor patientGiving adviceappropriateof the Humancodes ofProvidingprofessionalpublic
practicelegislationinnovationyour sectortax payerguidanceworkshopswebsitedonationthe deceasedtreatmentand guidanceproceduresTissue Actpracticelicencesconfidenceconfidence
362362362362362362362362362362362362362362362362362362Unweighted total
362362362362362362362362362362362362362362362362362362Weighted total
23915362132152206126130274259291262232270242223247278Very Important66%42%17%36%42%57%35%36%76%71%80%72%64%74%67%62%68%77%
9116511314714713019619359734989115791101149462Fairly Important25%46%31%41%41%36%54%53%16%20%14%25%32%22%30%31%26%17%
21251195138173233142188978171311Not Very Important6%7%33%14%11%5%9%9%4%6%2%2%2%2%2%5%4%3%
3730117-31-21-12-23-Not at all Important1%2%8%3%2%-1%*-**-**-1%1%-
8123721178551571336537511Don't know2%3%10%6%5%2%1%1%4%2%4%1%2%1%1%2%1%3%
331318176279299336323323333332340351346349351337341341Important91%88%48%77%83%93%89%89%92%92%94%97%96%96%97%93%94%94%
233314962451735341423981098181711Not important6%9%41%17%13%5%10%9%4%6%2%2%3%2%2%5%5%3%
30728526217254319288289320308332343337340343318324330Net85%79%7%60%70%88%80%80%88%85%92%95%93%94%95%88%89%91%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 137Q.9 How important, if at all, do you think each of the following activities are for the HTA?
- Summary -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
85110761132311010155234511-166984684Very effective23%10%21%24%34%22%28%33%22%26%22%35%19%27%19%-35%30%18%15%24%23%
201523178158071301743875843412282635109201Fairly effective56%59%50%56%46%56%56%33%63%44%63%56%62%h49%62%100%46%40%53%65%57%56%h
37293031211576113185-32671937Not very effective10%19%20%zr9%10%8%11%33%10%17%9%9%10%11%9%-5%12%12%12%10%10%
2-12-1----1-11----1-12Not at all effective1%-2%1%-1%----1%-1%1%----2%-**
3714333181-254-10226-63841638Don't know10%12%8%10%10%13%6%-5%13%5%-8%13%10%-13%18%16%8%8%10%
28663325425113102402758139813044138133543155286Effective79%68%70%80%80%78%83%67%85%70%85%91%81%76%81%100%81%70%70%80%81%79%
392103231311577113195-32772038Not effective11%19%21%zr10%10%9%11%33%10%17%10%9%11%11%9%-5%12%14%12%10%11%
2474232222210091352151128511140136112836135247Net68%49%49%70%70%70%72%33%75%53%74%82%70%65%72%100%76%58%56%67%71%68%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 138Q.10a How effective if at all do you feel the HTA is in relation to each of these activities?
- Improving public confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
85635951568793884Very effective23%59%15%26%25%15%18%33%27%37%31%28%16%23%
20121792022471212619728201Fairly effective56%22%72%47%55%65%58%62%37%34%64%59%60%56%
371343411-3211537Not very effective10%8%13%18%8%12%13%-11%9%3%6%11%10%
2-------2----2Not at all effective1%-------6%----*
371-253916411638Don't know10%10%-9%13%8%11%5%19%20%3%7%13%10%
28682014292862182013281035286Effective79%81%87%73%80%79%76%95%64%70%94%87%76%79%
391343411-5211538Not effective11%8%13%18%8%12%13%-16%9%3%6%11%11%
24771711272351181511271030247Net68%73%75%55%72%67%62%95%48%61%91%81%65%68%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 139Q.10a How effective if at all do you feel the HTA is in relation to each of these activities?
- Improving public confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
856275114-8484Very effective23%30%zg13%31%ze14%-26%zd23%de
20111530896318182201Fairly effective56%56%58%54%63%48%57%56%
371291216112437Not very effective10%6%17%h7%16%f30%zc8%10%ch
2-2-2112Not at all effective1%-3%zh-2%2%**
3715512672638Don't know10%7%9%7%6%19%c8%10%ch
286177361397718265286Effective79%87%zg70%85%z76%48%84%zd79%d
3912111218122538Not effective11%6%20%zh7%17%zf33%zc8%11%cfh
24716526128596240247Net68%80%50%78%59%16%76%68%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 140Q.10a How effective if at all do you feel the HTA is in relation to each of these activities?
- Improving public confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
106113961449411012158305516-246141351108Very effective29%10%28%30%43%34%33%33%22%31%22%53%24%32%29%-51%zabc30%28%25%27%30%
193626168167582282134772862612292729104192Fairly effective53%68%54%53%50%52%61%67%60%53%50%47%59%51%48%100%46%46%54%54%54%53%
3716312131-6411-14158--2482237Not very effective10%10%12%10%7%9%6%-12%10%17%z-11%9%15%--12%9%e15%e11%e10%e
12-212-3--125-452---22812Not at all effective3%-4%4%-2%--2%5%8%zp-4%3%3%---4%3%4%3%
141112-5--2-3-292-1232614Don't know4%12%2%4%-3%--5%-4%-2%5%4%-3%12%5%3%3%4%
299739264301241233933491410214242146144142155300Effective83%78%82%83%93%86%k94%100%81%84%72%100%84%83%77%100%97%zabc76%82%78%81%83%k
4918432151-6617-182010--26103048Not effective14%10%16%13%7%11%6%-13%16%24%zp-15%12%19%--12%12%e19%e16%e13%e
25063122227109113322733148412232146123532125252Net69%68%66%70%86%76%89%100%68%69%47%100%69%71%58%100%97%64%70%60%66%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 141Q.10b How effective if at all do you feel the HTA is in relation to each of these activities?
- Improving professional confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
106583101220711613211108Very effective29%50%34%15%28%35%25%35%36%32%44%20%23%30%
19349152116441113915926192Fairly effective53%41%39%75%57%46%54%59%41%49%51%72%56%53%
37-513712-21-1637Not very effective10%-23%4%7%19%14%-5%4%-7%13%10%
12111--2-311-212Not at all effective3%9%4%5%--2%-11%5%3%-4%3%
14---3-41221-214Don't know4%---8%-4%5%6%9%3%-4%4%
29991718312865182415281137300Effective83%91%73%90%85%81%79%95%77%82%94%93%79%83%
491623713-5211848Not effective14%9%27%10%7%19%16%-16%9%3%7%17%13%
25081016292151181913271029252Net69%82%45%81%78%61%63%95%61%72%91%85%62%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 142Q.10b How effective if at all do you feel the HTA is in relation to each of these activities?
- Improving professional confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1068036316-107108Very effective29%39%zg7%39%ze15%-34%zd30%deg
19310727845717173192Fairly effective53%52%52%52%56%46%55%53%
3711121117122037Not very effective10%6%23%zh6%17%zf34%zc6%10%cfh
12191104712Not at all effective3%*17%zh1%10%zf12%zc2%3%cfh
1461523914Don't know4%3%2%3%2%9%c3%4%c
299187301477217280300Effective83%91%zg58%90%ze72%46%89%zd83%deg
4912211127172748Not effective14%6%40%zh7%26%zf45%zc9%13%cfh
2501751013646*253252Net69%85%19%83%45%*80%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 143Q.10b How effective if at all do you feel the HTA is in relation to each of these activities?
- Improving professional confidence -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
21832519223731223322439739934-3491726128215Very effective60%30%53%60%72%51%94%67%69%p56%63%62%60%58%62%-72%bc48%35%49%67%zbc59%cp
103317925441113152353750151115102456108Fairly effective28%38%36%29%17%31%6%33%28%39%33%38%30%29%28%100%22%28%21%45%zc29%30%
1013813--123-443--122510Not very effective3%10%6%2%4%2%--2%5%4%-3%2%5%--6%4%3%3%3%
1--1-1-------1----1--1Not at all effective*--*-1%-------1%----2%--*
302326222--1---8173-33192228Don't know8%22%5%8%7%15%zklm--2%---7%10%6%-5%18%39%zabe3%1%8%akm
321642284281181234637661411014949145142851184323Effective89%68%89%89%89%82%100%100%97%zp95%96%zp100%90%87%89%100%95%c76%56%94%c96%zc89%cp
1113914--123-453--132511Not effective3%10%6%3%4%3%--2%5%4%-3%3%5%--6%5%3%3%3%
310539275271131234535631410614546145132549178312Net86%59%82%86%86%79%100%100%95%90%92%100%87%85%85%100%95%70%51%91%93%86%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 144Q.10c How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing licences -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
218912925203912151024634215Very effective60%91%51%48%68%g59%48%61%48%56%79%50%73%g59%g
103-971083161173410108Fairly effective28%-40%34%28%24%38%34%36%40%10%36%22%30%
10-21-32-1-1-110Not very effective3%-8%4%-7%2%-4%-3%-2%3%
1---------1--1Not at all effective*---------3%--*
301-313914122228Don't know8%9%-13%3%10%11%5%13%5%6%14%4%8%
32192116352970182617271044323Effective89%91%92%82%97%83%86%95%84%95%89%86%94%89%
11-21-32-1-2-111Not effective3%-8%4%-7%2%-4%-6%-2%3%
31091915352669182517251043312Net86%91%83%78%97%75%84%95%80%95%83%86%93%86%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 145Q.10c How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing licences -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
21815023114548203215Very effective60%73%zg44%70%ze53%21%64%zd59%dg
103412538382483108Fairly effective28%20%48%zh23%38%f67%zc26%30%cfh
1014252510Not very effective3%*8%zh1%5%5%2%3%ch
1----1-1Not at all effective*----2%zc-*
3013-9422528Don't know8%6%-6%4%5%8%8%g
321191481529232286323Effective89%93%z92%93%z91%87%90%z89%
1114253511Not effective3%*8%zh1%5%7%c2%3%ch
310190431508729281312Net86%93%84%92%86%80%89%86%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 146Q.10c How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing licences -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
19132216819721012516389639125-31102121106189Very effective53%29%47%53%59%50%78%33%52%41%55%65%52%53%46%-65%bc52%42%39%56%52%
14442012710583220192955265241156212875145Fairly effective40%40%43%40%31%41%22%67%43%48%42%35%42%38%44%100%32%30%42%51%39%40%
15151226--242-672-1132815Not very effective4%10%11%zr4%7%4%--3%10%3%-5%4%4%-3%6%5%3%4%4%
1--1-1-------1----1--1Not at all effective*--*-1%-------1%----2%--*
112-1117--1---183--243212Don't know3%22%-3%4%5%--2%---1%4%6%i--12%9%zae6%1%3%ai
335642295291301234535671411515649146154249181334Effective93%68%89%93%90%91%100%100%95%90%97%z100%94%91%90%100%97%c82%84%91%95%zc92%c
16151326--242-672-1132816Not effective4%10%11%zr4%7%4%--3%10%3%-5%4%4%-3%6%7%3%4%4%
319537283261241234331651410814847145143847173318Net88%59%78%89%83%86%100%100%92%79%95%100%89%87%86%100%95%76%77%88%90%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 147Q.10d How effective if at all do you feel the HTA is in relation to each of these activities?
- Producing codes of practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
1918772621311318720824189Very effective53%82%33%38%71%zg60%g38%67%57%37%68%64%51%52%g
1441139111043512106421145Fairly effective40%9%56%48%29%30%53%zhi28%40%54%21%29%45%40%
15-32-25---2-215Not very effective4%-12%10%-5%6%---6%-4%4%
1---------1--1Not at all effective*---------3%--*
111-1-2311211-12Don't know3%9%-4%-5%4%5%4%9%3%7%-3%
33592017373174183016271145334Effective93%91%88%86%100%90%90%95%96%91%89%93%96%92%
16-32-25---3-216Not effective4%-12%10%-5%6%---8%-4%4%
31991815372969183016241143318Net88%91%77%76%100%84%84%95%96%91%80%93%92%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 148Q.10d How effective if at all do you feel the HTA is in relation to each of these activities?
- Producing codes of practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
19112421102417179189Very effective53%61%zg41%62%ze40%19%57%zd52%de
1447026525219122145Fairly effective40%34%51%h32%52%zf52%39%40%fh
1553556915Not very effective4%3%5%3%5%16%zc3%4%c
1----1-1Not at all effective*----2%zc-*
1152434612Don't know3%3%3%3%3%10%zc2%3%c
335194481549326302334Effective93%95%z92%94%92%71%95%zd92%d
1653557916Not effective4%3%5%3%5%19%zc3%4%c
319189451488819293318Net88%92%87%91%87%52%93%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 149Q.10d How effective if at all do you feel the HTA is in relation to each of these activities?
- Producing codes of practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
20332318418907323183611669829-3793123103203Very effective56%38%48%58%56%63%56%100%49%47%53%73%54%57%53%-79%zab46%63%43%54%56%
13042010712396-2118264475918198132375128Fairly effective36%43%41%34%37%27%44%-44%p46%p38%27%39%34%33%100%19%42%26%42%e39%e35%ep
13131426---24-454--233614Not very effective4%10%6%4%7%4%---5%5%-4%3%8%--12%5%6%3%4%
1--1------1--1------11Not at all effective*--*------1%--1%------**
151213-8--312-583-1-35716Don't know4%10%5%4%-6%--7%3%3%-4%5%6%-3%-5%9%4%4%
333742291301301234436631411315747146174446178332Effective92%81%89%91%93%90%100%100%93%92%91%100%93%92%86%100%97%88%89%85%93%92%
14131526---24-464--233615Not effective4%10%6%5%7%4%---5%6%-4%4%8%--12%5%6%3%4%
319639276271241234434581410915143146144242171317Net88%71%83%87%86%86%100%100%93%87%85%100%89%88%79%100%97%76%84%78%90%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 150Q.10e How effective if at all do you feel the HTA is in relation to each of these activities?
- Overseeing the consent requirements of the Human Tissue Act -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
20361292222381318820927203Very effective56%62%51%44%60%63%46%69%59%46%66%71%58%56%
130310713123351188315128Fairly effective36%29%45%38%35%35%40%26%35%44%25%29%33%35%
13--2115-2-1-214Not very effective4%--10%2%3%7%-6%-3%-4%4%
1-1----------1Not at all effective*-4%----------*
151-21-61-22-216Don't know4%9%-9%2%-7%5%-9%5%-5%4%
33392216353471182916281242332Effective92%91%96%82%95%97%87%95%94%91%92%100%91%92%
14-12115-2-1-215Not effective4%-4%10%2%3%7%-6%-3%-4%4%
31992114343365182716271241317Net88%91%92%72%93%94%80%95%87%91%89%100%87%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 151Q.10e How effective if at all do you feel the HTA is in relation to each of these activities?
- Overseeing the consent requirements of the Human Tissue Act -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
20313219106425195203Very effective56%64%zg37%65%ze41%12%62%zd56%deg
1306425484723101128Fairly effective36%31%48%h29%47%zf63%zc32%35%cf
1316176714Not very effective4%*12%zh1%7%f17%zc2%4%cfh
1-1-1-11Not at all effective*-2%-1%-**
15918431216Don't know4%4%2%5%4%7%4%4%
333195441548928296332Effective92%95%zg84%95%89%75%93%zd92%d
1417186815Not effective4%*14%zh1%8%zf17%zc3%4%cfh
319194371538121287317Net88%95%71%94%81%58%91%88%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 152Q.10e How effective if at all do you feel the HTA is in relation to each of these activities?
- Overseeing the consent requirements of the Human Tissue Act -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1711241492158622918338528427-259926102171Very effective47%10%50%47%66%40%50%67%61%zp47%47%53%43%49%49%-54%c46%18%47%c54%zc47%c
1304181208495114193275455171176132274133Fairly effective36%49%39%38%24%34%39%33%29%48%46%m47%44%zh32%31%100%36%30%26%40%39%37%
15-310-41-224-473-1-121014Not very effective4%-6%3%-3%11%-5%5%6%-3%4%6%-3%-2%3%5%4%
1--1-1-------1----1--1Not at all effective*--*-1%-------1%----2%--*
454238332--2---11258-44265444Don't know12%41%5%12%11%22%zklm--5%k---9%15%14%-8%24%53%zabe9%a2%12%akl
301542269281071134337641410713944142142247177304Effective83%59%89%84%89%74%89%100%90%p95%zp94%zp100%87%81%80%100%89%c76%44%88%c92%zc84%cp
16-311-51-224-473-1-221015Not effective4%-6%4%-3%11%-5%5%6%-3%4%6%-3%-4%3%5%4%
285539258281021034035601410213141141142046167289Net79%59%83%81%89%71%78%100%85%90%87%100%84%77%74%100%87%76%40%85%87%80%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 153Q.10f How effective if at all do you feel the HTA is in relation to each of these activities?
- Inspecting organisations to ensure good standards and appropriate procedures -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
1715126231733915817520171Very effective47%56%52%31%62%g49%40%47%50%47%55%43%44%47%
1303810101030712510621133Fairly effective36%31%36%51%27%30%37%37%37%30%34%50%44%37%
15-21116--11-214Not very effective4%-7%4%2%2%7%--4%3%-4%4%
1---------1--1Not at all effective*---------3%--*
45113361334321344Don't know12%13%4%13%9%18%15%16%13%19%6%7%7%12%
30182016322863162714271141304Effective83%87%89%82%88%80%77%84%87%77%89%93%88%84%
16-21116--12-215Not effective4%-7%4%2%2%7%--4%6%-4%4%
28581915312757162713251139289Net79%87%81%78%86%78%70%84%87%72%83%93%84%80%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 154Q.10f How effective if at all do you feel the HTA is in relation to each of these activities?
- Inspecting organisations to ensure good standards and appropriate procedures -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1711171489395163171Very effective47%57%zg27%55%ze39%15%51%zd47%dg
1306229545016115133Fairly effective36%30%56%zh33%50%zf44%36%37%h
1555558614Not very effective4%2%10%zh3%5%21%zc2%4%c
1----1-1Not at all effective*----2%zc-*
4521416763344Don't know12%10%8%10%7%18%10%12%c
301179431438922277304Effective83%88%z83%88%88%59%88%zd84%d
1655559615Not effective4%2%10%h3%5%23%zc2%4%ch
285175381398413271289Net79%85%73%85%83%36%86%80%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 155Q.10f How effective if at all do you feel the HTA is in relation to each of these activities?
- Inspecting organisations to ensure good standards and appropriate procedures -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
16522314417666-2414298508223-2510242183163Very effective46%19%49%45%53%46%44%-51%36%42%53%41%48%43%-54%52%49%38%43%45%
16961815213657320203676673251218202794170Fairly effective47%70%39%48%41%46%56%100%42%51%53%47%54%43%46%100%44%42%40%49%49%47%
15151016--242-573-1-32915Not very effective4%11%10%zr3%3%4%--5%10%3%-4%4%6%-3%-5%3%5%4%r
6-1613---11-242--1-337Not at all effective2%-2%2%4%2%---3%1%-1%2%3%--6%-6%1%2%
7--7-3--1-1--52---3237Don't know2%--2%-2%--2%-1%--3%3%---5%3%1%2%
334841296301311234434651411615548146184447177333Effective92%89%88%93%93%91%100%100%93%87%95%100%95%91%88%100%97%94%89%88%92%92%
21161629--253-6115-11351222Not effective6%11%12%r5%7%6%--5%13%4%-5%6%9%-3%6%5%9%6%6%r
313736280281221234229631410914444145174242165311Net86%78%75%88%87%85%100%100%88%74%91%100%90%84%79%100%95%88%84%78%86%86%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 156Q.10g How effective if at all do you feel the HTA is in relation to each of these activities?
- Giving advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
1656882019291013817719163Very effective46%59%37%39%56%g53%35%52%43%43%55%59%41%45%g
16941210151343715811527170Fairly effective47%41%54%52%40%39%52%38%50%44%36%41%57%47%
15-22-231212-115Not very effective4%-9%10%-5%4%4%5%4%6%-2%4%
6---2-5-1----7Not at all effective2%---5%-6%z-3%----2%
7----131-21--7Don't know2%----3%3%5%-9%3%--2%
334102118353271172916281246333Effective92%100%91%90%95%92%87%91%92%86%92%100%98%g92%
21-222281212-122Not effective6%-9%10%5%5%10%4%8%4%6%-2%6%
313101916333063162615261245311Net86%100%82%81%91%87%78%86%84%82%86%100%97%86%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 157Q.10g How effective if at all do you feel the HTA is in relation to each of these activities?
- Giving advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1651101085304157163Very effective46%54%zg20%52%ze30%10%50%zd45%deg
1698732695720145170Fairly effective47%42%62%zh43%56%zf53%46%47%h
1527296815Not very effective4%1%13%zh1%9%zf17%zc3%4%cfh
64242437Not at all effective2%2%5%2%2%12%zc1%2%c
73-33337Don't know2%1%-2%3%7%zc1%2%c
334196421558723303333Effective92%96%zg82%95%e86%63%96%zd92%deg
2169611111122Not effective6%3%18%zh4%11%zf30%zc3%6%ch
313190331497612291311Net86%93%64%91%75%34%92%86%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 158Q.10g How effective if at all do you feel the HTA is in relation to each of these activities?
- Giving advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1693211542074621920239588026-3211202685173Very effective47%29%45%48%62%51%k50%67%41%52%33%62%48%47%48%-67%zac58%40%47%44%48%k
106418947463118151953649191132112358110Fairly effective29%40%38%30%23%32%22%33%37%38%27%38%30%28%35%100%28%12%23%43%31%30%
13-311-3--234-372---22912Not very effective4%-6%4%-2%--3%8%6%-3%4%3%---4%3%5%3%
2-11-1---1---2----1-12Not at all effective1%-2%*-1%---3%---1%----2%-1%1%
7234584203-9-23-24337-361633865Don't know20%32%9%18%14%14%l28%-19%l-33%zlp-20%20%13%-5%30%32%zbe6%20%e18%el
2756392482712093373541149412846145133149143283Effective76%68%83%78%86%83%k72%100%78%k90%k60%100%77%75%83%100%95%zac70%63%91%ac75%78%ck
15-412-4--244-392---321014Not effective4%-8%4%-3%--3%10%z6%-3%5%3%---5%3%5%4%
2606352362711593353137149111944145132947133269Net72%68%75%74%86%80%72%100%75%79%54%100%75%70%80%100%95%70%58%88%70%74%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 159Q.10h How effective if at all do you feel the HTA is in relation to each of these activities?
- Ensuring the safety and quality of human tissue, cells and organs used for patient treatment -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
16998111819317131119522173Very effective47%91%35%56%48%55%38%38%42%59%62%44%48%48%
10611059102710946513110Fairly effective29%9%42%26%26%30%33%52%27%23%21%42%28%30%
13-221-2-3---212Not very effective4%-8%10%3%-2%-11%---5%3%
2-----1---1--2Not at all effective1%-----1%---3%--1%
72-32952026342965Don't know20%-14%9%24%15%25%10%19%17%14%15%18%18%
275101816273058172215251036283Effective76%100%78%82%73%85%72%90%70%83%83%85%76%78%
15-221-3-3-1-214Not effective4%-8%10%3%-3%-11%-3%-5%4%
260101614263056171815241033269Net72%100%69%72%71%85%68%90%59%83%80%85%71%74%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 160Q.10h How effective if at all do you feel the HTA is in relation to each of these activities?
- Ensuring the safety and quality of human tissue, cells and organs used for patient treatment -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1691181793366164173Very effective47%58%zg33%57%ze36%17%52%zd48%deg
106531845381591110Fairly effective29%26%35%27%38%41%29%30%
13-10-114812Not very effective4%-19%zh-11%zf12%zc3%3%cfh
21-1-112Not at all effective1%*-1%-2%*1%
723372516105265Don't know20%16%13%15%15%28%16%18%c
275171351377421255283Effective76%84%zg68%84%z74%58%81%zd78%d
151101115914Not effective4%*19%zh1%11%zf14%zc3%4%cfh
260170261366416246269Net72%83%49%83%63%44%78%74%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 161Q.10h How effective if at all do you feel the HTA is in relation to each of these activities?
- Ensuring the safety and quality of human tissue, cells and organs used for patient treatment -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1351171201747821415268396920-247101678135Very effective37%10%36%38%53%33%61%67%30%39%38%53%32%40%36%-51%c36%21%29%41%c37%c
1135119974141198283464816183142363112Fairly effective31%59%23%31%23%28%33%33%41%l20%41%zl18%37%28%29%100%16%18%28%43%e33%e31%e
22-421110--23618104-11351323Not very effective6%-8%7%4%7%--5%8%9%9%6%6%8%-3%6%5%9%7%6%
7--7-3---14-34----1257Not at all effective2%--2%-2%---3%5%z-2%3%----2%3%2%2%
85315707441-111243284015-1482283385Don't know23%32%33%22%21%30%zk6%-24%k31%k6%20%23%23%27%-30%40%44%zab15%17%23%ak
2486282202488123342355108411736132102439140247Effective69%68%59%69%76%61%94%100%71%59%79%zlp71%69%68%65%100%67%54%49%72%c73%zc68%c
29-428112--2410110144-11371830Not effective8%-8%9%4%8%--5%10%14%z9%8%8%8%-3%6%7%12%9%8%
21962419123761233119459741023113092132123216Net60%68%52%60%72%53%94%100%66%48%65%62%61%60%57%100%64%48%42%60%64%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 162Q.10i How effective if at all do you feel the HTA is in relation to each of these activities?
- Ensuring dignity and respect for the deceased -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
135539151426912813517135Very effective37%48%15%44%40%40%32%46%39%43%43%38%36%37%
1134741113248748517112Fairly effective31%43%31%18%29%36%30%44%22%24%27%41%36%31%
221422-6-2122323Not very effective6%9%16%11%5%-8%-6%4%6%14%6%6%
7----111212--7Not at all effective2%----3%1%5%5%5%6%--2%
85-959724194611085Don't know23%-38%27%26%21%29%5%28%23%19%7%22%23%
24891112252751171912211034247Effective69%91%47%62%69%76%62%90%61%68%70%79%72%68%
2914221713232330Not effective8%9%16%11%5%3%9%5%11%9%11%14%6%8%
219871023264316161118831216Net60%82%31%51%64%73%53%85%50%58%59%65%67%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 163Q.10i How effective if at all do you feel the HTA is in relation to each of these activities?
- Ensuring dignity and respect for the deceased -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
13594770261133135Very effective37%46%zg13%43%e26%4%42%zd37%deg
113641652369100112Fairly effective31%31%31%32%36%24%32%31%
2241331691423Not very effective6%2%26%zh2%16%zf24%zc5%6%cfh
7-4-5347Not at all effective2%-9%zh-5%zf7%zc1%2%c
8542113917156485Don't know23%21%22%24%17%41%zc20%23%c
248158231226210234247Effective69%77%zg44%75%ze62%28%74%zd68%dg
29418321111930Not effective8%2%34%zh2%21%zf31%zc6%8%cfh
219154511941-1215216Net60%75%10%73%40%-3%68%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 164Q.10i How effective if at all do you feel the HTA is in relation to each of these activities?
- Ensuring dignity and respect for the deceased -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
15331814016824-1716138487823-3211312261157Very effective42%38%38%44%50%57%zkm33%-35%k41%k19%53%39%46%42%-67%zab58%63%za41%32%43%ak
99413911146311471973447151143132249102Fairly effective27%49%28%28%36%32%22%33%29%17%28%47%28%27%27%100%30%18%26%40%26%28%
23-223281-354-5127--2251524Not very effective6%-4%7%7%5%11%-7%13%5%-4%7%13%--12%4%9%8%7%
4--4-3----2-122---1224Not at all effective1%--1%-2%----3%-1%1%3%---2%3%1%1%
83114622642141131-34329-12336574Don't know23%12%30%19%7%4%33%67%29%p28%p45%zp-28%z19%16%-3%12%5%6%34%zbce21%bcep
2528312302712771312333148212538146144444110259Effective70%88%66%72%86%89%zklm56%33%65%k59%47%100%68%73%69%100%97%zab76%89%za81%a57%72%ak
27-2272101-355-6149--2371728Not effective7%-4%8%7%7%11%-7%13%8%-5%8%16%zi--12%5%12%e9%8%
225829203251176127182714771112914612423793231Net62%88%62%64%79%82%44%33%58%46%40%100%63%65%53%100%97%64%84%69%49%64%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 165Q.10j How effective if at all do you feel the HTA is in relation to each of these activities?
- Regulation to ensure that living donors are not coerced and understand the risks of organ or bone marrow donation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
1536611191830891013522157Very effective42%61%25%57%52%53%37%44%30%54%42%39%47%43%
993105762581258212102Fairly effective27%30%44%25%19%17%31%41%38%29%25%21%26%28%
23-11237-3122324Not very effective6%-4%4%5%8%9%-8%4%8%14%6%7%
4----121--1--4Not at all effective1%----3%2%5%--3%--1%
831638718272731074Don't know23%9%27%14%23%20%22%10%24%14%22%26%22%21%
2529161626245516211520734259Effective70%91%68%82%72%70%67%85%68%83%67%60%72%72%
27-1124913132328Not effective7%-4%4%5%10%11%5%8%4%11%14%6%8%
2259151524214615191417631231Net62%91%64%77%67%59%56%81%60%79%56%46%67%64%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 166Q.10j How effective if at all do you feel the HTA is in relation to each of these activities?
- Regulation to ensure that living donors are not coerced and understand the risks of organ or bone marrow donation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1531041181304152157Very effective42%51%zg20%50%ze29%12%48%zd43%deg
9956134630791102Fairly effective27%27%26%28%29%19%29%28%
23413415101424Not very effective6%2%25%zh3%15%zf27%zc4%7%cfh
4-3-3314Not at all effective1%-5%zh-3%f9%zc*1%c
8341133223125974Don't know23%20%24%20%23%33%c19%21%c
252160241275911243259Effective70%78%zg46%78%ze59%31%77%zd72%deg
27415418131528Not effective7%2%30%zh3%18%zf36%zc5%8%cfh
225155912341-2228231Net62%76%17%75%41%-5%72%64%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 167Q.10j How effective if at all do you feel the HTA is in relation to each of these activities?
- Regulation to ensure that living donors are not coerced and understand the risks of organ or bone marrow donation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
101211878415-1012175235514-1831985098Very effective28%19%23%27%26%28%39%-22%31%24%35%19%32%zi26%-38%b18%39%zb15%26%27%i
2025271751969623119449819019123132423113199Fairly effective56%60%58%55%61%48%50%67%66%p48%64%p65%66%zgh53%g34%100%49%72%49%43%59%z55%g
32172931611354-81413-3-2131835Not very effective9%11%15%9%9%11%11%33%7%13%6%-7%8%23%zhi-5%-4%23%zace9%10%
7-18-4--121-243---1348Not at all effective2%-2%2%-3%--2%5%1%-1%2%5%---2%6%2%2%
201121114--213-877-4237622Don't know6%10%2%6%4%10%--3%3%4%-7%4%12%-8%11%7%12%a3%6%a
303739262281101124231611410414633141174331163297Effective84%79%81%82%87%76%89%67%88%79%88%p100%85%g85%g60%100%87%b89%88%b58%85%zb82%bg
39183732011475-101815-3-3162143Not effective11%11%17%11%9%14%11%33%8%18%8%-8%10%28%zhi-5%-5%30%zace11%12%
2646312252589101382456149412817138174115142255Net73%68%65%71%78%62%78%33%80%61%81%100%77%75%32%100%81%89%82%28%74%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 168Q.10k How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing an effective website -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
101546118206861031198Very effective28%50%17%32%31%24%25%31%25%32%32%27%23%27%
20241592118401118915831199Fairly effective56%41%66%44%57%51%49%59%59%49%51%66%67%55%
32132-413-4211435Not very effective9%9%12%10%-12%i16%zi-14%10%3%7%8%10%i
7-112---1-3-18Not at all effective2%-4%5%5%---3%-8%-2%2%
20--23582-22--22Don't know6%--9%8%13%a9%a10%-9%6%--6%
30391915322661172615251142297Effective84%91%84%77%87%74%74%90%84%81%83%93%90%g82%
391432413-5231543Not effective11%9%16%15%5%12%16%-16%10%11%7%10%12%
26481512302247172113221037255Net73%82%68%62%83%62%58%90%67%71%72%85%80%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 169Q.10k How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing an effective website -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
101757641329698Very effective28%37%zg13%39%ze13%4%30%zd27%deg
20210926806015179199Fairly effective56%53%49%49%59%41%56%55%f
32714918122335Not very effective9%4%27%zh5%18%zf32%zc7%10%cfh
73333268Not at all effective2%2%6%2%3%5%2%2%
201038771322Don't know6%5%5%5%7%19%zc4%6%c
303184321437316274297Effective84%90%zg62%88%ze72%45%87%zd82%deg
3911171221132943Not effective11%5%33%zh7%21%zf37%zc9%12%cfh
26417315131513245255Net73%85%29%80%51%8%77%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 170Q.10k How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing an effective website -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
7729699383-105115273512-11310183780Very effective21%19%18%22%29%27%28%-22%13%15%35%22%21%22%-24%17%19%34%20%22%
17051915014706123173396176241287252286170Fairly effective47%60%41%47%43%49%44%33%48%43%49%65%50%45%43%100%60%36%51%41%45%47%
641105441621111213-26268-34774061Not very effective18%11%20%17%14%11%17%33%24%p31%zp19%-22%15%15%-5%24%14%12%21%ze17%ep
10-27-1-1114-351---2-79Not at all effective3%-4%2%-1%-33%2%3%5%p-2%3%2%---4%-4%2%
4118384181-248-52810-54672043Don't know11%10%17%12%14%12%11%-5%10%12%-4%16%zi17%i-11%24%12%12%11%12%i
2477282192310991332244148811136140103541124250Effective68%79%59%69%72%76%l72%33%70%56%64%100%72%65%65%100%84%za52%70%75%65%69%a
741116141722121317-293210-34974770Not effective20%11%24%19%14%12%17%67%25%p34%zp24%p-24%18%17%-5%24%18%12%25%ze19%ep
17361615819927-121927145980261375263476180Net48%68%34%50%59%64%56%-33%44%22%40%100%49%47%48%100%79%28%53%63%40%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 171Q.10l How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing training events and workshops -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
772469121545482980Very effective21%18%16%32%25%34%18%21%15%24%26%20%20%22%
17081191912361017812819170Fairly effective47%82%50%45%51%34%44%55%55%44%42%67%42%47%
64-522619352521261Not very effective18%-21%9%5%16%23%i14%15%14%17%13%25%i17%i
10---2-1-113-29Not at all effective3%---5%-1%-3%4%9%-4%2%
41-3356112432-443Don't know11%-14%14%15%16%14%10%13%14%7%-9%12%
247101515282450142212201029250Effective68%100%66%77%76%68%62%76%70%68%67%87%62%69%
74-523620353821470Not effective20%-21%9%9%16%24%14%17%18%26%13%29%i19%
1731010132418301216912915180Net48%100%45%69%67%52%37%62%53%50%41%74%32%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 172Q.10l How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing training events and workshops -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
77595461617980Very effective21%29%zg9%28%ze16%2%25%zd22%dg
170992472499159170Fairly effective47%48%46%44%48%25%50%zd47%d
6427142520124861Not very effective18%13%28%zh15%20%34%zc15%17%ch
105253549Not at all effective3%2%5%3%3%14%zc1%2%c
41156161292743Don't know11%7%12%10%12%25%zc8%12%ch
247159291186510238250Effective68%78%zg55%73%64%27%75%zd69%dg
7431172924185170Not effective20%15%32%zh18%23%48%zc16%19%ch
173127128941-8187180Net48%62%23%55%41%-21%59%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 173Q.10l How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing training events and workshops -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
771107110384-105106224113-1848173481Very effective21%10%22%22%30%26%k33%-20%13%14%44%18%24%23%-38%zac24%16%31%18%22%ak
13521611913463222153275359141186141479133Fairly effective37%19%35%37%40%32%22%67%46%38%46%zp47%43%g34%26%100%38%34%28%26%41%z37%
46164231711899-162210---3133248Not very effective13%11%13%13%9%12%6%33%17%23%13%-13%13%18%---5%25%ce17%zce13%ce
7-25-3--113-25----1247Not at all effective2%-4%2%-2%--2%3%4%-1%3%----2%3%2%2%
97512817415-79161304418-1182484293Don't know27%60%26%26%21%28%39%-15%23%23%9%25%26%34%-24%42%49%zabe15%22%26%am
21232719022847231204113749927136112231113214Effective59%29%57%60%70%58%56%67%66%51%60%91%61%58%49%100%76%zc58%44%57%59%c59%c
5318483191191011-172810---3153655Not effective15%11%17%15%9%13%6%33%19%26%17%-14%16%18%---7%28%zce19%zce15%e
1592191421965612310301357721713611181677159Net44%18%40%45%61%45%50%33%48%25%44%91%47%42%31%100%76%58%37%29%40%44%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 174Q.10m How effective if at all do you feel the HTA is in relation to each of these activities?
- Working with other organisations to ensure joined up regulation, advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
77426101213435821281Very effective21%37%10%30%27%34%g16%22%10%27%28%15%26%22%
1355107125271113611816133Fairly effective37%54%45%38%33%15%33%60%41%31%37%65%35%37%h
46-54541116222948Not very effective13%-20%18%12%12%13%4%20%9%5%15%18%13%
7----1411-1--7Not at all effective2%----3%4%4%3%-3%--2%
97163101327286811093Don't know27%9%25%14%27%36%33%10%27%33%26%6%21%26%
21291313221740161611201028214Effective59%91%55%68%61%49%49%82%51%58%65%80%61%59%
53-54551427222955Not effective15%-20%18%12%15%17%8%22%9%8%15%18%15%
1599810181226149917820159Net44%91%35%50%48%34%32%73%28%49%57%65%42%44%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 175Q.10m How effective if at all do you feel the HTA is in relation to each of these activities?
- Working with other organisations to ensure joined up regulation, advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
776244614-8181Very effective21%30%zg8%28%ze14%-26%zd22%deg
135791461346125133Fairly effective37%39%27%37%34%17%39%zd37%d
461415132793948Not very effective13%7%29%zh8%27%zf25%zc12%13%fh
71413527Not at all effective2%*8%zh1%3%14%zc1%2%ch
9749144322167093Don't know27%24%27%26%22%43%zc22%26%c
21214118106486206214Effective59%69%zg35%65%ze48%17%65%zd59%deg
5315201430144055Not effective15%7%38%zh9%30%zf39%zc13%15%cfh
159126-19218-8165159Net44%62%-2%56%18%-22%52%44%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 176Q.10m How effective if at all do you feel the HTA is in relation to each of these activities?
- Working with other organisations to ensure joined up regulation, advice and guidance -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
611753620318511118346-93973260Very effective17%10%14%17%20%14%22%33%17%13%17%9%15%20%12%-19%18%18%12%17%16%
1262141131738312019298525216112752182128Fairly effective35%21%30%35%53%27%22%33%43%p48%p42%p56%42%zh30%30%100%25%36%11%39%c43%zce35%cp
25-52311111363-7127-1-291427Not very effective7%-10%7%3%8%6%33%7%16%k4%-6%7%13%-3%-4%17%zc7%7%
13-311-3---17-471---32812Not at all effective4%-6%4%-2%---3%10%zmp-4%4%2%---5%3%4%3%
1376191198716-168195406624-259311555135Don't know38%70%40%37%24%49%zkl50%-34%21%27%35%33%39%44%-54%zab46%63%zab28%29%37%akl
1873211662358622824419708623121101428114188Effective52%30%44%52%73%41%44%67%60%p61%p59%p65%57%50%41%100%44%54%28%52%c60%zc52%cp
38-834115113710-12198-1-4112239Not effective10%-16%11%3%10%6%33%7%18%14%-10%11%14%-3%-9%20%e12%11%
149313132224351251731958661511910101791149Net41%30%28%41%70%30%39%33%53%43%45%65%48%39%27%100%41%54%19%31%48%41%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 177Q.10n How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing value for money for the tax payer -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
611-775764493760Very effective17%10%-34%18%14%9%31%13%22%32%22%16%16%g
126413713113051149616128Fairly effective35%43%57%35%37%30%37%24%34%22%31%49%34%35%
25--13573222-327Not very effective7%--4%8%15%8%15%5%10%6%-6%7%
13-111-3-312-112Not at all effective4%-4%5%2%-3%-11%5%6%-2%3%
13759413143561188420135Don't know38%46%39%22%35%41%43%30%37%42%26%29%42%37%
187513132015371015819923188Effective52%54%57%69%55%44%45%55%47%43%63%71%50%52%
38-1245103533-439Not effective10%-4%10%10%15%12%15%16%15%11%-8%11%
14951212161027810515920149Net41%54%53%59%45%29%34%40%31%28%51%71%42%41%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 178Q.10n How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing value for money for the tax payer -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
614933710-5960Very effective17%24%zg5%23%ze10%-19%zd16%dg
126831563364123128Fairly effective35%40%z30%38%36%10%39%zd35%d
2561061571827Not very effective7%3%19%zh4%15%zf20%zc6%7%cfh
1328294812Not at all effective4%1%15%zh1%9%zf12%zc3%3%cfh
1376616563121109135Don't know38%32%31%34%30%57%zc34%37%ch
18713118100474182188Effective52%64%zg35%61%ze46%10%58%zd52%dg
38818823122539Not effective10%4%35%zh5%23%zf32%zc8%11%cfh
149124*9223-8156149Net41%60%*56%23%-22%49%41%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 179Q.10n How effective if at all do you feel the HTA is in relation to each of these activities?
- Providing value for money for the tax payer -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
5116465202-778115297-102472852Very effective14%10%12%14%17%14%17%-15%18%12%9%12%17%12%-21%12%9%12%15%14%
1311161141442822312268505219116792177130Fairly effective36%10%34%36%44%29%61%67%48%zp31%37%56%41%31%35%100%33%36%18%38%c40%zc36%ch
69-7697251-613204243113-522174773Not very effective19%-15%22%23%17%6%-13%34%zmp29%zmp27%20%18%24%-11%12%4%31%ce25%zc20%c
29172428-1359-11135-1-371929Not at all effective8%11%15%7%6%6%-33%7%12%13%-9%8%8%-3%-5%12%10%8%
82611673482-8261214511-1583232078Don't know23%70%24%21%11%33%zklm17%-17%5%9%9%17%26%z20%-32%ab40%65%zabe6%10%22%abkl
1822221591962102301933965812612691327105182Effective50%19%46%50%60%43%78%67%63%zp49%49%65%53%48%47%100%54%c48%26%51%c55%zc50%c
9811493933111018294364418-6242366102Not effective27%11%30%29%29%23%6%33%20%46%zmp42%zmp27%29%26%33%-13%12%9%43%zce34%zce28%ce
84186710299120145293781197944080Net23%8%16%21%32%20%72%33%43%3%6%38%24%22%15%100%41%36%18%7%21%22%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 180Q.10o How effective if at all do you feel the HTA is in relation to each of these activities?
- Reducing the burden on your sector -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
512-364745681652Very effective14%21%-15%17%12%8%21%16%32%26%7%12%14%
13131581413296779415130Fairly effective36%26%64%42%39%37%35%34%23%40%30%31%33%36%
69245681557-731173Not very effective19%21%17%25%15%23%18%25%23%-22%29%25%20%
29-411211-422-429Not at all effective8%-16%5%2%5%13%-14%9%6%-8%8%
8231310820473541078Don't know23%32%4%13%26%23%25%20%24%19%16%33%22%22%
1825151120173610121317521182Effective50%47%64%57%56%49%44%55%40%72%57%38%45%50%
982767102551128315102Not effective27%21%33%30%18%29%31%25%37%9%28%29%33%28%
8437514710611191680Net23%26%31%27%38%20%13%30%3%63%29%10%13%22%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 181Q.10o How effective if at all do you feel the HTA is in relation to each of these activities?
- Reducing the burden on your sector -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
51451308-5252Very effective14%22%zg2%18%e8%-16%zd14%deg
13191775285124130Fairly effective36%45%zg14%46%ze28%14%39%zd36%deg
6925212136106073Not very effective19%12%40%zh13%35%zf28%19%20%fh
29518419111829Not at all effective8%3%34%zh2%19%zf30%zc6%8%cfh
823853410106378Don't know23%19%11%21%e10%28%20%22%ceg
1821368105365176182Effective50%67%zg15%64%ze36%14%56%zd50%deg
98303825552178102Not effective27%15%74%zh15%54%zf58%zc25%28%cfh
84106-3181-19-169880Net23%52%-59%49%-19%-44%31%22%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 182Q.10o How effective if at all do you feel the HTA is in relation to each of these activities?
- Reducing the burden on your sector -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
3117244111-44618157-61131931Very effective9%10%14%8%13%7%11%-8%10%9%9%7%9%12%-13%c6%2%6%10%c9%c
83197812311-1181973137121987174487Fairly effective23%10%20%24%38%21%11%-24%21%27%47%25%22%21%100%20%42%14%32%23%24%
4819415152-8127-182210-112123349Not very effective13%11%19%13%16%10%17%-17%31%zkp10%-15%13%17%-3%6%4%22%ce17%zce14%ce
16-314-5-1234-4101---331016Not at all effective4%-6%4%-4%-33%3%8%6%-4%6%2%---5%6%5%4%
1846201621183822212336618626-309371885180Don't know51%70%41%51%33%58%zl61%67%47%30%47%44%50%50%47%-64%ab46%75%zab34%44%50%al
11421610216413-1512258395318116982163118Effective31%19%34%32%51%29%22%-33%31%36%56%32%31%33%100%33%48%16%38%c33%c33%c
641125552021101511-223211-114154365Not effective18%11%24%17%16%14%17%33%20%39%zkp17%-18%19%19%-3%6%9%28%ce22%zce18%ce
50154711221-16-3138172181148362053Net14%8%10%15%35%15%6%-33%12%-8%19%56%14%12%14%100%30%42%7%10%11%15%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 183Q.10p How effective if at all do you feel the HTA is in relation to each of these activities?
- Supporting business and innovation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
311133352414-331Very effective9%10%4%15%9%9%7%12%13%6%14%-7%9%
8315971015556831087Fairly effective23%12%22%48%20%30%19%24%15%36%28%28%23%24%
48-5264133425-549Not very effective13%-21%10%16%11%16%16%13%10%17%-12%14%
16-1-3141311-216Not at all effective4%-4%-7%3%4%5%11%4%3%-4%4%
1848115181644815811926180Don't know51%78%48%27%48%47%54%44%48%44%38%72%56%50%
114261211132179813314118Effective31%22%26%63%29%39%25%36%28%41%42%28%29%33%
64-6285174836-765Not effective18%-25%10%23%14%20%21%24%14%20%-15%18%
502*1138431573653Net14%22%1%54%7%24%5%15%4%27%22%28%14%15%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 184Q.10p How effective if at all do you feel the HTA is in relation to each of these activities?
- Supporting business and innovation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
31251186-3131Very effective9%12%zg2%11%6%-10%z9%
83635511618587Fairly effective23%31%zg10%31%ze16%3%27%zd24%deg
481612172694049Not very effective13%8%23%zh10%25%zf24%13%14%h
16585851116Not at all effective4%3%15%zh3%8%14%zc3%4%c
1849526724522149180Don't know51%47%50%44%45%59%47%50%c
11488669221116118Effective31%43%zg11%42%ze22%3%37%zd33%deg
6422202233145165Not effective18%11%38%zh14%33%zf38%zc16%18%ch
5066-1447-11-136653Net14%32%-27%29%-11%-34%21%15%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 185Q.10p How effective if at all do you feel the HTA is in relation to each of these activities?
- Supporting business and innovation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
881108413393-811128304213-2379124292Very effective24%10%21%26%40%27%22%-17%28%18%53%24%24%23%-48%zabc36%18%22%22%25%
13721712612624224151944963261127163273141Fairly effective38%19%36%40%37%43%k33%67%51%zk39%28%29%40%37%47%100%25%36%33%60%zace38%39%k
161213241-224-565---131116Not very effective4%11%4%4%6%3%11%-5%5%5%-4%3%8%---2%6%6%4%
5-33-2---32--6-----336Not at all effective1%-6%zr1%-1%---7%z3%--4%zi-----6%1%2%r
1165169353741138323385412-13523362107Don't know32%60%33%29%17%26%33%33%27%21%46%zlmp18%31%32%22%-27%b28%47%zabe6%33%b30%b
2253272102410172322632127910438135132544115233Effective62%29%58%66%77%70%k56%67%68%k67%k46%82%65%61%70%100%73%c72%51%81%zac60%64%ack
211416261-255-5125---171422Not effective6%11%9%5%6%4%11%-5%12%8%-4%7%8%---2%12%e7%6%
20422319422956230222612749234135132437101212Net56%18%48%61%70%66%44%67%63%55%38%82%61%54%62%100%73%72%49%69%53%58%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 186Q.10q How effective if at all do you feel the HTA is in relation to each of these activities?
- Working with Government and Europe to implement legislation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
88327813178651021292Very effective24%29%7%36%23%38%21%40%19%27%33%15%25%25%
13741310171127711611520141Fairly effective38%45%56%50%46%33%33%37%34%34%35%44%42%39%
16-21115--121216Not very effective4%-9%4%2%4%7%--5%6%7%3%4%
5-----4-3----6Not at all effective1%-----4%-8%----2%
1163621192941268414107Don't know32%26%28%10%29%26%35%23%39%34%26%34%29%30%
2257141725244415161121731233Effective62%74%63%86%69%70%54%77%53%62%69%58%67%64%g
21-21119-3121222Not effective6%-9%4%2%4%11%-8%5%6%7%3%6%
2047121624233515141019630212Net56%74%54%82%66%66%43%77%45%57%63%51%64%58%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 187Q.10q How effective if at all do you feel the HTA is in relation to each of these activities?
- Working with Government and Europe to implement legislation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
887165522-9192Very effective24%35%zg11%34%ze22%-29%zd25%dg
1378020673810129141Fairly effective38%39%39%41%38%26%41%39%
1648477916Not very effective4%2%15%zh2%7%18%zc3%4%ch
53315246Not at all effective1%1%7%zh1%5%zf5%1%2%
116471536291883107Don't know32%23%29%22%29%51%zc26%30%cfh
225151261226010220233Effective62%74%zg49%75%ze59%26%70%zd64%dg
2171151281322Not effective6%3%21%zh3%12%zf23%zc4%6%cfh
20414415117481207212Net56%70%28%72%47%3%65%58%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 188Q.10q How effective if at all do you feel the HTA is in relation to each of these activities?
- Working with Government and Europe to implement legislation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
88110829404-11712626489-20411124289Very effective24%10%20%26%30%28%33%-24%18%18%44%21%28%17%-43%zac24%23%22%22%25%
17132614515666227203185678281197232693170Fairly effective47%38%54%45%46%46%44%67%58%51%45%56%46%46%51%100%41%36%47%47%49%47%
4714455151-5814-22199-132123149Not very effective13%11%8%14%17%11%6%-10%21%21%-18%11%16%-3%18%4%22%ce16%ce14%ce
10-28-2--115-44----2-79Not at all effective3%-4%2%-1%--2%3%8%zp-4%3%----4%-4%2%
46464022121336-14229-641151845Don't know13%41%14%13%7%15%17%33%7%8%9%-11%13%16%-13%22%23%za9%9%12%a
25943522624106102392743148212637140113537135259Effective72%48%75%71%76%73%78%67%81%k69%63%100%67%74%67%100%84%60%70%69%71%72%
5716525171-6919-26239-133123858Not effective16%11%12%16%17%12%6%-12%23%28%zmp-22%13%16%-3%18%7%22%e20%zce16%ce
2023301741988923318241456103281388312696201Net56%37%63%55%59%62%72%67%70%46%35%100%46%60%51%100%81%42%63%47%50%55%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 189Q.10r How effective if at all do you feel the HTA is in relation to each of these activities?
- Sharing best practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
88417101417655113789Very effective24%39%6%34%28%40%zag21%33%16%27%35%26%14%25%
1714148171042811913528170Fairly effective47%44%60%42%46%30%51%h41%34%51%45%46%59%h47%h
47172561015133649Not very effective13%9%30%10%15%18%12%5%18%4%9%21%13%14%
101----313-2--9Not at all effective3%8%----3%5%8%-6%--2%
46-13441038321645Don't know13%-4%14%11%12%12%17%24%18%6%7%13%12%
2598151527245914151424934259Effective72%83%66%76%74%70%73%74%50%78%80%72%73%72%
57272561228143658Not effective16%17%30%10%15%18%15%9%26%4%15%21%13%16%
20268132218471271320628201Net56%65%36%67%59%53%57%65%24%73%65%51%60%55%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 190Q.10r How effective if at all do you feel the HTA is in relation to each of these activities?
- Sharing best practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
886655116-8889Very effective24%32%zg9%31%ze16%-28%zd25%deg
17110317834511158170Fairly effective47%50%g34%51%45%29%50%zd47%d
4717181425103949Not very effective13%8%35%zh8%25%zf27%zc12%14%fh
102425549Not at all effective3%1%8%zh1%5%14%zc1%2%ch
46177149112745Don't know13%8%14%8%9%29%zc9%12%cfh
259169221346111246259Effective72%82%zg43%82%ze60%29%78%zd72%deg
5719231531154358Not effective16%9%43%zh9%30%zf41%zc14%16%cfh
202150*11930-5203201Net56%73%-1%73%30%-12%64%55%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 191Q.10r How effective if at all do you feel the HTA is in relation to each of these activities?
- Sharing best practice -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
Regulation toensure that
Working withliving donorsEnsuring theotherare notsafety andInspecting
organisationscoerced andquality oforganisationsWorking withto ensureunderstandhuman tissue,to ensureOverseeingGovernmentProvidingjoined upProvidingthe risks ofEnsuringcells andgoodthe consent
and Europe toSupportingReducing thevalue forregulation,trainingProviding anorgan or bonedignity andorgans usedstandards andrequirementsProducingImprovingImprovingSharing bestimplementbusiness andburden onmoney for theadvice andevents andeffectivemarrowrespect forfor patientGiving adviceappropriateof the Humancodes ofProvidingprofessionalpublic
practicelegislationinnovationyour sectortax payerguidanceworkshopswebsitedonationthe deceasedtreatmentand guidanceproceduresTissue Actpracticelicencesconfidenceconfidence
362362362362362362362362362362362362362362362362362362Unweighted total
362362362362362362362362362362362362362362362362362362Weighted total
899231526081809815713517316317120318921510884Very effective25%25%9%14%16%22%22%27%43%37%48%45%47%56%52%59%30%23%
17014187130128133170199102112110170133128145108192201Fairly effective47%39%24%36%35%37%47%55%28%31%30%47%37%35%40%30%53%56%
491649732748613524231215141415103737Not very effective14%4%14%20%7%13%17%10%7%6%3%4%4%4%4%3%10%10%
9616291279847271111122Not at all effective2%2%4%8%3%2%2%2%1%2%1%2%****3%*
45107180781359343227485657441612281438Don't know12%30%50%22%37%26%12%6%21%23%18%2%12%4%3%8%4%10%
259233118182188214250297259247283333304332334323300286Effective72%64%33%50%52%59%69%82%72%68%78%92%84%92%92%89%83%79%
5822651023955704328301422151516114838Not effective16%6%18%28%11%15%19%12%8%8%4%6%4%4%4%3%13%11%
2012125380149159180255231216269311289317318312252247Net55%58%15%22%41%44%50%70%64%60%74%86%80%88%88%86%70%68%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 192Q.10 How effective if at all do you feel the HTA is in relation to each of these activities?
- Summary -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1801231581868722919269588526-278232398178A great deal50%10%48%49%55%48%56%67%61%zk49%38%62%47%50%48%-56%40%47%42%51%49%k
15161913411646116163555468261188183079154A fair amount42%71%41%42%34%45%44%33%34%40%51%m38%45%40%47%100%38%42%37%55%41%43%
17-413-3--245-591---3-1215Not very much5%-8%4%-2%--3%10%p8%p-4%5%2%---7%-6%z4%
1--1------1-1-------11Not at all*--*------1%-1%-------**
711724--1----62--23217No opinion2%10%2%2%7%3%--2%----3%i3%--12%5%a3%*2%a
611614----1-42--312-16Don't know2%10%2%2%4%3%----1%-3%1%--5%a6%4%-*2%a
331742292281321234535621411215452145154252177332Confident91%81%89%92%89%92%100%100%95%90%90%100%92%90%95%100%95%82%84%97%c93%92%c
18-414-3--246-691---3-1316Not confident5%-8%4%-2%--3%10%p9%zp-5%5%2%---7%-7%z4%
313738277281301234331561410614551145153852164316Net86%81%81%87%89%90%100%100%92%79%81%100%87%85%93%100%95%82%77%97%86%87%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 193Q.11 To what extent, if at all, do you have confidence in the HTA as a regulator of the removal, storage, use and disposal of human tissue?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
180411112016347141218724178A great deal50%44%46%56%54%46%41%37%45%68%59%61%52%49%
15151081617371113410519154A fair amount42%47%46%39%42%49%45%58%41%23%35%39%40%43%
17-21--5-322-215Not very much5%-8%5%--6%-8%9%6%-4%4%
1-----1------1Not at all*-----1%------*
71---2211---17No opinion2%9%---5%2%4%4%---2%2%
6---1-3-1---16Don't know2%---3%-4%-3%---2%2%
33192119353371182716281243332Confident91%91%92%95%97%95%87%96%85%91%94%100%93%92%
18-21--6-322-216Not confident5%-8%5%--7%-8%9%6%-4%4%
31391918353365182415271241316Net86%91%83%90%97%95%80%96%77%81%88%100%89%87%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 194Q.11 To what extent, if at all, do you have confidence in the HTA as a regulator of the removal, storage, use and disposal of human tissue?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1801211194354172178A great deal50%59%zg22%58%ze34%11%54%zd49%deg
1517628615222128154A fair amount42%37%54%h38%52%zf61%zc40%43%ch
172112127715Not very much5%1%21%zh1%12%zf19%zc2%4%cfh
1----1-1Not at all*----2%zc-*
73242137No opinion2%1%3%2%2%3%1%2%c
63-2-156Don't know2%2%-1%-3%2%2%
331197401558727300332Confident91%96%zg76%95%ze86%73%95%zd92%deg
182112128716Not confident5%1%21%zh1%12%zf21%zc2%4%cfh
313195291537419293316Net86%95%56%94%74%51%93%87%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 195Q.11 To what extent, if at all, do you have confidence in the HTA as a regulator of the removal, storage, use and disposal of human tissue?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
22122026--33817105-1--51622Strongly agree6%11%4%6%6%4%--7%8%12%z9%5%6%8%-3%--9%8%zc6%
76-12704313-131214433301218-5184678Tend to agree21%-25%22%13%22%22%-27%30%21%27%27%17%23%100%16%-11%34%c24%c22%c
843117133721115203254113-1141793982Neither agree nor23%29%24%22%11%26%17%33%23%13%29%18%21%24%24%-24%24%35%za17%21%23%disagree
10311293133942147204364914-148111654103Tend to disagree28%10%25%29%40%27%33%67%29%18%29%29%30%29%25%-30%42%23%30%28%29%
6118518203-7115115358-93953460Strongly disagree17%10%17%16%26%14%28%-15%28%zkp8%9%13%20%15%-19%18%18%9%18%17%k
164213110---111663-437-216Don't know4%41%5%4%4%7%---3%1%9%5%4%5%-8%a17%14%zab-1%4%a
98114916373-161522539401719-52362101Agree27%11%30%28%19%26%22%-34%38%32%35%32%23%31%100%19%-11%43%zce33%zc28%c
1642201442159822118265528422-2311202188163Disagree45%19%42%45%66%41%61%67%44%47%37%38%42%49%40%-49%60%40%39%46%45%
-66-1-6-53-15-22-5-2-5-3-4*-13-44-51-14-11-152-25-62Net agree-18%-8%-12%-17%-47%-15%-39%-67%-10%-9%-5%-3%-10%-26%-9%100%-30%-60%-30%4%-13%-17%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 196Q.12a To what extent do you agree or disagree that the overall level of regulation in the UK health sector is an obstacle to your organisation's success?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2213-12414-31222Strongly agree6%9%12%-3%6%5%5%14%-11%7%4%6%
76-5561020762541078Tend to agree21%-22%25%16%28%24%37%20%9%17%32%21%22%
84-648519485721382Neither agree nor23%-25%22%22%15%24%20%24%28%25%20%29%23%disagree
1032871311206668313103Tend to disagree28%22%34%34%35%32%24%33%21%32%26%29%28%29%
61724751315562660Strongly disagree17%69%7%18%18%16%15%5%15%25%18%13%13%17%
16---216-211-316Don't know4%---6%4%7%-6%6%3%-6%4%
981857122481028511101Agree27%9%34%25%19%34%29%42%34%9%28%38%25%28%
16499102016337111013519163Disagree45%91%41%53%53%47%40%38%36%57%45%42%41%45%
-66-8-2-5-12-5-91-1-9-5*-8-62Net agree-18%-82%-7%-27%-34%-14%-11%4%-2%-48%-17%-3%-16%-17%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 197Q.12a To what extent do you agree or disagree that the overall level of regulation in the UK health sector is an obstacle to your organisation's success?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
2299-2241822Strongly agree6%4%17%zh-22%zf12%6%6%f
762036-78136278Tend to agree21%10%69%zh-78%zf35%c19%22%cfh
84225--107182Neither agree nor23%11%11%--26%22%23%efghdisagree
103931103-398103Tend to disagree28%45%zg2%63%ze-9%31%zd29%deg
6158160-65360Strongly disagree17%28%zg2%37%ze-15%17%17%eg
163---11516Don't know4%1%---3%5%4%efh
982944-1011780101Agree27%14%86%zh-100%zf47%zc25%28%cfh
1641512163-9151163Disagree45%74%zg4%100%ze-24%48%zd45%deg
-66-12242-1631018-71-62Net agree-18%-59%82%-100%100%22%-23%-17%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 198Q.12a To what extent do you agree or disagree that the overall level of regulation in the UK health sector is an obstacle to your organisation's success?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
8-18-3--222-242---1258Strongly agree2%-2%2%-2%--3%5%3%-2%2%3%---2%3%3%2%
42-442-181-5414318158-512102644Tend to agree12%-9%13%-13%6%-10%10%21%z18%15%9%15%-11%6%4%19%c14%c12%c
913157763711139196234516110316134790Neither agree nor25%30%31%24%20%26%11%33%28%23%27%44%19%26%29%100%21%18%32%23%25%25%disagree
11231398844421611222464915-174141859112Tend to disagree31%32%28%31%26%31%33%67%34%28%32%12%38%29%28%-36%24%28%33%31%31%
941128115316-1213113295011-11710125393Strongly disagree26%10%25%25%46%22%50%-25%34%k17%18%24%29%19%-24%36%21%22%28%26%k
153213210----11383-437-115Don't know4%29%5%4%7%7%----1%9%2%5%5%-8%a17%14%zab-*4%a
50-549-211-66163211810-513123152Agree14%-11%16%-15%6%-13%16%23%z18%17%11%19%-11%6%5%22%c16%c14%c
20642517923751022824334759926-28112430112205Disagree57%41%53%56%73%52%83%67%59%61%49%29%62%58%48%-60%60%49%55%58%57%
-156-4-20-129-23-54-10-2-22-18-18-2-55-81-160-23-10-22-18-80-153Net agree-43%-41%-41%-41%-73%-38%-78%-67%-45%-46%-26%-12%-45%-47%-29%0%-49%-54%-44%-33%-42%-42%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 199Q.12b To what extent do you agree or disagree that the level of regulation by the Human Tissue Authority (HTA) is an obstacle to your organisation's success?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
8-21--2-3---18Strongly agree2%-8%5%--2%-8%---2%2%
42122271134232544Tend to agree12%9%8%12%5%20%14%15%14%9%12%14%10%12%
91-43108236104721490Neither agree nor25%-16%18%28%22%28%31%32%21%24%20%29%25%disagree
11221371510235758512112Tend to disagree31%22%56%38%40%28%28%26%21%29%27%46%26%31%
9473588185671021393Strongly disagree26%69%12%27%21%24%22%27%18%41%35%20%27%26%
15---225-2-1-315Don't know4%---6%6%6%-6%-3%-6%4%
50143271337232552Agree14%9%16%17%5%20%16%15%22%9%12%14%12%14%
2069161323184110121319825205Disagree57%91%68%65%62%52%50%53%39%70%62%66%53%57%
-156-8-12-10-21-11-28-7-5-11-15-6-19-153Net agree-43%-82%-52%-49%-57%-32%-34%-38%-17%-61%-50%-52%-42%-42%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 200Q.12b To what extent do you agree or disagree that the level of regulation by the Human Tissue Authority (HTA) is an obstacle to your organisation's success?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
8-817268Strongly agree2%-15%zh1%7%zf5%2%2%fh
42-44137113144Tend to agree12%-85%zh1%37%zf30%zc10%12%cfh
91--827137590Neither agree nor25%--5%26%f36%24%25%fghdisagree
112112-77205106112Tend to disagree31%55%zg-47%ze20%14%34%zd31%deg
9493-74958793Strongly disagree26%45%zg-45%ze9%13%28%z26%eg
15--2111215Don't know4%--1%1%3%4%4%efh
50-52244133752Agree14%-100%zh1%44%zf34%zc12%14%cfh
206205-1512910193205Disagree57%100%zg-92%ze29%26%61%zd57%deg
-156-20552-149153-156-153Net agree-43%-100%100%-91%15%8%-49%-42%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 201Q.12b To what extent do you agree or disagree that the level of regulation by the Human Tissue Authority (HTA) is an obstacle to your organisation's success?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
71-8677354-7885263211-1889122874Obtaining consent20%-17%21%21%24%k33%-15%21%12%35%21%19%21%-38%zac42%18%22%15%21%ak
22582919520816333194977710135119103133126221Seeking consent62%89%62%61%63%56%50%100%70%l49%72%zlp47%64%59%64%100%41%52%63%e61%66%ze61%e
11-110-51-213156--4--2611Taking consent3%-2%3%-4%6%-3%3%4%9%4%3%--8%--3%3%3%
10-110161-12--38--1-23510Securing consent3%-2%3%3%4%6%-2%5%--2%5%--3%-4%5%2%3%
14121236--213-276-31-21015Consenting4%11%4%4%10%4%--5%3%4%-2%4%11%zi-5%6%-3%5%4%
17-313-71-242-5102-1-53717Other5%-7%4%-5%6%-5%9%3%-4%6%4%-3%-11%za6%4%5%
14-31114---44158--1-3-913Don't know4%-6%4%3%3%---10%zmp6%9%4%4%--3%-5%-5%4%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 202Q.13 Members of the public or their families have to give informed consent for organs and tissue to be donated for scheduled purposes under the Human Tissue Act.When a professional is talking to a member of the public, what do you consider the most appropriate terminology to describe what the professional is doing in that conversation?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
711336911269921274Obtaining consent20%7%15%15%17%26%14%11%19%52%31%19%25%21%
225716132216531422817726221Seeking consent62%76%70%65%61%45%65%74%70%43%57%57%56%61%
11--1122---21211Taking consent3%--5%3%6%3%---6%11%3%3%
10---352-----110Securing consent3%---8%13%zag3%-----1%3%
1421-21411--2115Consenting4%17%5%-5%2%5%7%3%--14%3%4%
17-121131111-517Other5%-6%10%2%2%3%8%3%6%3%-11%z5%
14-11126-2-1--13Don't know4%-4%5%3%5%7%-6%-3%--4%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 203Q.13 Members of the public or their families have to give informed consent for organs and tissue to be donated for scheduled purposes under the Human Tissue Act.When a professional is talking to a member of the public, what do you consider the most appropriate terminology to describe what the professional is doing in that conversation?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
714210381556674Obtaining consent20%21%19%23%15%15%21%21%
225127301016224192221Seeking consent62%62%57%62%61%66%61%61%
11722711011Taking consent3%3%3%1%7%zf2%3%3%f
108172-1010Securing consent3%4%2%4%2%-3%3%
146557-1515Consenting4%3%10%h3%7%-5%4%
171036531317Other5%5%5%4%5%7%4%5%
14524341013Don't know4%2%4%2%3%10%zc3%4%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 204Q.13 Members of the public or their families have to give informed consent for organs and tissue to be donated for scheduled purposes under the Human Tissue Act.When a professional is talking to a member of the public, what do you consider the most appropriate terminology to describe what the professional is doing in that conversation?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
301740270231261223535561310613749140124254156305Email83%79%84%85%73%88%m94%67%75%90%81%91%87%80%89%100%84%64%84%100%zace82%84%m
28263524116105111393354129313829-4084726152272Received e-newsletter or78%67%74%76%52%73%89%33%82%85%78%82%76%g81%zg53%-84%b40%95%zab47%79%zb75%bgbulletin
2675382312095113353456129312435-32103336152263HTA website74%57%81%72%62%66%89%100%75%87%zp81%p82%76%72%64%-68%52%67%67%80%zc73%
2184301961898102143434137310233-4193629105220Telephone call60%48%64%62%56%68%km78%67%30%87%zkmp50%m91%60%60%59%-87%zab46%74%za54%55%61%akm
1726221622396115262196585221369422568181Used the HTA's online48%67%47%51%72%67%zkm6%33%10%66%zkm31%m65%53%50%40%100%76%zab48%84%zab46%35%50%akmportal, e.g. for
submitting SeriousAdverse Events andAdverse Reactions(SAEARs), HTA ReportableIncidents (HTARIs),annual activity data orIndependent Assessor(IA) Reports
1203201161159411029154505130-8164772135Face-to-face meetings33%30%43%36%35%41%km33%33%20%74%zkmp22%29%41%30%54%zh-17%6%12%88%zace38%ce37%cehkm
73411718501-3771223423-3122302680Training20%48%23%22%25%35%zklm6%-7%17%10%9%18%20%42%zhi-5%5%44%zae55%zae13%22%aekm
5227554373-31314182812-7-5282262Conferences or events14%21%16%17%13%25%zkm22%-7%33%zkm1%29%15%16%22%-14%-11%52%zace11%17%akm
591951717-212810-192811-51583958Letter16%10%18%16%23%12%-67%25%zp21%14%-16%16%21%-11%6%11%15%20%z16%
3911444321-244123193-616201346Contributed to11%11%2%14%s13%22%zkm6%-3%10%5%9%19%zg11%5%-13%6%12%36%zace7%13%akmsconsultation
30-3263811645-15122-3-332028Press release8%-6%8%10%6%6%33%13%10%8%-12%z7%3%-5%-5%5%11%z8%
23-419161-46413137-11-61524Other6%-8%6%4%4%6%-8%16%zp6%9%2%7%13%i-3%6%-11%c8%c6%i
1--11-------1----1---1Had no contact*--*4%-------1%----6%---*
----------------------Don't know----------------------
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 205Q.14 Which, if any, of the following forms of communications with or from the HTA have you had in the past 12 months?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
3017212030316917251325840305Email83%71%91%100%81%90%84%91%81%69%84%66%85%84%
2827171629285817211524930272Received e-newsletter or78%73%73%83%79%81%71%91%67%80%79%79%65%75%bulletin
26761715292362132112221131263HTA website74%59%75%78%80%66%76%69%69%67%73%93%67%73%
218618162523501019822716220Telephone call60%62%77%83%68%a68%a62%a53%61%44%72%59%35%61%a
17251313171745714917518181Used the HTA's online48%54%57%67%48%48%55%37%46%51%58%39%38%50%portal, e.g. for
submitting SeriousAdverse Events andAdverse Reactions(SAEARs), HTA ReportableIncidents (HTARIs),annual activity data orIndependent Assessor(IA) Reports
120-16121911325868216135Face-to-face meetings33%-71%59%51%33%39%28%25%35%27%14%34%37%
733298817364711380Training20%32%7%44%21%23%21%18%19%24%22%7%28%22%
52255672033412462Conferences or events14%22%20%27%15%21%24%a13%11%20%3%20%9%17%
59165511255432858Letter16%8%25%23%14%3%15%26%17%25%12%18%18%h16%h
3914463925211746Contributed to11%13%16%23%16%10%11%11%17%9%3%7%16%13%consultation
30-1224852112128Press release8%-4%10%5%13%10%25%5%5%2%18%2%8%
23-234161221-224Other6%-7%14%12%3%7%4%6%11%3%-5%6%
1-1----------1Had no contact*-5%----------*
--------------Don't know--------------
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 206Q.14 Which, if any, of the following forms of communications with or from the HTA have you had in the past 12 months?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
301171451358632266305Email83%83%87%82%85%88%84%84%
282163361317015251272Received e-newsletter or78%80%z69%80%z69%40%79%zd75%dbulletin
267158341237019240263HTA website74%77%z66%75%69%51%76%zd73%d
218133321055621199220Telephone call60%65%62%64%56%56%63%61%
1729925855019159181Used the HTA's online48%48%49%52%49%52%50%50%portal, e.g. for
submitting SeriousAdverse Events andAdverse Reactions(SAEARs), HTA ReportableIncidents (HTARIs),annual activity data orIndependent Assessor(IA) Reports
1207924594913120135Face-to-face meetings33%39%46%36%48%z36%38%37%
73497382327880Training20%24%13%23%23%5%25%zd22%d
524373520-6262Conferences or events14%21%z14%21%20%-20%zd17%d
593682020104858Letter16%18%14%12%20%26%15%16%
39309201324446Contributed to11%15%17%13%13%5%14%13%consultation
3017311822328Press release8%8%6%7%8%7%7%8%
2311710632024Other6%5%14%h6%6%9%6%6%
11----11Had no contact*1%----**
--------Don't know--------
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 207Q.14 Which, if any, of the following forms of communications with or from the HTA have you had in the past 12 months?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
1203201011140611228173474723-6172977120Unweighted total
1203**20**116*11**59*4**1**10**29**15**4**50*51*30**-**8**1**6**47**72*135Weighted total
88116838423182493353722-5-5365297Very Useful73%32%80%72%72%70%67%100%83%83%59%60%71%73%76%-63%-86%75%72%72%
2624273171-153211127-211121632Fairly Useful22%68%20%23%28%28%33%-8%17%18%40%21%24%24%-21%100%14%25%22%23%
1--1----1---1-------11Not Very Useful1%--1%----8%---2%-------1%1%
----------------------Not at all Useful----------------------
5--5-1----4-32--1---45No Opinion4%--4%-2%----24%-6%3%--16%---5%4%
----------------------Don't know----------------------
114320110115841929114464930-7164768129Useful95%100%100%95%100%98%100%100%92%100%76%100%92%97%100%-84%100%100%100%94%96%
1--1----1---1-------11Not useful1%--1%----8%---2%-------1%1%
11332010911584182911445493007164767128Net useful94%100%100%94%100%98%100%100%83%100%76%100%91%97%100%0%84%100%100%100%93%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 208Q.15a How useful, if at all, do you personally find the following forms of communication with the HTA?
- Face-to-face meetings -
Base : All those who have had face-to-face meetings with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
120-1491911285667114120Unweighted total
120-**16**12**19**11**32**5**8**6**8**2**16**135Weighted total
88-1211199192567-897Very Useful73%-73%91%100%78%61%33%68%100%84%-51%72%
26-31-21143--2732Fairly Useful22%-16%9%-22%34%67%32%--100%44%23%
1-----------11Not Very Useful1%-----------5%1%
--------------Not at all Useful--------------
5-2---2---1--5No Opinion4%-11%---6%---16%--4%
--------------Don't know--------------
114-15121911305867215129Useful95%-89%100%100%100%94%100%100%100%84%100%95%96%
1-----------11Not useful1%-----------5%1%
113015121911305867214128Net useful94%0%89%100%100%100%94%100%100%100%84%100%90%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 209Q.15a How useful, if at all, do you personally find the following forms of communication with the HTA?
- Face-to-face meetings -
Base : All those who have had face-to-face meetings with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
1207220544112107120Unweighted total
12079*24**59*49*13**120*135Weighted total
886811483459397Very Useful73%87%z48%82%z70%35%77%z72%
2691091262432Fairly Useful22%12%40%16%24%44%20%23%ch
1-----11Not Very Useful1%-----1%1%
--------Not at all Useful--------
51313325No Opinion4%2%11%2%5%20%2%4%c
--------Don't know--------
1147821584610117129Useful95%98%89%98%95%80%98%z96%
1-----11Not useful1%-----1%1%
1137821584610116128Net useful94%98%89%98%95%80%97%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 210Q.15a How useful, if at all, do you personally find the following forms of communication with the HTA?
- Face-to-face meetings -
Base : All those who have had face-to-face meetings with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
73511648421-4681203121-2125182773Unweighted total
73*4**11**71*8**50*1**-**3**7**7**1**22**34**23**-**3**1**22**30**26**80*Weighted total
4634466331-2241102216-3115171550Very Useful63%80%33%64%75%66%100%-50%30%62%100%48%63%71%-100%100%68%56%57%62%
221522116--143-10116---513826Fairly Useful30%20%49%31%13%31%--25%55%38%-44%31%26%---24%44%32%33%
3-12-2---1--21----2-13Not Very Useful4%-9%2%-3%---15%--8%3%----8%-4%3%
----------------------Not at all Useful----------------------
----------------------No Opinion----------------------
2-121---1----11-----22Don't know3%-9%3%13%---25%----3%3%-----7%2%
6849687491-2671203222-3120302376Useful93%100%82%95%88%97%100%-75%85%100%100%92%94%97%-100%100%92%100%89%94%
3-12-2---1--21----2-13Not useful4%-9%2%-3%---15%--8%3%----8%-4%3%
65486674710257118312203118302273Net useful89%100%72%93%88%93%100%0%75%70%100%100%84%91%97%0%100%100%84%100%85%91%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 211Q.15b How useful, if at all, do you personally find the following forms of communication with the HTA?
- Training -
Base : All those who have had training with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
733178716354611273Unweighted total
73*3**2**9**8**8**17**3**6**4**7**1**13**80*Weighted total
463235792344-850Very Useful63%100%100%40%65%87%53%51%57%80%63%-59%62%
22--53-623121426Fairly Useful30%--60%35%-37%49%43%20%25%100%35%33%
3-----2-----13Not Very Useful4%-----11%-----7%3%
--------------Not at all Useful--------------
--------------No Opinion--------------
2----1----1--2Don't know3%----13%----12%--2%
683298715364611276Useful93%100%100%100%100%87%89%100%100%100%88%100%93%94%
3-----2-----13Not useful4%-----11%-----7%3%
653298714364611173Net useful89%100%100%100%100%87%78%100%100%100%88%100%86%91%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 212Q.15b How useful, if at all, do you personally find the following forms of communication with the HTA?
- Training -
Base : All those who have had training with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
73436341927073Unweighted total
73*49*7**38*23**2**78*80*Weighted total
46354281014950Very Useful63%71%60%74%42%50%63%62%
2213381112526Fairly Useful30%27%40%22%49%50%33%33%
31-21-33Not Very Useful4%2%-5%4%-4%3%
--------Not at all Useful--------
--------No Opinion--------
2---1-12Don't know3%---4%-1%2%c
68487362127476Useful93%98%100%95%91%100%95%94%
31-21-33Not useful4%2%-5%4%-4%3%
65477342027173Net useful89%96%100%91%87%100%92%91%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 213Q.15b How useful, if at all, do you personally find the following forms of communication with the HTA?
- Training -
Base : All those who have had training with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
1727221532284116252476282211288481572172Unweighted total
1726**22**16223**96*1**1**5**26**21**9**65*85*22**1**36**9**42*25**68*181Weighted total
72356712491-253327369-2762321774Very Useful42%57%21%42%50%51%z100%-33%19%13%27%42%42%39%-74%63%56%za7%25%41%a
78312741137-13121472939618218153681Fairly Useful45%43%56%45%50%39%-100%67%45%67%73%44%47%28%100%22%25%44%60%53%45%
11-311-8---42-446-1--7614Not Very Useful6%-15%7%-8%---16%8%-6%4%29%-4%--27%9%c8%
3--3-----21-21------33Not at all Useful2%--2%-----8%4%-3%1%------4%z2%
2--3-2------12---1-2-3No Opinion1%--2%-2%------2%2%---13%-7%-2%
6-24-----32-231-----66Don't know3%-9%2%-----12%8%-3%3%5%-----9%zc3%
1506171412386115171795675151358421753155Useful87%100%76%87%100%90%100%100%100%65%79%100%87%89%66%100%96%87%100%za67%79%86%a
14-314-8---63-556-1--7917Not useful8%-15%9%-8%---23%13%-8%6%29%-4%--27%13%c9%c
136614126237811511149517181338421045139Net useful79%100%61%78%100%82%100%100%100%42%67%100%78%84%37%100%93%87%100%40%66%77%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 214Q.15c How useful, if at all, do you personally find the following forms of communication with the HTA?
- HTA's online portal -
Base : All those who have used the HTA's online portal in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
17251112171642714916518172Unweighted total
1725**13**13**17**17**45*7**14**9**17**5**18**181Weighted total
7232791112351831174Very Useful42%48%17%53%51%65%26%49%34%11%47%63%64%41%g
78284742639681581Fairly Useful45%35%61%32%40%23%57%37%60%60%44%18%31%45%
111322-5---2--14Not Very Useful6%17%22%15%10%-10%---10%--8%
3----11-1----3Not at all Useful2%----6%2%-6%----2%
2-----1--2---3No Opinion1%-----3%--18%---2%
6----111-1-116Don't know3%----5%2%14%-11%-19%6%3%
15041011161537614716417155Useful87%83%78%85%90%89%83%86%94%71%90%81%94%86%
14132216-1-2--17Not useful8%17%22%15%10%6%12%-6%-10%--9%
136479141432613714417139Net useful79%67%55%69%81%83%70%86%88%71%81%81%94%77%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 215Q.15c How useful, if at all, do you personally find the following forms of communication with the HTA?
- HTA's online portal -
Base : All those who have used the HTA's online portal in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
1729423804617152172Unweighted total
17299*25**85*50*19**159181Weighted total
72456391127374Very Useful42%46%25%46%e21%9%46%z41%e
784111342887181Fairly Useful45%41%42%40%56%42%45%45%
1156585914Not Very Useful6%5%26%5%16%z25%6%8%c
31212213Not at all Useful2%1%7%1%4%10%1%2%c
23-3-2-3No Opinion1%3%-3%-9%-2%
64-41156Don't know3%4%-4%2%5%3%3%
1508617723910144155Useful87%88%67%86%78%51%91%z86%
146861071017Not useful8%6%33%7%20%zf35%6%9%c
13681967293134139Net useful79%82%34%79%58%16%84%77%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 216Q.15c How useful, if at all, do you personally find the following forms of communication with the HTA?
- HTA's online portal -
Base : All those who have used the HTA's online portal in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
5227464264-4121316249-5-6172452Unweighted total
52*2**7**55*4**37**3**-**3**13**1**4**18**28**12**-**7**-**5**28**22**62*Weighted total
2412263161-17--6174-3-3101228Very Useful46%46%27%46%75%44%25%-25%55%--33%62%36%-38%-67%36%53%45%
2514281211-251410108-4-218832Fairly Useful48%54%59%51%25%56%50%-50%37%100%100%58%34%64%-62%-33%64%36%51%
2-11----11--11------22Not Very Useful4%-14%1%----25%8%--4%4%------8%3%
----------------------Not at all Useful----------------------
1--1--1-----1-------11No Opinion2%--1%--25%-----4%-------3%1%
----------------------Don't know----------------------
4926544372-21214162712-7-5281959Useful94%100%86%97%100%100%75%-75%92%100%100%92%96%100%-100%-100%100%89%96%
2-11----11--11------22Not useful4%-14%1%----25%8%--4%4%------8%3%
47255343720211141626120705281858Net useful90%100%73%96%100%100%75%0%50%84%100%100%87%93%100%0%100%0%100%100%80%93%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 217Q.15d How useful, if at all, do you personally find the following forms of communication with the HTA?
- Conferences or events -
Base : All those who have attended conferences or events with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
52234561722313452Unweighted total
52*2**5**5**6**7**20**3**3**4**1**2**4**62*Weighted total
2421-2412-24-1128Very Useful46%100%28%-36%50%59%-50%100%-29%20%45%
25-3544632-12332Fairly Useful48%-72%100%64%50%28%100%50%-100%71%80%51%
2-----2------2Not Very Useful4%-----9%------3%
--------------Not at all Useful--------------
1-----1------1No Opinion2%-----4%------1%
--------------Don't know--------------
49255671733412459Useful94%100%100%100%100%100%87%100%100%100%100%100%100%96%
2-----2------2Not useful4%-----9%------3%
47255671633412458Net useful90%100%100%100%100%100%78%100%100%100%100%100%100%93%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 218Q.15d How useful, if at all, do you personally find the following forms of communication with the HTA?
- Conferences or events -
Base : All those who have attended conferences or events with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
523853115-5252Unweighted total
52*43*7**35**20**-**62*62*Weighted total
24212195-2828Very Useful46%48%24%53%27%-45%45%
252151513-3232Fairly Useful48%49%76%43%68%-51%51%
21-11-22Not Very Useful4%2%-2%5%-3%3%
--------Not at all Useful--------
11-1--11No Opinion2%2%-2%--1%1%
--------Don't know--------
494273419-5959Useful94%97%100%96%95%-96%96%
21-11-22Not useful4%2%-2%5%-3%3%
47417331805858Net useful90%95%100%93%90%0%93%93%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 219Q.15d How useful, if at all, do you personally find the following forms of communication with the HTA?
- Conferences or events -
Base : All those who have attended conferences or events with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
2185301941784142183339107510429-3284218118218Unweighted total
2184**30**19618**98*10**2**14**34*34*13**73*102*33**-**41*9**36*29**105220Weighted total
17122215614847211242413548027-406292278175Very Useful78%40%72%80%82%86%k71%100%78%70%69%100%74%79%84%-97%zac74%79%77%74%79%a
4338373132-3109-17214--2872542Fairly Useful20%60%28%19%18%13%21%-22%30%p26%-23%20%14%--26%21%e23%24%ze19%e
----------------------Not Very Useful----------------------
----------------------Not at all Useful----------------------
4--3-11---2-211-1---24No Opinion2%--2%-1%7%---5%-3%1%2%-3%---2%2%
----------------------Don't know----------------------
214430193189692143433137110132-4093629103217Useful98%100%100%98%100%99%93%100%100%100%95%100%97%99%98%-97%100%100%100%98%98%
----------------------Not useful----------------------
21443019318969214343313711013204093629103217Net useful98%100%100%98%100%99%93%100%100%100%95%100%97%99%98%0%97%100%100%100%98%98%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 220Q.15e How useful, if at all, do you personally find the following forms of communication with the HTA?
- Telephone call -
Base : All those who have had a telephone call with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
218616142524491119821817218Unweighted total
2186**18**16**25**23**50*10**19**8**22**7**16**220Weighted total
17151211191637915819715175Very Useful78%85%70%71%77%69%73%91%81%100%89%100%91%79%
43155471314-2-142Fairly Useful20%15%26%29%15%31%25%9%19%-11%-9%19%
--------------Not Very Useful--------------
--------------Not at all Useful--------------
4-1-2-1------4No Opinion2%-4%-9%-2%------2%
--------------Don't know--------------
214617162323491019822716217Useful98%100%96%100%91%100%98%100%100%100%100%100%100%98%
--------------Not useful--------------
214617162323491019822716217Net useful98%100%96%100%91%100%98%100%100%100%100%100%100%98%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 221Q.15e How useful, if at all, do you personally find the following forms of communication with the HTA?
- Telephone call -
Base : All those who have had a telephone call with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
218133301055420197218Unweighted total
21813332**105*56*21**199220Weighted total
17111123904310164175Very Useful78%83%73%85%z76%48%82%z79%
43209131483442Fairly Useful20%15%27%13%24%38%17%19%cf
--------Not Very Useful--------
--------Not at all Useful--------
42-2-314No Opinion2%1%-2%-14%*2%c
--------Don't know--------
214131321035618198217Useful98%99%100%98%100%86%100%z98%
--------Not useful--------
214131321035618198217Net useful98%99%100%98%100%86%100%98%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 222Q.15e How useful, if at all, do you personally find the following forms of communication with the HTA?
- Telephone call -
Base : All those who have had a telephone call with the HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3911374241-244120162-517121439Unweighted total
39*1**1**44*4**32**1**-**2**4**4**1**23**19**3**-**6**1**6**20**13**46*Weighted total
15-1172141--1-1782-4136317Very Useful38%-100%38%53%42%100%--25%-100%29%41%62%-60%100%57%32%21%38%
161-19116--13--1371-1-312520Fairly Useful41%100%-44%25%49%--50%75%--54%36%38%-20%-43%60%38%44%
4--5-3--1-1-23--1--225Not Very Useful10%--10%-9%--50%-25%-9%13%--20%--9%13%10%
1--1------1-1-------11Not at all Useful3%--2%------25%-4%-------7%2%
1--1------1--1------11No Opinion3%--2%------25%--5%------7%2%
2--21-----1-11------22Don't know5%--4%22%-----25%-4%5%------14%4%
3111363291-14-119153-51618838Useful79%100%100%82%78%91%100%-50%100%-100%83%77%100%-80%100%100%91%59%82%
5--5-3--1-2-33--1--235Not useful13%--12%-9%--50%-50%-13%13%--20%--9%20%12%
2611303261004-2116123041616532Net useful67%100%100%69%78%82%100%0%0%100%-50%100%71%64%100%0%60%100%100%83%39%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 223Q.15f How useful, if at all, do you personally find the following forms of communication with the HTA?
- Contributed to consultation -
Base : All those who have contributed to a HTA consultation in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3913453824111639Unweighted total
39*1**4**4**6**3**9**2**5**2**1**1**7**46*Weighted total
15131226-1---217Very Useful38%100%79%20%38%51%62%-21%---23%38%
16-14324122-1320Fairly Useful41%-21%80%47%49%38%59%31%100%-100%37%44%
4---1---2---25Not Very Useful10%---15%---31%---28%10%
1-------1----1Not at all Useful3%-------17%----2%
1---------1--1No Opinion3%---------100%--2%
2------1----12Don't know5%------41%----12%4%
31144539132-1438Useful79%100%100%100%85%100%100%59%52%100%-100%60%82%
5---1---3---25Not useful13%---15%---48%---28%12%
261444391*201232Net useful67%100%100%100%69%100%100%59%5%100%0%100%31%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 224Q.15f How useful, if at all, do you personally find the following forms of communication with the HTA?
- Contributed to consultation -
Base : All those who have contributed to a HTA consultation in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
39267171123739Unweighted total
39*30**9**20**13**2**44*46*Weighted total
1515-92-1717Very Useful38%48%-45%13%-39%38%
1613497-2020Fairly Useful41%44%48%46%55%-46%44%
41412145Not Very Useful10%3%42%4%19%47%9%10%
1-1-11-1Not at all Useful3%-10%-7%53%-2%
11-1--11No Opinion3%3%-4%--2%2%
21--1-22Don't know5%3%--7%-4%4%
31284199-3838Useful79%91%48%91%68%-85%z82%
51513245Not useful13%3%52%4%26%100%9%12%c
2627*185-23432Net useful67%88%-3%87%42%-100%77%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 225Q.15f How useful, if at all, do you personally find the following forms of communication with the HTA?
- Contributed to consultation -
Base : All those who have contributed to a HTA consultation in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
301841265221031724434631010814043131114833177301Unweighted total
3017**40*27023**126*12**2**35*35*56*13**10613749*1**40*12**42*54*156305Weighted total
184326166167910-23202810539330-338243092186Very Useful61%48%66%61%71%63%82%-64%57%51%78%50%67%zi62%-83%zabc63%58%55%59%61%i
10331392640121213253464015153152158104Fairly Useful34%40%34%34%24%32%12%100%34%38%44%22%44%zh29%31%100%14%28%35%e39%e37%e34%e
5--5-3---12-312---1235Not Very Useful2%--2%-2%---3%3%-3%1%3%---2%3%2%2%
----------------------Not at all Useful----------------------
71-6141--11-341-111238No Opinion2%12%-2%5%3%6%--3%2%-3%3%1%-3%9%2%3%2%2%
2--2-1--1---1-1---1-12Don't know1%--1%-1%--2%---1%-2%---2%-1%1%
28764025722119112353353139913346138113951150290Useful95%88%100%95%95%94%94%100%98%94%95%100%94%97%94%100%97%91%94%94%96%95%
5--5-3---12-312---1235Not useful2%--2%-2%---3%3%-3%1%3%---2%3%2%2%
28264025222117112353251139613244138113849147285Net useful94%88%100%93%95%92%94%100%98%91%92%100%91%96%90%100%97%91%92%91%94%94%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 226Q.15g How useful, if at all, do you personally find the following forms of communication with the HTA?
- Email -
Base : All those who have communicated with the HTA via email in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3017191731316618251226940301Unweighted total
3017**21**20**30**31**69*17**25**13**25**8**40*305Weighted total
18469121821431211720523186Very Useful61%87%45%59%60%66%63%70%46%56%77%67%57%61%
10311081182451135316104Fairly Useful34%13%47%41%36%26%35%30%42%23%20%33%41%34%
5----3--2---15Not Very Useful2%----8%--8%---2%2%
--------------Not at all Useful--------------
7-2-1-1-13---8No Opinion2%-8%-4%-1%-4%21%---2%
2-----1---1--2Don't know1%-----1%---3%--1%
2877192028296717221025839290Useful95%100%92%100%96%92%97%100%88%79%97%100%98%95%
5----3--2---15Not useful2%----8%--8%---2%2%
2827192028266717201025838285Net useful94%100%92%100%96%84%97%100%80%79%97%100%96%94%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 227Q.15g How useful, if at all, do you personally find the following forms of communication with the HTA?
- Email -
Base : All those who have communicated with the HTA via email in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
301170431338232263301Unweighted total
30117145*13586*32**266305Weighted total
18411322934310174186Very Useful61%66%g49%69%ze50%32%65%z61%e
103512135391787104Fairly Useful34%30%46%26%46%zf51%33%34%f
51314135Not Very Useful2%1%6%h1%4%3%1%2%ch
--------Not at all Useful--------
76-5-528No Opinion2%3%-4%-14%1%2%c
21-1--12Don't know1%1%-1%--*1%
287164431288227261290Useful95%96%94%95%96%83%98%z95%
51314135Not useful2%1%6%h1%4%3%1%2%ch
282163401277926258285Net useful94%95%89%95%92%80%97%94%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 228Q.15g How useful, if at all, do you personally find the following forms of communication with the HTA?
- Email -
Base : All those who have communicated with the HTA via email in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
2827382481694161493361910014528-3175416174282Unweighted total
2826**35*24116**105*11**1**39*33*54*12**93*13829**-**40*8**47*26**152272Weighted total
9618857395-14816327575-1931564992Very Useful34%14%22%35%44%37%44%-37%24%30%21%30%42%z18%-48%41%31%24%32%34%
1504191287555-2315328596018-193261680145Fairly Useful53%71%53%53%43%53%44%-59%45%59%68%64%zh43%61%-49%44%56%63%53%53%h
2916232101118415166-11531728Not Very Useful10%14%19%9%13%9%13%100%2%24%zkmp8%11%6%12%19%-3%15%11%13%11%10%m
2-12-----11--2------22Not at all Useful1%-3%1%-----3%2%--1%------1%1%
3-12-1---11-12----1-23No Opinion1%-3%1%-1%---3%2%-1%1%----2%-1%1%
2--2----1----11-----22Don't know1%--1%----2%----1%3%-----1%1%
246526213149410-372348118711723-3864122129237Useful87%86%76%88%s87%90%l87%-96%zl70%89%l89%93%z85%78%-97%85%87%87%85%87%ls
3118252101119515186-11531930Not useful11%14%22%zr10%13%9%13%100%2%27%zkmp10%11%6%13%19%-3%15%11%13%13%11%im
21541918812858-1371442981991703753619110207Net useful76%71%54%78%74%81%75%-100%94%42%79%79%87%72%59%0%94%70%76%74%72%76%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 229Q.15h How useful, if at all, do you personally find the following forms of communication with the HTA?
- Received e-newsletter or bulletin -
Base : All those who have received a HTA e-newsletter or bulletin in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
28271615312960182215241134282Unweighted total
2827**17**16**29**28**58*17**21**15**24**9**30*272Weighted total
9633215121985673992Very Useful34%42%19%13%53%42%32%44%26%38%29%35%31%34%
1503101212113498715617145Fairly Useful53%46%57%74%41%39%58%50%38%51%65%65%58%53%
29141244-621-328Not Very Useful10%12%23%6%6%16%7%-31%11%3%-11%10%
2--1-1-------2Not at all Useful1%--6%-3%-------1%
3-----2-1----3No Opinion1%-----3%-5%----1%
2------1--1--2Don't know1%------6%--3%--1%
2466131427235216131322927237Useful87%88%77%88%94%81%90%94%64%89%94%100%89%87%
31142254-621-330Not useful11%12%23%12%6%19%7%-31%11%3%-11%11%
21559122518481671122923207Net useful76%75%53%75%88%63%83%94%33%77%91%100%77%76%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 230Q.15h How useful, if at all, do you personally find the following forms of communication with the HTA?
- Received e-newsletter or bulletin -
Base : All those who have received a HTA e-newsletter or bulletin in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
282169361357217259282Unweighted total
28216336*13170*15**251272Weighted total
96687561719292Very Useful34%42%zg20%43%ze24%5%37%z34%e
150831766357136145Fairly Useful53%51%48%50%50%46%54%53%
29111171562028Not Very Useful10%7%30%zh6%22%zf43%8%10%cfh
2-111-22Not at all Useful1%-3%h1%1%-1%1%
31-111-3No Opinion1%1%-1%1%6%-1%
2---1-12Don't know1%---1%-*1%
24615124122528227237Useful87%93%zg67%93%ze74%51%91%z87%eg
31111281662230Not useful11%7%33%zh6%23%zf43%9%11%cfh
21514112114361205207Net useful76%86%35%87%51%9%82%76%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 231Q.15h How useful, if at all, do you personally find the following forms of communication with the HTA?
- Received e-newsletter or bulletin -
Base : All those who have received a HTA e-newsletter or bulletin in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
591951714-215811-192911-41654359Unweighted total
59*1**9**51*7**17**-**2**12**8**10**-**19**28**11**-**5**1**5**8**39*58*Weighted total
22-32046--534-8131-11231422Very Useful37%-35%39%58%37%--40%38%36%-43%45%9%-25%100%33%40%37%37%
30162327-2654-10118-4-322029Fairly Useful51%100%65%46%28%43%-100%47%63%45%-52%39%69%-75%-67%20%51%49%
2--21-----1--2------22Not Very Useful3%--4%14%-----9%--7%------5%3%
----------------------Not at all Useful----------------------
3--4-3--1----22----314No Opinion5%--8%-20%--7%----9%15%----40%2%7%a
2--2----1-1-1-1-----22Don't know3%--3%----7%-9%-5%-7%-----4%3%
521943614-21088-18249-51553451Useful88%100%100%85%86%80%-100%87%100%82%-95%84%78%-100%100%100%60%89%87%
2--21-----1--2------22Not useful3%--4%14%-----9%--7%------5%3%
501941514021087018229051553249Net useful85%100%100%81%72%80%0%100%87%100%73%0%95%78%78%0%100%100%100%60%84%84%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 232Q.15i How useful, if at all, do you personally find the following forms of communication with the HTA?
- Letter -
Base : All those who have communicated with the HTA via letter in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
59154611256442959Unweighted total
59*1**6**5**5**1**12**5**5**4**3**2**8**58*Weighted total
22-5121322221322Very Useful37%-82%19%31%100%21%36%34%45%52%41%33%37%
301144-6331-1629Fairly Useful51%100%18%81%69%-51%64%48%18%-59%67%49%
2-------1-1--2Not Very Useful3%-------19%-25%--3%
--------------Not at all Useful--------------
3-----2--2---4No Opinion5%-----20%--37%---7%
2-----1---1--2Don't know3%-----7%---23%--3%
5216551954322851Useful88%100%100%100%100%100%72%100%81%63%52%100%100%87%
2-------1-1--2Not useful3%-------19%-25%--3%
5016551953312849Net useful85%100%100%100%100%100%72%100%62%63%27%100%100%84%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 233Q.15i How useful, if at all, do you personally find the following forms of communication with the HTA?
- Letter -
Base : All those who have communicated with the HTA via letter in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
59357202094959Unweighted total
59*36*8**20**20**10**48*58*Weighted total
221819712122Very Useful37%51%z11%44%34%11%43%z37%
3015410942529Fairly Useful51%41%55%48%44%37%53%49%
211-2-22Not Very Useful3%3%12%-10%-4%3%
--------Not at all Useful--------
322224-4No Opinion5%5%22%8%12%43%-7%
2----1-2Don't know3%----9%-3%
52335191554651Useful88%93%66%92%78%48%96%z87%
211-2-22Not useful3%3%12%-10%-4%3%
50324191454449Net useful85%90%54%92%68%48%92%84%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 234Q.15i How useful, if at all, do you personally find the following forms of communication with the HTA?
- Letter -
Base : All those who have communicated with the HTA via letter in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-3273711846-15132-2-322330Unweighted total
30*-**3**26**3**8**1**1**6**4**5**-**15**12**2**-**3**-**3**3**20**28**Weighted total
8-2611--311-161----167Very Useful27%-64%22%33%16%--50%25%17%-5%47%56%----43%30%26%
15--1527-1213-104--3-32815Fairly Useful50%--58%67%84%-100%25%25%50%-71%38%--100%-100%57%40%53%
4-12--1-111-31------33Not Very Useful13%-36%9%--100%-13%25%17%-18%6%------17%12%
----------------------Not at all Useful----------------------
2--2----1-1-1-1-----22No Opinion7%--7%----13%-17%-6%-44%-----8%6%
1--1-----1---1------11Don't know3%--4%-----25%---9%------5%4%
23-22038-1524-11101-3-331422Useful77%-64%80%100%100%-100%75%50%67%-76%85%56%-100%-100%100%70%79%
4-12--1-111-31------33Not useful13%-36%9%--100%-13%25%17%-18%6%------17%12%
19011838-114130991030331119Net useful63%0%28%71%100%100%-100%100%62%25%50%0%58%80%56%0%100%0%100%100%53%67%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 235Q.15j How useful, if at all, do you personally find the following forms of communication with the HTA?
- Press release -
Base : All those who have read a HTA press release in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-1224952112130Unweighted total
30*-**1**2**2**4**8**5**2**1**1**2**1**28**Weighted total
8---21221----7Very Useful27%---100%23%25%35%47%----26%
15--2-34111-2-15Fairly Useful50%--100%-77%54%26%53%100%-100%-53%
4-1----1--1-13Not Very Useful13%-100%----18%--100%-100%12%
--------------Not at all Useful--------------
2-----2------2No Opinion7%-----21%------6%
1------1-----1Don't know3%------21%-----4%
23--2246321-2-22Useful77%--100%100%100%79%61%100%100%-100%-79%
4-1----1--1-13Not useful13%-100%----18%--100%-100%12%
190-12246221-12-119Net useful63%0%-100%100%100%100%79%43%100%100%-100%100%-100%67%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 236Q.15j How useful, if at all, do you personally find the following forms of communication with the HTA?
- Press release -
Base : All those who have read a HTA press release in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
3018312832430Unweighted total
30*17**3**11**8**2**23**28**Weighted total
85-52-77Very Useful27%28%-42%23%-31%26%
151026411215Fairly Useful50%58%76%49%48%32%53%53%
421-1133Not Very Useful13%9%24%-19%32%11%12%
--------Not at all Useful--------
2---11-2No Opinion7%---10%36%-6%
11-1--11Don't know3%6%-9%--4%4%
2315210612022Useful77%85%76%91%71%32%85%79%
421-1133Not useful13%9%24%-19%32%11%12%
1913210401719Net useful63%76%51%91%52%0%74%67%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 237Q.15j How useful, if at all, do you personally find the following forms of communication with the HTA?
- Press release -
Base : All those who have read a HTA press release in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
267640233197916344336399812931-2593822173267Unweighted total
2675**38*23120**95*11**3**35*34*56*12**93*12435**-**32**10**33*36**152263Weighted total
106-1493543411512208275713-236131152105Very Useful40%-37%40%27%45%37%33%41%35%37%64%30%46%zi37%-71%66%39%31%34%40%ai
1415211181343721919304585717-83162089137Fairly Useful53%100%55%51%68%45%63%67%54%56%54%36%63%zh47%50%-25%34%50%55%59%z52%
13-21217--114-553-1-33613Not Very Useful5%-6%5%4%8%--2%3%6%-6%4%8%-4%-8%9%4%5%
5-15-2---22-231----245Not at all Useful2%-3%2%-2%---6%3%-2%2%3%----5%2%2%
1--1-1-------1----1--1No Opinion*--*-1%-------1%----3%za--*
1--1----1-----1-----11Don't know*--*----2%-----2%-----1%*
2475352121986113343150128611530-31103031141243Useful93%100%92%92%96%90%100%100%95%91%90%100%92%93%87%-96%100%89%86%93%92%
18-31819--135-784-1-351019Not useful7%-8%8%4%9%--2%9%10%-8%6%11%-4%-8%14%7%7%
2295321941877113332845127910726030102726131224Net useful86%100%84%84%91%80%100%100%93%82%81%100%85%87%75%0%92%100%82%72%86%85%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 238Q.15k How useful, if at all, do you personally find the following forms of communication with the HTA?
- HTA website -
Base : All those who have visited the HTA website in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
26761613312461142212221234267Unweighted total
2676**17**15**29**23**62*13**21**12**22**11**31*263Weighted total
106547169235569313105Very Useful40%85%26%46%56%39%38%38%25%47%40%27%41%40%
1411126111232814610718137Fairly Useful53%15%68%42%39%53%52%62%63%53%45%65%56%52%
13----26-2-31113Not Very Useful5%----8%9%-8%-12%8%3%5%
5-112-1-1----5Not at all Useful2%-6%7%6%-1%-4%----2%
1--1---------1No Opinion*--6%---------*
1---------1--1Don't know*---------4%--*
24761613282155131912191030243Useful93%100%94%88%94%92%90%100%88%100%85%92%97%92%
18-11226-3-31119Not useful7%-6%7%6%8%10%-12%-12%8%3%7%
2296151226194913161216930224Net useful86%100%88%81%89%84%79%100%76%100%73%84%94%85%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 239Q.15k How useful, if at all, do you personally find the following forms of communication with the HTA?
- HTA website -
Base : All those who have visited the HTA website in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
267162331266820242267Unweighted total
26715834*12370*19**240263Weighted total
10678559222102105Very Useful40%49%zg15%48%ze32%8%42%z40%g
1417222564010127137Fairly Useful53%45%64%45%57%52%53%52%fh
1364655813Not Very Useful5%4%12%h5%7%25%3%5%c
52323245Not at all Useful2%1%8%zh1%4%10%2%2%
11-1-1-1No Opinion*1%-1%-5%-*
1------1Don't know*------*
247150271156211229243Useful93%95%zg79%93%88%60%95%z92%g
18777861219Not useful7%5%21%zh6%12%35%5%7%ch
22914220107545217224Net useful86%90%58%87%77%26%90%85%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 240Q.15k How useful, if at all, do you personally find the following forms of communication with the HTA?
- HTA website -
Base : All those who have visited the HTA website in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
Received e-newsletter orContributed toConferences orHTA's onlineFace-to-face
HTA websitePress releaseLetterbulletinEmailconsultationTelephone calleventsportalTrainingmeetings
2673059282301392185217273120Unweighted total
2632858272305462206218180135Weighted total
105722921861717528745097Very Useful40%26%37%34%61%38%79%45%41%62%72%
1371529145104204232812632Fairly Useful52%53%49%53%34%44%19%51%45%33%23%
13322855-21431Not Very Useful5%12%3%10%2%10%-3%8%3%1%
5--2-1--3--Not at all Useful2%--1%-2%--2%--
124381413-5No Opinion*6%7%1%2%2%2%1%2%-4%
112222--62-Don't know*4%3%1%1%4%--3%2%-
2432251237290382175915576129Useful92%79%87%87%95%82%98%96%86%94%96%
19323055-21731Not useful7%12%3%11%2%12%-3%9%3%1%
2241949207285322175813973128Net useful85%67%84%76%94%70%98%93%77%91%95%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 241Q.15 How useful, if at all, do you personally find the following forms of communication with the HTA?
- Summary -
Base : All those who have had used the form of communication with HTA in the past 12 months
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
9321179103742141011431469-1841654690Very well informed26%19%24%25%33%26%33%67%29%26%15%27%25%27%17%-38%b24%33%b9%24%25%bk
22363019916936125254997910235-27102941120226Fairly well informed62%71%63%63%49%65%50%33%54%64%72%m65%65%60%64%-57%52%58%75%63%62%
3214283112-43718167131371832Not very well informed9%10%9%9%11%8%17%-8%8%10%9%6%9%13%100%5%6%5%12%9%9%
5-1411--2-1-23---11-24Not at all well informed1%-2%1%4%1%--3%-1%-1%2%---6%2%-1%1%
7--713--2---223--21227No opinion2%--2%4%2%--5%k---2%1%6%--12%2%3%1%2%
2-11-----11--2------22Don't know1%-2%*-----3%1%--1%------1%1%
316841279261291033935601311014844-45144546167316Well informed87%90%87%87%82%90%83%100%83%90%87%91%91%87%81%-95%76%91%85%87%87%
3715325122-638110197132372037Not well informed10%10%10%10%14%8%17%-12%8%12%9%8%11%13%100%5%12%7%12%11%10%
27973624722117833432521210113037-142124239146280Net77%81%77%78%68%82%67%100%71%82%76%82%83%76%68%-100%89%64%84%72%76%77%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 242Q.16A How well informed, if at all, do you feel HTA keeps you about....
- Its work generally? -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
9328511719394931190Very well informed26%26%34%26%29%19%24%17%28%21%29%25%23%25%
2237121324254516161117932226Fairly well informed62%74%54%65%65%71%55%83%52%60%57%75%68%62%
32-322114-323-332Not very well informed9%-11%9%6%3%17%zh-11%9%9%-7%9%
5-----1-111-14Not at all well informed1%-----1%-3%4%3%-2%1%
7----23-1-1--7No opinion2%----7%z3%-4%-3%--2%
2-------11---2Don't know1%-------3%5%---1%
316102018353164192515261242316Well informed87%100%89%91%94%g90%78%100%80%82%86%100%91%87%g
37-322115-424-437Not well informed10%-11%9%6%3%18%zh-14%14%12%-9%10%
279101816323149192112221238280Net77%100%77%82%88%88%60%100%66%68%74%100%82%77%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 243Q.16A How well informed, if at all, do you feel HTA keeps you about....
- Its work generally? -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
936744519-9090Very well informed26%33%zg8%27%19%-28%zd25%dg
2231263310761-226226Fairly well informed62%61%63%65%60%-72%zd62%d
32101091532-32Not very well informed9%5%20%zh5%14%zf88%zc-9%cfh
5-2-24-4Not at all well informed1%-5%zh-2%12%zc-1%
71224--7No opinion2%1%5%h1%4%--2%ch
21-1---2Don't know1%*-1%---1%
3161933715180-316316Well informed87%94%zg71%93%ze79%-100%zd87%deg
37101391737-37Not well informed10%5%24%zh5%17%zf100%zc-10%cfh
2791842414263-37316280Net77%90%47%87%62%-100%100%77%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 244Q.16A How well informed, if at all, do you feel HTA keeps you about....
- Its work generally? -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
723761832219610419406-1611533570Very well informed20%29%15%19%26%22%17%33%19%16%14%27%16%24%12%-35%zab6%30%zb5%18%19%b
1853251651571612319415648431-2012243197185Fairly well informed51%32%52%52%47%50%50%33%50%49%59%35%53%49%57%-43%64%49%57%51%51%
71311625293-131011430318-716154473Not very well informed20%30%22%20%16%20%22%-27%25%17%29%24%18%14%-14%6%12%28%23%20%
14-31325--133136511123615Not at all well informed4%-7%4%8%4%--2%8%4%9%2%3%10%i100%3%6%4%6%3%4%
151-1517111-2-573-3332515No opinion4%10%-5%4%5%11%33%2%-3%-4%4%6%-5%18%5%3%3%4%a
5-23----113-131-----44Don't know1%-4%1%----2%3%4%zp-1%2%2%-----2%z1%r
257532226231038232255098412438-37133934132255Well informed71%60%67%71%73%72%67%67%68%65%73%62%69%73%69%-78%70%79%63%69%70%
85314757343-14131453237131828185088Not well informed23%30%29%24%23%24%22%-29%33%21%38%26%22%24%100%17%12%16%34%26%24%
1723181511669621912363528724-12911311681167Net48%30%37%47%50%48%44%67%39%32%53%24%42%51%45%-100%61%58%63%29%42%46%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 245Q.16B How well informed, if at all, do you feel HTA keeps you about....
- Why it takes specific decisions? -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
72344681648253870Very well informed20%31%17%20%18%22%20%19%24%13%15%25%17%19%
185491020203512151218624185Fairly well informed51%43%38%53%55%58%43%61%49%64%61%48%52%51%
7111047417243531373Not very well informed20%8%46%18%18%10%21%13%12%18%18%21%27%20%
141-1--8-3-1-215Not at all well informed4%9%-5%--10%z-8%-3%-4%4%
151-123411-11-15No opinion4%9%-4%7%8%5%7%4%-3%6%-4%
5---111-11---4Don't know1%---2%2%1%-3%5%---1%
2577121427285115231423932255Well informed71%74%54%72%73%79%62%80%73%77%76%73%69%70%
8521057426263631488Not well informed23%17%46%23%18%10%31%h13%20%18%21%21%31%h24%h
172521020242513161117618167Net48%57%8%49%54%69%31%67%53%58%56%52%38%46%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 246Q.16B How well informed, if at all, do you feel HTA keeps you about....
- Why it takes specific decisions? -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
725333710-7070Very well informed20%26%zg5%22%e10%-22%zd19%deg
1851092290432182185Fairly well informed51%53%43%55%43%5%58%zd51%d
7132162433225073Not very well informed20%15%30%h15%33%zf59%zc16%20%cfh
143731011415Not at all well informed4%2%14%zh2%10%zf31%zc1%4%cfh
1573832815No opinion4%3%5%5%3%5%2%4%c
51212-34Don't know1%*3%1%2%-1%1%c
25716225127532252255Well informed71%79%zg48%78%ze53%5%80%zd70%deg
8535232843335488Not well informed23%17%44%zh17%43%zf90%zc17%24%cfh
17212729910-31198167Net48%62%4%61%10%-85%62%46%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 247Q.16B How well informed, if at all, do you feel HTA keeps you about....
- Why it takes specific decisions? -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
10231587114631179113315711-155171648102Very well informed28%29%31%27%33%32%k22%33%35%k23%17%18%25%34%z21%-32%28%35%30%25%28%k
18041816314706-1918469667728-3010222495180Fairly well informed50%43%39%51%43%49%50%-39%46%67%zlmp65%54%45%51%-62%54%44%45%50%50%
56111496212199732025111124133658Not very well informed15%10%23%15%20%15%17%33%19%23%10%18%16%15%20%100%3%12%9%25%e19%e16%e
912712--122-351-112-59Not at all well informed2%10%5%2%4%1%--2%5%3%-2%3%2%-3%6%4%-2%2%
81-6-31-2---132---3-36No opinion2%10%-2%-2%11%-3%---1%2%4%---7%za-2%2%
7-15---1113-241---1-56Don't know2%-2%2%---33%2%3%4%p-1%2%2%---2%-3%2%
2826332502411791352757129613540-45153941143283Well informed78%71%70%79%76%81%72%33%75%69%83%82%79%79%72%-95%zabc82%79%75%75%78%
6521357824211011932230121336134067Not well informed18%19%28%18%24%16%17%33%20%28%k13%18%18%18%22%100%5%18%12%25%e21%e18%e
21752019417937026164897410528-142123327102216Net60%52%42%61%53%65%56%0%55%40%71%65%61%61%50%-100%89%64%67%51%54%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 248Q.16C How well informed, if at all, do you feel HTA keeps you about....
- Forthcoming changes to regulation / legislation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
10254101381931068413102Very well informed28%52%16%49%35%22%23%17%33%31%27%32%29%28%
18031451920421414816621180Fairly well informed50%31%60%23%51%59%51%75%44%46%52%48%45%50%
56-453712253521158Not very well informed15%-19%23%9%19%14%8%17%18%16%14%23%16%
9-1---5-1-1-19Not at all well informed2%-4%---6%z-3%-3%-2%2%
81-11-2---1116No opinion2%9%-4%2%-2%---3%6%2%2%
71--1-3-11---6Don't know2%8%--2%-3%-3%5%---2%
28281714322860172414241034283Well informed78%83%76%72%86%81%74%92%77%77%79%80%73%78%
65-553717263621267Not well informed18%-24%23%9%19%21%8%20%18%19%14%25%18%
2178121028224316181118823216Net60%83%53%49%77%62%53%83%57%58%60%67%49%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 249Q.16C How well informed, if at all, do you feel HTA keeps you about....
- Forthcoming changes to regulation / legislation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
1027375018-101102Very well informed28%36%zg13%31%e18%-32%zd28%deg
1801042686528169180Fairly well informed50%51%51%53%52%22%54%zd50%d
5621152026193758Not very well informed15%10%29%zh12%26%zf52%zc12%16%ch
92424819Not at all well informed2%1%7%h1%4%21%zc*2%ch
82-21146No opinion2%1%-1%1%2%1%2%c
73-3-136Don't know2%1%-2%-2%1%2%c
28217733136708271283Well informed78%86%zg64%83%ze69%22%86%zd78%deg
6523192230273867Not well informed18%11%36%zh14%30%zf73%zc12%18%cfh
2171541411440-19232216Net60%75%27%70%40%-51%73%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 250Q.16C How well informed, if at all, do you feel HTA keeps you about....
- Forthcoming changes to regulation / legislation -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
85-166210632211519-28417-12326977Very well informed23%-34%zr20%32%4%22%67%44%zp39%zp28%p-23%24%13%-3%12%5%3%36%zbce21%bcep
12411910482671181739-465520-4122490121Fairly well informed34%10%40%33%26%18%56%33%39%p43%p56%zmp-38%32%36%-8%6%4%45%ce47%zce33%cep
3813387212-335462391534101741Not very well informed10%11%6%12%21%15%17%-7%8%8%27%5%13%i16%i100%11%18%9%19%9%11%i
241426120--24135138-81310729Not at all well informed7%10%8%8%4%14%zkm--3%10%k1%18%4%7%15%i-16%a6%7%19%za3%8%ak
3114311221-2-3314106-92105733No opinion9%10%9%10%4%16%zklm6%-3%-4%18%12%6%11%-19%za12%21%za9%3%9%ah
605157449--2-2522305-219273362Don't know17%60%2%18%s14%34%zklm--4%-3%38%18%17%9%-44%zab46%54%zab5%1%17%aklms
2091351661931103393258-749627-53426158197Well informed58%10%74%zr52%58%22%78%100%82%zp82%zp85%zp-61%56%49%-11%18%9%48%ce83%zbce54%cepr
6227648412-576612351711348202470Not well informed17%21%15%20%24%29%zkm17%-10%18%9%44%10%21%i30%zi100%27%a24%16%37%zac12%19%aikm
147-12810211-1083342552-6626110-1-8-1-36135127Net41%-11%59%32%34%-7%61%100%72%64%76%-44%51%36%19%-100%-16%-6%-7%11%70%35%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 251Q.16D How well informed, if at all, do you feel HTA keeps you about....
- the fees charged and how you can pay them -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
8531312414696531077Very well informed23%30%4%16%33%h12%17%31%28%35%17%22%22%21%
124211415122468611418121Fairly well informed34%19%50%18%40%33%29%31%27%32%37%34%40%33%
38127168252-3441Not very well informed10%8%10%35%3%17%10%13%16%9%-21%10%11%
24-131211-3-7-129Not at all well informed7%-4%13%3%7%13%a-11%-22%-2%8%
31-1-17721222933No opinion9%-4%-2%20%zi9%11%3%9%6%16%18%zi9%
60463641735351462Don't know17%43%27%17%17%11%21%13%16%14%18%7%9%17%
209512727163812171216729197Well informed58%49%54%34%73%zgh45%47%62%55%67%54%55%62%54%
62139381928273570Not well informed17%8%15%48%7%24%23%i13%26%9%22%21%11%19%i
14749-324719991010423127Net41%40%40%-14%66%21%24%50%29%58%32%34%50%35%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 252Q.16D How well informed, if at all, do you feel HTA keeps you about....
- the fees charged and how you can pay them -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
855511412417477Very well informed23%27%z22%25%24%2%23%zd21%d
1247116593211109121Fairly well informed34%35%31%36%31%29%35%33%
38167122093141Not very well informed10%8%14%7%20%zf24%zc10%11%cfh
249689111829Not at all well informed7%5%12%5%9%30%zc6%8%cfh
31176111132933No opinion9%8%12%7%11%7%9%9%
6036533635662Don't know17%18%9%20%e6%8%18%17%e
209126271005611183197Well informed58%62%z53%61%z55%31%58%zd54%d
6226142029204970Not well informed17%13%26%h12%29%zf54%zc15%19%cfh
147101148027-8135127Net41%49%27%49%26%-22%43%35%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 253Q.16D How well informed, if at all, do you feel HTA keeps you about....
- the fees charged and how you can pay them -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
the feesForthcomingcharged and howchanges toWhy it takes
you can payregulation /specificIts workthemlegislationdecisions?generally?
362362362362Unweighted total
362362362362Weighted total
771027090Very well informed21%28%19%25%
121180185226Fairly well informed33%50%51%62%
41587332Not very well informed11%16%20%9%
299154Not at all well informed8%2%4%1%
336157No opinion9%2%4%2%
62642Don't know17%2%1%1%
197283255316Well informed54%78%70%87%
70678837Not well informed19%18%24%10%
127216167280Net35%60%46%77%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 254Q.16 How well informed, if at all, do you feel HTA keeps you about....
- Summary -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1663241471679711917219518323-269302676167Very good46%38%51%46%49%55%zk56%33%41%44%31%65%42%49%43%-54%46%61%za47%40%46%ak
153317135951522119384636124-186152391152Fairly good42%32%35%42%30%35%39%67%44%48%55%zp27%51%zh36%44%-38%30%30%43%47%zc42%ch
3327285131-63515216142351834Neither good nor poor9%21%14%9%14%9%6%-13%8%8%9%4%13%i12%100%8%12%7%9%9%9%i
5--51-----4-32---1--45Fairly poor1%--1%4%-----5%zp-2%1%---6%--2%1%
1--1--------1-------11Very poor*--*--------1%-------**
2--21---1----11--1--12No opinion1%--1%4%---2%----1%1%--6%--*1%
21-1-1----1--2----1-12Don't know1%10%-*-1%----1%--1%----2%-**
319641283251301234036591311414548-43144549167319Good88%70%86%89%79%90%94%100%85%92%86%91%93%zh85%87%-92%76%91%91%87%88%
6--51-----4-32---1--45Poor2%--2%4%-----5%zp-3%1%---6%--2%2%
313641277241301234036561311014348043134549163314Net86%70%86%87%75%90%94%100%85%92%81%91%91%83%87%0%92%70%91%91%85%87%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 255Q.17 And overall, how would you rate your communications with the HTA? Would you say they are...
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
16649101815411011714622167Very good46%45%41%49%48%44%50%55%36%37%47%52%46%46%
1535118181725717813618152Fairly good42%47%47%42%49%49%31%36%55%45%42%48%39%42%g
3312213141-23-634Neither good nor poor9%8%8%10%3%7%17%zi4%-14%8%-13%9%
5-----211---15Fairly poor1%-----2%5%3%---2%1%
1-------1----1Very poor*-------3%----*
2-------1-1--2No opinion1%-------4%-3%--1%
2-1------1---2Don't know1%-4%------5%---*
31992018353266172815271240319Good88%92%88%90%97%g93%81%91%91%82%89%100%85%88%g
6-----212---15Poor2%-----2%5%5%---2%2%
31392018353264162715271239314Net86%92%88%90%97%93%78%87%86%82%89%100%84%87%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 256Q.17 And overall, how would you rate your communications with the HTA? Would you say they are...
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
166121894313161167Very good46%59%zg16%58%ze31%9%51%zd46%deg
1537331595010141152Fairly good42%36%59%zh36%50%f26%45%zd42%fh
3399816211034Neither good nor poor9%4%18%zh5%15%zf57%zc3%9%cfh
51313235Fairly poor1%*5%zh1%3%5%zc1%1%c
1-1-11-1Very poor*-2%-1%2%c-*
2--1---2No opinion1%--1%---1%
21----12Don't know1%*----**
319194391538213302319Good88%95%zg75%94%ze81%35%96%zd88%deg
61313335Poor2%*7%zh1%3%8%zc1%2%ch
313193361527810300314Net86%94%69%93%78%28%95%87%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 257Q.17 And overall, how would you rate your communications with the HTA? Would you say they are...
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
14-312-51-224-923-1--3914Quicker response time to4%-6%4%-3%11%-5%5%5%-7%zh1%5%-3%--6%5%4%he-mailed/written/queries
15-1121211225-76----2-1113Able to contact a4%-2%4%3%1%6%33%3%5%8%zp-6%4%----4%-6%z4%specific person/
telephone contact
11-11116--123-463--115512Better search facilities3%-2%4%4%4%--2%5%4%-3%4%5%--6%2%9%3%3%on the website/more user
friendly
11139-51-122-452-1-12811Frequency/More frequent3%10%6%3%-3%11%-2%5%3%-3%3%4%-3%-2%3%4%3%newsletters/emails/
updates to website
9-26--1-25--422-----88More consistency in2%-4%2%--6%-5%kp13%zkp--3%1%3%-----4%z2%information given
7-3713---221322-1--258Information specific to2%-7%zr2%3%2%---5%3%9%2%1%3%-3%--3%3%2%me/my/each sector
8-1612--221-242---2-67Nothing/Satisfied/Happy2%-2%2%3%1%--3%5%1%-1%2%3%---4%-3%2%with communication
6--62----13-24---1--56More face to face2%--2%7%----3%4%p-2%2%---6%--2%2%meetings / training
events / conferences
4-23-----22-22------44Less/detailed1%-4%zr1%-----5%zp3%-1%1%------2%1%information/shorter
communications
3--311----1--3---11-13Less jargon/clear1%--1%4%1%----1%--2%---6%2%-*1%responses
1--1-1------1---1----1Staff are pleasant/*--*-1%------1%---3%a----*polite/friendly on the
phone
1--1-----1----1-----11HTA is dictatorial/*--*-----3%z----2%-----1%*inflexible
3-131---2----21-----33Other1%-2%1%3%---3%zp----1%1%-----1%1%
2496282211910582341848118112334-33134037124247Nothing in particular69%70%59%69%59%73%l67%67%71%l47%71%l73%66%72%62%-71%70%81%za69%65%68%l
2925256151-3233913619335931Don't know8%21%10%8%18%10%6%-7%4%4%18%8%8%12%100%19%za18%7%9%5%9%a
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 258Q.18 How, if at all, could the communications you receive from the HTA be improved?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
14--22122--31214Quicker response time to4%--9%5%2%3%9%--9%6%4%4%e-mailed/written/queries
15---31211121313Able to contact a4%---7%3%2%5%3%6%6%6%5%4%specific person/
telephone contact
11--1421-1-31-12Better search facilities3%--6%10%zag5%1%-3%-11%7%-3%on the website/more user
friendly
11-3---2-13-2111Frequency/More frequent3%-13%---2%-3%15%-14%3%3%newsletters/emails/
updates to website
9-111-2-1-2--8More consistency in2%-4%5%3%-2%-3%-8%--2%information given
7-21-22-1----8Information specific to2%-9%5%-5%3%-3%----2%me/my/each sector
8---121-11--27Nothing/Satisfied/Happy2%---2%5%1%-3%6%--4%2%with communication
6----121----26More face to face2%----3%2%5%----4%2%meetings / training
events / conferences
4--1--2-1----4Less/detailed1%--5%--2%-3%----1%information/shorter
communications
3--1-1----1--3Less jargon/clear1%--6%-3%----3%--1%responses
1---1--------1Staff are pleasant/*---3%z--------*polite/friendly on the
phone
1-1----------1HTA is dictatorial/*-4%----------*inflexible
3---111------3Other1%---2%3%1%------1%
2498141421255414241319934247Nothing in particular69%79%62%71%56%71%67%72%76%69%62%73%74%68%
292214-122411-331Don't know8%21%7%4%11%-14%h9%12%5%4%-7%9%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 259Q.18 How, if at all, could the communications you receive from the HTA be improved?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
14836431114Quicker response time to4%4%5%4%4%7%4%4%e-mailed/written/queries
15838411213Able to contact a4%4%5%5%4%2%4%4%specific person/
telephone contact
111129311212Better search facilities3%5%3%6%3%2%4%3%on the website/more user
friendly
1153546611Frequency/More frequent3%3%5%3%4%15%zc2%3%cnewsletters/emails/
updates to website
95235-78More consistency in2%2%3%2%5%-2%2%information given
72414248Information specific to2%1%7%zh1%4%5%1%2%cfhme/my/each sector
83332-67Nothing/Satisfied/Happy2%1%5%2%2%-2%2%with communication
64141156More face to face2%2%2%2%1%2%2%2%meetings / training
events / conferences
4-3-4134Less/detailed1%-5%zh-4%zf2%1%1%information/shorter
communications
31-2-123Less jargon/clear1%1%-1%-2%1%1%responses
11-1-1-1Staff are pleasant/*1%-1%-3%zc-*polite/friendly on the
phone
1-1-1-11HTA is dictatorial/*-2%-1%-**inflexible
31-12-33Other1%*-*2%-1%1%
249146281145915228247Nothing in particular69%71%g54%70%59%40%72%zd68%deg
2913691192231Don't know8%6%12%6%11%24%zc7%9%c
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 260Q.18 How, if at all, could the communications you receive from the HTA be improved?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
36-82541211077-15152--11-3032Strongly agree10%-17%zr8%13%1%17%33%20%zp18%zp10%p-12%9%3%--6%2%-16%zbce9%cp
94-137781631231422-344214--21177190Tend to agree26%-28%24%26%11%22%33%49%zkp36%p32%p-28%25%26%--12%2%31%ce37%zce25%cep
56-11455103-7917-20276-3-384053Neither agree nor15%-23%14%16%7%28%-15%22%p24%zp-16%16%11%-5%-5%14%21%zce15%cpdisagree
3713322102-4413-8235---272836Tend to disagree10%11%6%10%6%7%17%-8%10%19%zp-7%13%10%---4%12%e15%zce10%e
22-522-161--3445106-9-35725Strongly disagree6%-10%7%-11%zm6%--8%m5%27%4%6%10%-19%za-7%9%4%7%am
3524333211-115-14173-62143935No opinion10%19%8%10%10%15%zm6%-2%3%8%-12%10%6%-13%a12%28%zab6%5%10%am
8264849691131111253718130132615791Don't know23%70%9%26%s29%48%zklm6%33%6%3%1%73%21%22%33%100%62%zab70%53%zab27%a4%25%aklms
130-21102121752332129-495716--3217100122Agree36%-45%32%39%12%39%67%69%zkp54%zp42%p-40%33%29%--18%4%31%ce52%zbce34%cep
5917552273-47174143211-9-5123561Disagree16%11%16%17%6%18%22%-8%18%24%zm27%11%19%20%-19%-11%22%18%17%i
71-1144711-1022291412-4352550-93-356561Net agree20%-11%29%15%33%-7%17%67%61%36%18%-27%29%15%9%0%-19%18%-7%9%34%17%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 261Q.19A To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- I have enough information about how the HTA's fees are calculated -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
36-1253624-2-732Strongly agree10%-3%10%14%7%8%12%13%-6%-15%9%
9447412121754655990Tend to agree26%41%31%19%34%34%21%26%14%34%17%41%18%25%
5613273878251653Neither agree nor15%9%12%9%19%8%10%38%27%11%16%7%13%15%disagree
37-2-3412132-1836Tend to disagree10%-8%-10%13%15%5%9%9%-6%18%10%
22124--10-323-125Strongly disagree6%7%10%18%--12%hi-9%12%8%-2%7%
35-2124823151635No opinion10%-8%4%6%12%10%11%9%5%16%7%12%10%
8246869201751151091Don't know23%43%28%39%17%25%24%7%21%29%36%39%22%25%
1304861814247867515122Agree36%41%34%30%48%42%29%39%26%34%23%41%33%34%
59144342215431961Disagree16%7%18%18%10%13%27%zi5%17%21%8%6%20%17%
713421410263244661Net agree20%33%16%12%38%29%2%34%9%13%15%35%13%17%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 262Q.19A To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- I have enough information about how the HTA's fees are calculated -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
3627122513132Strongly agree10%13%zg2%13%ze5%2%10%9%
945911482538690Tend to agree26%29%22%30%25%7%27%zd25%d
56278201844953Neither agree nor15%13%15%12%18%12%15%15%disagree
37111481852936Tend to disagree10%6%26%zh5%18%zf13%9%10%fh
221266771725Strongly disagree6%6%11%4%7%20%zc5%7%cf
35157111342735No opinion10%7%13%7%13%12%9%10%
825464813127791Don't know23%26%g11%29%e13%33%24%25%eg
130861270303117122Agree36%42%zg24%43%ze30%10%37%zd34%d
5923191426124661Disagree16%11%38%zh9%25%zf34%zc15%17%cfh
7163-7565-97161Net agree20%31%-14%34%5%-24%22%17%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 263Q.19A To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- I have enough information about how the HTA's fees are calculated -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
22-6141-1-844-8102--1--1819Strongly agree6%-13%zr4%4%-11%-17%zp10%p6%p-6%6%3%--6%--9%zce5%pr
78-962784-231019-31328--1176271Tend to agree22%-19%19%23%5%33%-49%zklp26%p27%p-25%19%15%--6%2%12%e32%zbce19%cep
75111649184-9920-204310-313165174Neither agree nor21%11%23%20%29%12%33%-19%22%29%zp-17%25%z19%-5%6%7%30%ce27%zce20%cepdisagree
28-4242612368-15121---152228Tend to disagree8%-9%8%6%4%6%67%7%16%p12%p-12%zg7%2%---2%9%11%zce8%
16-511--1--86-2103-----1515Strongly disagree4%-10%zr3%--6%--21%zmp9%zmp-2%6%5%-----8%zc4%p
4326413291-214-181710-631681145No opinion12%19%12%13%10%20%zklm6%-3%3%6%-15%10%18%-13%18%32%zae15%6%12%alm
10066104983113171429472113812291813111Don't know28%70%13%32%s29%58%zklm6%33%6%3%10%100%24%27%38%100%81%zabc64%58%zab33%a7%31%aiklms
100-1575886-311423-384110--2178089Agree28%-32%24%26%5%44%-66%zklp36%p33%zp-31%z24%18%--12%2%12%e42%zbce25%cep
44-936261231414-16224---153742Disagree12%-19%11%6%4%11%67%7%36%zmp21%zmp-14%13%7%---2%9%19%zce12%cep
560640624-22809022196002024347Net agree15%0%13%12%20%1%33%-67%59%0%13%0%18%11%11%0%0%12%0%3%23%13%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 264Q.19B To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- The fees charged are currently about right -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
22--131222-3-519Strongly agree6%--5%9%2%2%12%6%-9%-10%5%
78441791346544971Tend to agree22%41%16%5%20%25%16%23%20%29%13%34%20%19%
75-577417654521074Neither agree nor21%-22%37%20%13%21%33%17%21%17%20%21%20%disagree
28---64634-3-328Tend to disagree8%---17%z11%7%13%13%-8%-5%8%
16151214-11---15Strongly disagree4%7%21%5%5%3%5%-3%5%---4%
43122261125151745No opinion12%9%8%9%6%17%14%11%17%5%16%7%16%12%
1004888102917711513111Don't know28%43%34%39%22%30%35%7%24%41%36%39%27%31%
10044211915785741489Agree28%41%16%10%30%27%18%35%26%29%22%34%30%25%
4415185103513-342Disagree12%7%21%5%22%za14%12%13%16%5%8%-5%12%
563-11355434441247Net agree15%33%-5%5%7%13%6%22%11%24%14%34%25%13%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 265Q.19B To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- The fees charged are currently about right -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
2215110511819Strongly agree6%7%2%6%5%2%6%5%
78526421636771Tend to agree22%25%zg11%26%z16%7%21%z19%d
75408302066874Neither agree nor21%19%16%18%20%16%22%20%disagree
2813781722428Tend to disagree8%7%13%5%17%zf5%8%8%
16494931215Strongly disagree4%2%18%zh2%9%zf8%4%4%h
431912151773245No opinion12%9%23%zh9%17%20%10%12%c
10062954161695111Don't know28%30%17%33%e16%43%30%31%eg
100677522138589Agree28%33%zg13%32%z21%9%27%zd25%d
441716122643642Disagree12%8%31%zh7%26%zf12%11%12%fh
5650-940-5-14947Net agree15%24%-18%25%-5%-3%16%13%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 266Q.19B To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- The fees charged are currently about right -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
2--22-------11---1--12Strongly agree1%--1%7%-------1%1%---6%--1%1%
16--154-1-334-2102--2--1215Tend to agree4%--5%13%-6%-7%p8%p5%p-2%6%4%--12%--6%z4%p
1081198281451192031-405110-3-31184101Neither agree nor30%11%41%zr26%25%10%39%33%40%zp51%zp45%zp-33%30%18%-5%-7%20%44%zbce28%ceprdisagree
52-840364110914-22196---154247Tend to disagree14%-17%13%10%4%33%33%22%zp23%p21%zp-18%11%12%---2%9%22%zce13%cep
18-3132-1-634-510------1616Strongly disagree5%-5%4%6%-6%-13%zp8%p5%p-4%6%------8%zc4%p
5126473291-428-21228-621681951No opinion14%19%14%15%10%20%zl11%-8%5%12%-17%13%15%-13%12%32%zae15%10%14%a
115611119994114291431572813813303018130Don't know32%70%23%37%s29%65%zklm6%33%9%5%13%100%25%33%52%zhi100%81%zabc70%60%za55%za10%36%aiklms
18--176-1-334-3112--3--1317Agree5%--5%20%-6%-7%p8%p5%p-3%7%4%--18%--7%zc5%p
70-11535651171218-27306---155763Disagree19%-23%17%16%4%39%33%35%zp31%zp26%zp-22%17%12%---2%9%30%zbce17%cep
-520-11-371-6-4-1-14-9-140-24-19-4003-1-5-44-46Net agree-14%0%-23%-11%4%-4%-33%-33%-29%-23%-21%0%-19%-11%-8%0%0%18%-2%-9%-23%-13%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 267Q.19C To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- Fees change too much from year to year -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2-----1-1----2Strongly agree1%-----1%-4%----1%
16221-24-1---215Tend to agree4%22%8%6%-7%5%-3%---4%4%
108-441212239107739101Neither agree nor30%-16%23%32%34%28%47%32%40%23%28%20%28%disagree
5213191744342947Tend to disagree14%7%12%5%26%zgh3%8%22%11%15%15%20%18%h13%
181113131--21316Strongly disagree5%10%4%5%10%2%3%4%--5%7%6%4%
51232351225261851No opinion14%17%15%9%8%15%14%11%17%10%21%7%18%14%
1154101091432310611516130Don't know32%43%45%53%24%40%39%16%33%35%36%39%34%36%
18221-25-2---217Agree5%22%8%6%-7%7%-7%---4%5%
7024213210543631163Disagree19%18%16%10%35%zgh5%12%26%11%15%20%26%24%h17%h
-52*-2-1-131-4-5-1-3-6-3-9-46Net agree-14%4%-8%-5%-35%2%-5%-26%-4%-15%-20%-26%-20%-13%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 268Q.19C To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- Fees change too much from year to year -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
21-1--22Strongly agree1%*-1%--1%1%
16657621315Tend to agree4%3%9%4%6%5%4%4%
10854144035891101Neither agree nor30%27%28%24%35%23%29%28%disagree
52374271324547Tend to disagree14%18%z7%16%13%5%14%13%
1812210311516Strongly disagree5%6%3%6%3%2%5%4%
512311172084051No opinion14%11%21%10%20%f22%13%14%ch
1157217622416110130Don't know32%35%32%38%e24%43%35%36%e
18758621517Agree5%3%9%5%6%5%5%5%
70496371536063Disagree19%24%zg11%22%z15%7%19%17%
-52-42-1-29-9-1-45-46Net agree-14%-21%-2%-18%-9%-2%-14%-13%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 269Q.19C To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- Fees change too much from year to year -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
I have enoughThe feesinformation
Fees change toocharged areabout how themuch from yearcurrently aboutHTA's fees are
to yearrightcalculated
362362362Unweighted total
362362362Weighted total
21932Strongly agree1%5%9%
157190Tend to agree4%19%25%
1017453Neither agree nor28%20%15%disagree
472836Tend to disagree13%8%10%
161525Strongly disagree4%4%7%
514535No opinion14%12%10%
13011191Don't know36%31%25%
1789122Agree5%25%34%
634261Disagree17%12%17%
-464761Net agree-13%13%17%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 270Q.19 To what extent, if at all, do you agree or disagree with each of the following descriptions about the HTA's fees and payments.
- Summary -
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
20--18------18-891-----1818A significant positive26%--26%------26%-25%28%17%-----26%26%impact
22-119------19-1172-----1919A minor positive impact28%-50%27%------28%-33%22%33%-----28%28%
20-118------18-6111-----1818No impact either way26%-50%26%------26%-19%33%17%-----26%26%
2--2------2-2-------22A minor negative impact3%--3%------3%-6%-------3%3%
----------------------A significant negative----------------------impact
13--11------11-542-----1111Don't know17%--17%------17%-17%14%33%-----17%17%
1--1------1--1------11Not applicable to my1%--1%------1%--3%------1%1%establishment
42-136------37-19163-----3737Positive impact54%-50%53%------54%-58%50%50%-----54%54%
2--2------2-2-------22Negative impact3%--3%------3%-6%-------3%3%
40013400000035017163000003535Net51%0%50%51%0%0%0%0%0%0%51%0%53%50%50%0%0%0%0%0%51%51%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 271Q.20a Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Themed inspections -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
20-1-43212-3-318A significant positive26%-33%-62%33%13%14%22%-33%-30%26%impact
221--14432-31219A minor positive impact28%100%--13%44%31%43%22%-33%25%20%28%
20---22431133118No impact either way26%---25%22%25%43%11%50%33%75%10%26%
2-----1-----12A minor negative impact3%-----6%-----10%3%
--------------A significant negative--------------impact
13-2---4-41--211Don't know17%-67%---25%-44%50%--20%17%
1-----------11Not applicable to my1%-----------10%1%establishment
4211-56644-51437Positive impact54%100%33%-75%78%44%57%44%-67%25%50%54%
2-----1-----12Negative impact3%-----6%-----10%3%
4011056544051435Net51%100%33%0%75%78%38%57%44%0%67%25%40%51%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 272Q.20a Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Themed inspections -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
2013111211718A significant positive26%39%z6%41%8%11%28%26%impact
227551011919A minor positive impact28%21%33%21%44%11%31%28%
20836421618No impact either way26%24%17%24%20%22%26%26%
2-2-2-22A minor negative impact3%-11%-8%-3%3%
--------A significant negative--------impact
1345344611Don't know17%13%33%10%20%56%10%17%c
11-1--11Not applicable to my1%3%-3%--1%1%establishment
42206161123537Positive impact54%61%39%62%52%22%59%z54%
2-2-2-22Negative impact3%-11%-8%-3%3%
40204161023335Net51%61%28%62%44%22%56%51%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 273Q.20a Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Themed inspections -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
24-120------21-11101-----2121A significant positive31%-50%30%------31%-33%31%17%-----31%31%impact
27--24------24-11113-----2424A minor positive impact35%--35%------35%-33%33%50%-----35%35%
12-111------11-451-----1111No impact either way15%-50%16%------15%-14%17%17%-----15%15%
1--1------1--1------11A minor negative impact1%--1%------1%--3%------1%1%
----------------------A significant negative----------------------impact
7--6------6-421-----66Don't know9%--9%------9%-11%6%17%-----9%9%
7--6------6-34------66Not applicable to my9%--9%------9%-8%11%------9%9%establishment
51-144------45-21204-----4545Positive impact65%-50%65%------65%-67%64%67%-----65%65%
1--1------1--1------11Negative impact1%--1%------1%--3%------1%1%
50014300000044021194000004444Net64%0%50%64%0%0%0%0%0%0%64%0%67%61%67%0%0%0%0%0%64%64%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 274Q.20b Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- A more proportionate approach to the regulation of microscope slides, introduced from 1 April 2013 -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
24-1-33332-41321A significant positive31%-33%-38%33%19%43%22%-56%25%30%31%impact
2712-33411113524A minor positive impact35%100%67%-38%33%31%14%11%50%11%75%60%35%
12---12331-1-111No impact either way15%---13%22%19%43%11%-11%-10%15%
1---------1--1A minor negative impact1%---------11%--1%
--------------A significant negative--------------impact
7-----1-411--6Don't know9%-----6%-44%50%11%--9%
7---114-1----6Not applicable to my9%---13%11%25%-11%----9%establishment
5113-55743154845Positive impact65%100%100%-75%67%50%57%33%50%67%100%90%65%
1---------1--1Negative impact1%---------11%--1%
5013055743144844Net64%100%100%0%75%67%50%57%33%50%56%100%90%64%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 275Q.20b Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- A more proportionate approach to the regulation of microscope slides, introduced from 1 April 2013 -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
2414410812021A significant positive31%42%z22%38%36%11%34%31%impact
271189732124A minor positive impact35%34%50%34%32%33%35%35%
1241442911No impact either way15%13%6%17%16%22%15%15%
1-1-1-11A minor negative impact1%-6%-4%-1%1%
--------A significant negative--------impact
72222336Don't know9%5%11%7%8%33%4%9%c
72111-66Not applicable to my9%5%6%3%4%-10%9%establishment
512611191544145Positive impact65%76%z72%72%68%44%69%65%
1-1-1-11Negative impact1%-6%-4%-1%1%
502611191444144Net64%76%67%72%64%44%68%64%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 276Q.20b Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- A more proportionate approach to the regulation of microscope slides, introduced from 1 April 2013 -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
6--5------5-321-----55A significant positive8%--8%------8%-8%6%17%-----8%8%impact
17--15------15-78------1515A minor positive impact22%--22%------22%-22%25%------22%22%
47-241------41-19194-----4141No impact either way60%-100%60%------60%-58%58%83%-----60%60%
2--2------2--2------22A minor negative impact3%--3%------3%--6%------3%3%
----------------------A significant negative----------------------impact
6--5------5-42------55Don't know8%--8%------8%-11%6%------8%8%
----------------------Not applicable to my----------------------establishment
23--20------20-10101-----2020Positive impact29%--30%------29%-31%31%17%-----29%29%
2--2------2--2------22Negative impact3%--3%------3%--6%------3%3%
2100190000001901081000001919Net27%0%0%27%0%0%0%0%0%0%27%0%31%25%17%0%0%0%0%0%27%27%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 277Q.20c Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Changing the name of Serious Untoward Incidents (SUIs) to HTA Reportable Incidents (HTARIs) -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
6---1-11----35A significant positive8%---13%-6%14%----30%8%impact
17---12412-22215A minor positive impact22%---13%22%31%14%22%-22%50%20%22%
4713-55644162441No impact either way60%100%100%-75%67%44%71%44%50%78%50%50%60%
2----11------2A minor negative impact3%----11%6%------3%
--------------A significant negative--------------impact
6-----2-31---5Don't know8%-----13%-33%50%---8%
--------------Not applicable to my--------------establishment
23---22522-22420Positive impact29%---25%22%38%29%22%-22%50%50%29%
2----11------2Negative impact3%----11%6%------3%
2100021422022419Net27%0%0%0%25%11%31%29%22%0%22%50%50%27%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 278Q.20c Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Changing the name of Serious Untoward Incidents (SUIs) to HTA Reportable Incidents (HTARIs) -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
64-12-55A significant positive8%13%-3%8%-9%8%impact
178283-1515A minor positive impact22%24%11%31%12%-25%22%
471911151643741No impact either way60%58%72%59%72%56%62%60%
2111-112A minor negative impact3%3%6%3%-11%1%3%
--------A significant negative--------impact
61212325Don't know8%3%11%3%8%33%3%8%c
--------Not applicable to my--------establishment
2312294-2020Positive impact29%37%11%34%20%-34%z29%
2111-112Negative impact3%3%6%3%-11%1%3%
2111184-11919Net27%34%6%31%20%-11%32%27%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 279Q.20c Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Changing the name of Serious Untoward Incidents (SUIs) to HTA Reportable Incidents (HTARIs) -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
7-16------6-232-----66A significant positive9%-50%9%------9%-6%8%33%-----9%9%impact
19--17------17-881-----1717A minor positive impact24%--25%------24%-25%25%17%-----24%24%
27-123------24-11111-----2424No impact either way35%-50%34%------35%-36%36%17%-----35%35%
----------------------A minor negative impact----------------------
----------------------A significant negative----------------------impact
15--13------13-842-----1313Don't know19%--19%------19%-25%11%33%-----19%19%
10--9------9-36------99Not applicable to my13%--13%------13%-8%19%------13%13%establishment
26-123------23-10113-----2323Positive impact33%-50%34%------33%-31%33%50%-----33%33%
----------------------Negative impact----------------------
26012300000023010113000002323Net33%0%50%34%0%0%0%0%0%0%33%0%31%33%50%0%0%0%0%0%33%33%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 280Q.20d Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Increased licensing options for the removal of tissue from deceased donors, introduced from May 2012 -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
7----1-1--1-46A significant positive9%----11%-14%--11%-40%9%impact
19---23232-32217A minor positive impact24%---25%33%13%43%22%-33%50%20%24%
27-2-5452214--24No impact either way35%-67%-75%44%38%29%22%50%44%--35%
--------------A minor negative impact--------------
--------------A significant negative--------------impact
151----3141-2313Don't know19%100%----19%14%44%50%-50%30%19%
10-1--14-1-1-19Not applicable to my13%-33%--11%31%-11%-11%-10%13%establishment
26---24242-42523Positive impact33%---25%44%13%57%22%-44%50%60%33%
--------------Negative impact--------------
2600024242042523Net33%0%0%0%25%44%13%57%22%0%44%50%60%33%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 281Q.20d Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Increased licensing options for the removal of tissue from deceased donors, introduced from May 2012 -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
75-4--66A significant positive9%16%-17%--10%9%impact
19917311617A minor positive impact24%26%6%28%12%11%26%24%
2711781132124No impact either way35%32%44%31%48%33%35%35%
--------A minor negative impact--------
--------A significant negative--------impact
1564454913Don't know19%18%22%17%24%44%15%19%c
103424189Not applicable to my13%8%28%7%16%11%13%13%establishment
2614111312223Positive impact33%42%6%45%12%11%37%33%
--------Negative impact--------
2614111312223Net33%42%6%45%12%11%37%33%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 282Q.20d Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Increased licensing options for the removal of tissue from deceased donors, introduced from May 2012 -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
4--4------4-3-1-----44A significant positive5%--5%------5%-8%-17%-----5%5%impact
23--20------20-1011------2020A minor positive impact29%--30%------29%-31%33%------29%29%
22--19------19-8111-----1919No impact either way28%--29%------28%-25%33%17%-----28%28%
----------------------A minor negative impact----------------------
----------------------A significant negative----------------------impact
20-217------18-774-----1818Don't know26%-100%25%------26%-22%22%67%-----26%26%
9--8------8-44------88Not applicable to my12%--12%------12%-14%11%------12%12%establishment
27--24------24-12111-----2424Positive impact35%--35%------35%-39%33%17%-----35%35%
----------------------Negative impact----------------------
27002400000024012111000002424Net35%0%0%35%0%0%0%0%0%0%35%0%39%33%17%0%0%0%0%0%35%35%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 283Q.20e Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- The work of the Histopathology Working Group -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
4------1--1-24A significant positive5%------14%--11%-20%5%impact
23-2-33313-33220A minor positive impact29%-67%-38%33%19%14%33%-33%75%20%29%
22-1-24331141219No impact either way28%-33%-25%44%19%43%11%50%44%25%20%28%
--------------A minor negative impact--------------
--------------A significant negative--------------impact
201--2132411-418Don't know26%100%--25%11%19%29%56%50%11%-40%26%
9---116------8Not applicable to my12%---13%11%44%------12%establishment
27-2-33323-43424Positive impact35%-67%-38%33%19%29%33%-44%75%40%35%
--------------Negative impact--------------
2702033323043424Net35%0%67%0%38%33%19%29%33%0%44%75%40%35%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 284Q.20e Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- The work of the Histopathology Working Group -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
44-11-44A significant positive5%11%-3%4%-6%5%impact
2312511711920A minor positive impact29%37%33%41%32%11%32%29%
221048621819No impact either way28%29%22%31%28%22%29%28%
--------A minor negative impact--------
--------A significant negative--------impact
20554741318Don't know26%16%33%17%32%44%22%26%h
93221268Not applicable to my12%8%11%7%4%22%10%12%establishment
2716511812324Positive impact35%47%z33%45%36%11%38%35%
--------Negative impact--------
2716511812324Net35%47%33%45%36%11%38%35%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 285Q.20e Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- The work of the Histopathology Working Group -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
21-119------19-1144-----1919A significant positive27%-50%27%------27%-33%14%67%-----27%27%himpact
31--27------27-10171-----2727A minor positive impact40%--40%------40%-31%53%z17%-----40%40%
13-111------11-461-----1111No impact either way17%-50%16%------17%-14%19%17%-----17%17%r
1--1------1-1-------11A minor negative impact1%--1%------1%-3%-------1%1%
----------------------A significant negative----------------------impact
8--7------7-52------77Don't know10%--10%------10%-17%6%------10%10%
4--4------4-13------44Not applicable to my5%--5%------5%-3%8%------5%5%establishment
52-146------46-20214-----4646Positive impact67%-50%68%------67%-64%67%83%-----67%67%
1--1------1-1-------11Negative impact1%--1%------1%-3%-------1%1%
51014500000045019214000004545Net65%0%50%66%0%0%0%0%0%0%65%0%61%67%83%0%0%0%0%0%65%65%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 286Q.20f Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- The creation of the adult post mortem information leaflet, and the perinatal Sands information leaflet and consent forms -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
2111-3-131-41419A significant positive27%100%33%-38%-6%43%11%-56%25%50%27%impact
31---35543113427A minor positive impact40%---38%67%38%57%33%50%11%75%40%40%
13-2-223-112--11No impact either way17%-67%-25%22%19%-11%50%22%--17%
1---------1--1A minor negative impact1%---------11%--1%
--------------A significant negative--------------impact
8-----4-3---17Don't know10%-----25%-33%---10%10%
4----12-1----4Not applicable to my5%----11%13%-11%----5%establishment
5211-55664154846Positive impact67%100%33%-75%67%44%100%44%50%67%100%90%67%
1---------1--1Negative impact1%---------11%--1%
5111055664144845Net65%100%33%0%75%67%44%100%44%50%56%100%90%65%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 287Q.20f Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- The creation of the adult post mortem information leaflet, and the perinatal Sands information leaflet and consent forms -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
21134106-1919A significant positive27%39%z28%38%28%-31%z27%impact
3110510832427A minor positive impact40%29%33%38%36%33%40%40%
13543511111No impact either way17%16%22%10%24%11%18%17%
1---11-1A minor negative impact1%---4%11%-1%
--------A significant negative--------impact
84222347Don't know10%11%11%7%8%33%7%10%c
4212-134Not applicable to my5%5%6%7%-11%4%5%establishment
522310191434246Positive impact67%68%61%76%64%33%71%67%
1---11-1Negative impact1%---4%11%-1%
512310191324245Net65%68%61%76%60%22%71%65%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 288Q.20f Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- The creation of the adult post mortem information leaflet, and the perinatal Sands information leaflet and consent forms -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
The creation ofthe adult postIncreased
mortemlicensingChanging theA moreinformationoptions for thename of Seriousproportionateleaflet, andremoval ofUntowardapproach to the
the perinataltissue fromIncidentsregulation ofSandsdeceased(SUIs) to HTAmicroscope
informationThe work of thedonors,Reportableslides,leaflet andHistopathologyintroduced fromIncidentsintroduced fromThemed
consent formsWorking GroupMay 2012(HTARIs)1 April 2013inspections
787878787878Unweighted total
696969696969Weighted total
194652118A significant positive27%5%9%8%31%26%impact
272017152419A minor positive impact40%29%24%22%35%28%
111924411118No impact either way17%28%35%60%15%26%
1--212A minor negative impact1%--3%1%3%
------A significant negative------impact
718135611Don't know10%26%19%8%9%17%
489-61Not applicable to my5%12%13%-9%1%establishment
462423204537Positive impact67%35%33%29%65%54%
1--212Negative impact1%--3%1%3%
452423194435Net65%35%33%27%64%51%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 289Q.20 Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Summary -
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
9-17------8-242-----88Very easy12%-50%10%------12%-6%14%33%-----12%12%r
46--41------41-19192-----4141Fairly easy59%--60%------59%-61%61%33%-----59%59%
17--15------15-951-----1515Neither easy nor22%--22%------22%-28%17%17%-----22%22%difficult
4-14------4-121-----44Fairly difficult5%-50%5%------5%-3%6%17%-----5%5%
2--2------2-11------22Very difficult3%--3%------3%-3%3%------3%3%
----------------------No opinion----------------------
----------------------Don't know----------------------
55-148------48-21244-----4848Easy71%-50%70%------71%-67%75%67%-----71%71%
6-15------5-231-----55Difficult8%-50%8%------8%-6%8%17%-----8%8%
49004200000043019213000004343Net63%0%0%62%0%0%0%0%0%0%63%0%61%67%50%0%0%0%0%0%63%63%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 290Q.21 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the post mortem sector?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
9---3-1-1-1-38Very easy12%---38%-6%-11%-11%-30%12%
4611-36654243641Fairly easy59%100%33%-38%78%44%86%44%100%56%75%70%59%
17-2-215-3-21-15Neither easy nor22%-67%-25%11%38%-33%-22%25%-22%difficult
4----111--1--4Fairly difficult5%----11%6%14%--11%--5%
2-----1-1----2Very difficult3%-----6%-11%----3%
--------------No opinion--------------
--------------Don't know--------------
5511-56754253948Easy71%100%33%-75%78%50%86%56%100%67%75%100%71%
6----1211-1--5Difficult8%----11%13%14%11%-11%--8%
4911055544243943Net63%100%33%0%75%67%38%71%44%100%56%75%100%63%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 291Q.21 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the post mortem sector?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
96142-88Very easy12%18%6%14%8%-13%12%
46209181313941Fairly easy59%61%56%69%60%11%65%z59%
17644441115Neither easy nor22%18%28%17%20%56%18%22%cdifficult
41--1134Fairly difficult5%3%--4%11%4%5%
2-2-22-2Very difficult3%-11%-8%22%-3%
--------No opinion--------
--------Don't know--------
552610211514748Easy71%79%61%83%68%11%78%z71%
612-3335Difficult8%3%11%-12%33%4%8%c
492682112-24443Net63%76%50%83%56%-22%74%63%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 292Q.21 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the post mortem sector?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
2--2------2-2-------22A significant positive3%--3%------3%-6%-------3%3%impact
6--5------5-42------55A minor positive impact8%--8%------8%-11%6%------8%8%
39-133------34-19151-----3434No impact either way50%-50%49%------50%-58%47%17%-----50%50%
3--3------3-12------33A minor negative impact4%--4%------4%-3%6%------4%4%
----------------------A significant negative----------------------impact
6--5------5-33------55Don't know8%--8%------8%-8%8%------8%8%
3--3------3--3------33Not applicable4%--4%------4%--8%------4%4%
19-117------17-484-----1717Have not seen the ACPO24%-50%25%------24%-14%25%83%-----24%24%ireport
8--7------7-52------77Positive impact10%--10%------10%-17%6%------10%10%
3--3------3-12------33Negative impact4%--4%------4%-3%6%------4%4%
5004000000404000000044Net6%0%0%6%0%0%0%0%0%0%6%0%14%0%0%0%0%0%0%0%6%6%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 293Q.22 What level of impact, if any, has the Association of Chief Police Officers (ACPO) report on the retention of tissue holdings for the police had on your practice?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
2------1----12A significant positive3%------14%----10%3%impact
6---2--11--2-5A minor positive impact8%---25%--14%11%--50%-8%
39-1-4483317-434No impact either way50%-33%-50%56%56%43%33%50%89%-50%50%
3----1-1----13A minor negative impact4%----11%-14%----10%4%
--------------A significant negative--------------impact
6-1--2--21---5Don't know8%-33%--22%--22%50%---8%
3---1-1---1--3Not applicable4%---13%-6%---11%--4%
1911-11513--2317Have not seen the ACPO24%100%33%-13%11%38%14%33%--50%30%24%report
8---2--21--217Positive impact10%---25%--29%11%--50%10%10%
3----1-1----13Negative impact4%----11%-14%----10%4%
50002-101100204Net6%0%0%0%25%-11%0%14%11%0%0%50%0%6%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 294Q.22 What level of impact, if any, has the Association of Chief Police Officers (ACPO) report on the retention of tissue holdings for the police had on your practice?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
21111-22A significant positive3%3%6%3%4%-3%3%impact
64-31145A minor positive impact8%11%-10%4%11%7%8%
39185111133234No impact either way50%53%33%41%48%33%53%50%
32121-33A minor negative impact4%5%6%7%4%-4%4%
--------A significant negative--------impact
62223235Don't know8%5%11%7%12%22%4%8%c
31212-33Not applicable4%3%11%3%8%-4%4%
19757431417Have not seen the ACPO24%21%33%28%20%33%24%24%report
84142167Positive impact10%13%6%14%8%11%10%10%
32121-33Negative impact4%5%6%7%4%-4%4%
53021144Net6%8%0%7%4%11%6%6%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 295Q.22 What level of impact, if any, has the Association of Chief Police Officers (ACPO) report on the retention of tissue holdings for the police had on your practice?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
2--2------2-2-------22Strongly agree3%--3%------3%-6%-------3%3%
29--26------26-14111-----2626Tend to agree37%--38%------37%-44%33%17%-----37%37%
21-119------19-5112-----1919Neither agree nor27%-50%27%------27%-17%36%33%-----27%27%disagree
14--12------12-841-----1212Tend to disagree18%--18%------18%-25%11%17%-----18%18%
3--3------3-12------33Strongly disagree4%--4%------4%-3%6%------4%4%
9-17------8-242-----88Don't know12%-50%10%------12%-6%14%33%-----12%12%r
31--27------27-16111-----2727Agree40%--40%------40%-50%33%17%-----40%40%
17--15------15-951-----1515Disagree22%--22%------22%-28%17%17%-----22%22%
140012000000120750000001212Net agree18%0%0%18%0%0%0%0%0%0%18%0%22%17%0%0%0%0%0%0%18%18%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 296Q.23 To what extent do you agree or disagree that the HTA takes into account the views of the post mortem sector when making decisions that might affect the sector?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
2------1----12Strongly agree3%------14%----10%3%
29---34732-42326Tend to agree37%---38%44%50%43%22%-44%50%30%37%
21---43222-32319Neither agree nor27%---50%33%13%29%22%-33%50%30%27%disagree
1413---31211-212Tend to disagree18%100%100%---19%14%22%50%11%-20%18%
3-----2-1----3Strongly disagree4%-----13%-11%----4%
9---121-211-18Don't know12%---13%22%6%-22%50%11%-10%12%
31---34742-42427Agree40%---38%44%50%57%22%-44%50%40%40%
1713---41311-215Disagree22%100%100%---31%14%33%50%11%-20%22%
14-1-303433-1-132212Net agree18%-100%-100%0%38%44%19%43%-11%-50%33%50%20%18%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 297Q.23 To what extent do you agree or disagree that the HTA takes into account the views of the post mortem sector when making decisions that might affect the sector?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
22-1--22Strongly agree3%5%-3%--3%3%
29192134-2626Tend to agree37%55%z11%52%20%-43%z37%
21817311819Neither agree nor27%24%6%28%12%11%29%27%disagree
143921011112Tend to disagree18%8%56%7%44%11%19%18%h
3-2-23-3Strongly disagree4%-11%-8%33%-4%
93334448Don't know12%8%17%10%16%44%6%12%c
31202144-2727Agree40%61%z11%55%20%-46%z40%
1731121141115Disagree22%8%67%7%52%44%19%22%h
1418-912-7-41612Net agree18%53%-56%48%-32%-44%26%18%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 298Q.23 To what extent do you agree or disagree that the HTA takes into account the views of the post mortem sector when making decisions that might affect the sector?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
78-277------78-36366-----7878Unweighted total
78*-**2**68*-**-**-**-**-**-**69*-**32*32*5**-**-**-**-**-**69*69*Weighted total
2--2------2-11------22Strongly agree3%--3%------3%-3%3%------3%3%
32--28------28-16112-----2828Tend to agree41%--42%------41%-50%33%33%-----41%41%
22--19------19-712------1919Neither agree nor28%--29%------28%-22%39%------28%28%disagree
8--7------7-52------77Tend to disagree10%--10%------10%-17%6%------10%10%
2--2------2--2------22Strongly disagree3%--3%------3%--6%------3%3%
12-210------11-344-----1111Don't know15%-100%14%------15%-8%14%67%-----15%15%r
34--30------30-17112-----3030Agree44%--44%------44%-53%36%33%-----44%44%
10--9------9-54------99Disagree13%--13%------13%-17%11%------13%13%
2400210000002101182000002121Net agree31%0%0%31%0%0%0%0%0%0%31%0%36%25%33%0%0%0%0%0%31%31%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 299Q.24 To what extent do you agree or disagree that the HTA takes action following feedback from the post mortem sector?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
7813-8916792941078Unweighted total
78*1**3**-**7**8**14**6**8**2**8**4**9**69*Weighted total
2-------1---12Strongly agree3%-------11%---10%3%
32---43541-42528Tend to agree41%---50%33%38%71%11%-56%50%60%41%
22-2-343-3132119Neither agree nor28%-67%-38%44%19%-33%50%33%50%10%28%disagree
8-----412---17Tend to disagree10%-----25%14%22%---10%10%
2-1---1------2Strongly disagree3%-33%---6%------3%
121--1221211-111Don't know15%100%--13%22%13%14%22%50%11%-10%15%
34---43542-42630Agree44%---50%33%38%71%22%-56%50%70%44%
10-1---412---19Disagree13%-33%---31%14%22%---10%13%
240-1043140042521Net agree31%0%-33%0%50%33%6%57%0%0%56%50%60%31%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 300Q.24 To what extent do you agree or disagree that the HTA takes action following feedback from the post mortem sector?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
783818292596878Unweighted total
78*33*16**26**22**8**60*69*Weighted total
22----22Strongly agree3%5%----3%3%
32203156-2828Tend to agree41%61%z17%59%28%-47%z41%
22736431719Neither agree nor28%21%17%24%20%33%28%28%disagree
81515167Tend to disagree10%3%33%3%24%11%10%10%h
2-2-2112Strongly disagree3%-11%-8%11%1%3%
1244444611Don't know15%11%22%14%20%44%10%15%c
34223156-3030Agree44%66%z17%59%28%-50%z44%
101717279Disagree13%3%44%3%32%22%12%13%h
2421-414-1-22321Net agree31%63%-28%55%-4%-22%38%31%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 301Q.24 To what extent do you agree or disagree that the HTA takes action following feedback from the post mortem sector?
Base : All in the post mortem sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-1823-----38--12206----13738Unweighted total
38*-**19**23**-**-**-**-**-**39*-**-**12**21**6**-**-**-**-**2**37*39*Weighted total
6-15-----6--141-----66Very easy16%-5%22%-----16%--8%19%17%-----16%16%
20-1112-----21--1182----21921Fairly easy53%-57%52%-----53%--92%37%33%----100%51%53%
6-42-----6---51-----66Neither easy nor16%-21%9%-----16%---24%17%-----16%16%difficult
4-13-----4---22-----44Fairly difficult11%-5%13%-----10%---10%33%-----11%10%
2-21-----2---2------22Very difficult5%-11%4%-----5%---10%------5%5%
----------------------No opinion----------------------
----------------------Don't know----------------------
26-1217-----27--12123----22527Easy68%-62%74%-----69%--100%56%50%----100%68%69%
6-34-----6---42-----66Difficult16%-16%17%-----16%---19%33%-----16%16%
2009130000021001281000021921Net53%0%46%57%0%0%0%0%0%53%0%0%100%37%17%0%0%0%0%100%51%53%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 302Q.25 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the human application (tissue for treatment) sector?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-536471441-338Unweighted total
38*-**5**3**6**4**8**1**4**4**1**-**3**39*Weighted total
6-1--12-11---6Very easy16%-20%--25%26%-25%25%---16%
20-12422-331-321Fairly easy53%-20%67%67%50%22%-75%75%100%-100%53%
6-1-2-21-----6Neither easy nor16%-20%-33%-26%100%-----16%difficult
4-2--11------4Fairly difficult11%-40%--25%13%------10%
2--1--1------2Very difficult5%--33%--13%------5%
--------------No opinion--------------
--------------Don't know--------------
26-22434-441-327Easy68%-40%67%67%75%48%-100%100%100%-100%69%
6-21-12------6Difficult16%-40%33%-25%26%------16%
2000142204410321Net53%0%0%33%67%50%22%0%100%100%100%0%100%53%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 303Q.25 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the human application (tissue for treatment) sector?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
38236181433438Unweighted total
38*24**6**18**15**3**35*39*Weighted total
65-5--66Very easy16%21%-28%--17%16%
201428911921Fairly easy53%58%33%44%59%33%54%53%
63-32156Neither easy nor16%13%-17%14%33%14%16%difficult
41313134Fairly difficult11%4%50%6%20%33%9%10%
21111-22Very difficult5%4%17%6%7%-6%5%
--------No opinion--------
--------Don't know--------
2619213912527Easy68%79%33%72%59%33%71%69%
62424156Difficult16%8%67%11%27%33%14%16%
2017-211502021Net53%70%-33%61%32%0%57%53%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 304Q.25 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the human application (tissue for treatment) sector?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-1823-----38--12206----13738Unweighted total
38*-**19**23**-**-**-**-**-**39*-**-**12**21**6**-**-**-**-**2**37*39*Weighted total
17-89-----17--5102-----1717A significant positive45%-43%39%-----44%--42%48%33%-----46%44%impact
5-24-----5--32------55A minor positive impact13%-11%17%-----13%--25%10%------14%13%
4-23-----4--22------44No impact either way11%-11%13%-----10%--17%10%------11%10%
3-12-----3---21-----33A minor negative impact8%-5%9%-----8%---10%17%-----8%8%
----------------------A significant negative----------------------impact
5-61-----6---42----246Don't know13%-30%4%-----15%---18%33%----100%11%15%a
4--4-----4--211-----44Not applicable to my11%--17%-----10%--17%5%17%-----11%10%establishment
22-1013-----22--8122-----2222Positive impact58%-54%57%-----57%--67%58%33%-----59%z57%
3-12-----3---21-----33Negative impact8%-5%9%-----8%---10%17%-----8%8%
1909110000019008101000001919Net50%0%48%48%0%0%0%0%0%49%0%0%67%48%17%0%0%0%0%0%51%49%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 305Q.26a Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Themed inspections -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-536471441-338Unweighted total
38*-**5**3**6**4**8**1**4**4**1**-**3**39*Weighted total
17-2-433131---17A significant positive45%-40%-67%75%39%100%75%25%---44%impact
5--11-1-1-1--5A minor positive impact13%--33%17%-13%-25%-100%--13%
4---1----1--24No impact either way11%---17%----25%--67%10%
3-1--11------3A minor negative impact8%-20%--25%13%------8%
--------------A significant negative--------------impact
5-11--3-----16Don't know13%-20%33%--35%-----33%15%
4-11-----2---4Not applicable to my11%-20%33%-----50%---10%establishment
22-215341411--22Positive impact58%-40%33%83%75%52%100%100%25%100%--57%
3-1--11------3Negative impact8%-20%--25%13%------8%
1901152314110019Net50%0%20%33%83%50%39%100%100%25%100%0%0%49%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 306Q.26a Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Themed inspections -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
38236181433438Unweighted total
38*24**6**18**15**3**35*39*Weighted total
1710185-1617A significant positive45%42%17%44%34%-46%44%impact
52223145A minor positive impact13%8%33%11%20%33%12%13%
43-22-44No impact either way11%13%-11%14%-12%10%
32-2-123A minor negative impact8%8%-11%-33%6%8%
--------A significant negative--------impact
55133156Don't know13%20%17%17%18%33%13%15%
42212-44Not applicable to my11%8%33%6%14%-12%10%establishment
2212310812022Positive impact58%51%50%56%55%33%58%57%
32-2-123Negative impact8%8%-11%-33%6%8%
191038801819Net50%42%50%44%55%0%52%49%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 307Q.26a Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Themed inspections -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-1823-----38--12206----13738Unweighted total
38*-**19**23**-**-**-**-**-**39*-**-**12**21**6**-**-**-**-**2**37*39*Weighted total
6-16-----6--321-----66A significant positive16%-5%26%-----16%--25%10%17%-----16%16%impact
5-41-----5--131-----55A minor positive impact13%-21%4%-----13%--8%15%17%-----14%13%
2-12-----2--11------22No impact either way5%-5%9%-----5%--8%5%------5%5%
----------------------A minor negative impact----------------------
4-22-----4--22------44A significant negative11%-11%9%-----10%--17%10%------11%10%impact
9-74-----10---82----2810Don't know24%-36%17%-----25%---37%33%----100%22%25%a
12-48-----12--552-----1212Not applicable to my32%-21%35%-----31%--42%24%33%-----32%31%establishment
11-57-----11--452-----1111Positive impact29%-27%30%-----28%--33%24%33%-----30%28%
4-22-----4--22------44Negative impact11%-11%9%-----10%--17%10%------11%10%
7035000007002320000077Net18%0%16%22%0%0%0%0%0%18%0%0%17%15%33%0%0%0%0%0%19%18%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 308Q.26b Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Joint inspections with Medicines and Healthcare products Regulatory Agency (MHRA) in the regenerative medicine sector -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-536471441-338Unweighted total
38*-**5**3**6**4**8**1**4**4**1**-**3**39*Weighted total
6--1-13---1--6A significant positive16%--33%-25%39%---100%--16%impact
5-1111--1----5A minor positive impact13%-20%33%17%25%--25%----13%
2---1-------12No impact either way5%---17%-------33%5%
--------------A minor negative impact--------------
4-1-1-1--1---4A significant negative11%-20%-17%-13%--25%---10%impact
9-111-3111--110Don't know24%-20%33%17%-35%100%25%25%--33%25%
12-2-221-22--112Not applicable to my32%-40%-33%50%13%-50%50%--33%31%establishment
11-12123-1-1--11Positive impact29%-20%67%17%50%39%-25%-100%--28%
4-1-1-1--1---4Negative impact11%-20%-17%-13%--25%---10%
700202201-11007Net18%0%0%67%0%50%26%0%25%-25%100%0%0%18%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 309Q.26b Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Joint inspections with Medicines and Healthcare products Regulatory Agency (MHRA) in the regenerative medicine sector -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
38236181433438Unweighted total
38*24**6**18**15**3**35*39*Weighted total
64242-66A significant positive16%17%33%22%14%-17%16%impact
53-21-55A minor positive impact13%13%-11%7%-14%13%
21--2-22No impact either way5%4%--14%-6%5%
--------A minor negative impact--------
42121224A significant negative11%8%17%11%7%67%6%10%cimpact
98163-910Don't know24%32%17%33%18%-25%25%
12624611112Not applicable to my32%25%33%22%41%33%32%31%establishment
117263-1111Positive impact29%30%33%33%20%-32%28%
42121224Negative impact11%8%17%11%7%67%6%10%c
75142-297Net18%21%17%22%14%-67%26%18%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 310Q.26b Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Joint inspections with Medicines and Healthcare products Regulatory Agency (MHRA) in the regenerative medicine sector -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-1823-----38--12206----13738Unweighted total
38*-**19**23**-**-**-**-**-**39*-**-**12**21**6**-**-**-**-**2**37*39*Weighted total
11-49-----12--561----21012A significant positive29%-20%39%-----30%--42%27%17%----100%27%30%aimpact
11-74-----11--362-----1111A minor positive impact29%-38%17%-----28%--25%29%33%-----30%28%
3-22-----3--12------33No impact either way8%-11%9%-----8%--8%10%------8%8%
1--1-----1--1-------11A minor negative impact3%--4%-----3%--8%-------3%3%
----------------------A significant negative----------------------impact
8-54-----8---62-----88Don't know21%-27%17%-----21%---29%33%-----22%21%
4-13-----4--211-----44Not applicable to my11%-5%13%-----10%--17%5%17%-----11%10%establishment
22-1113-----23--8123----22123Positive impact58%-57%57%-----59%--67%56%50%----100%57%59%
1--1-----1--1-------11Negative impact3%--4%-----3%--8%-------3%3%
21011120000022007123000022022Net55%0%57%52%0%0%0%0%0%56%0%0%58%56%50%0%0%0%0%100%54%56%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 311Q.26c Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Joint advice and guidance produced with other regulators or agencies -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-536471441-338Unweighted total
38*-**5**3**6**4**8**1**4**4**1**-**3**39*Weighted total
11--1215--11-112A significant positive29%--33%33%25%61%--25%100%-33%30%impact
11-2141111----11A minor positive impact29%-40%33%67%25%13%100%25%----28%
3-----1--1--13No impact either way8%-----13%--25%--33%8%
1-------1----1A minor negative impact3%-------25%----3%
--------------A significant negative--------------impact
8-31-11-11---8Don't know21%-60%33%-25%13%-25%25%---21%
4----1--11--14Not applicable to my11%----25%--25%25%--33%10%establishment
22-226261111-123Positive impact58%-40%67%100%50%74%100%25%25%100%-33%59%
1-------1----1Negative impact3%-------25%----3%
2102262610110122Net55%0%40%67%100%50%74%100%0%25%100%0%33%56%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 312Q.26c Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Joint advice and guidance produced with other regulators or agencies -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
38236181433438Unweighted total
38*24**6**18**15**3**35*39*Weighted total
118256-1212A significant positive29%32%33%28%39%-34%30%impact
117-63-1111A minor positive impact29%30%-33%20%-32%28%
31112123No impact either way8%4%17%6%14%33%6%8%
1---1-11A minor negative impact3%---7%-3%3%
--------A significant negative--------impact
84343168Don't know21%17%50%22%20%33%17%21%
44-2-134Not applicable to my11%17%-11%-33%9%10%establishment
22152119-2323Positive impact58%62%33%61%59%-65%z59%
1---1-11Negative impact3%---7%-3%3%
2115211802222Net55%62%33%61%52%0%62%56%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 313Q.26c Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Joint advice and guidance produced with other regulators or agencies -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
Jointinspections
with Medicinesand Healthcare
Joint adviceproductsand guidanceRegulatoryproduced withAgency (MHRA)
otherin theregulators orregenerativeThemed
agenciesmedicine sectorinspections
383838Unweighted total
393939Weighted total
12617A significant positive30%16%44%impact
1155A minor positive impact28%13%13%
324No impact either way8%5%10%
1-3A minor negative impact3%-8%
-4-A significant negative-10%-impact
8106Don't know21%25%15%
4124Not applicable to my10%31%10%establishment
231122Positive impact59%28%57%
143Negative impact3%10%8%
22719Net56%18%49%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 314Q.26 Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Summary -
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-1823-----38--12206----13738Unweighted total
38*-**19**23**-**-**-**-**-**39*-**-**12**21**6**-**-**-**-**2**37*39*Weighted total
3--3-----3---21-----33Strongly agree8%--13%-----8%---10%17%-----8%8%
19-912-----20--992----21820Tend to agree50%-46%52%-----51%--75%42%33%----100%49%51%a
11-66-----11--362-----1111Neither agree nor29%-32%26%-----28%--25%29%33%-----30%28%disagree
2-11-----2---11-----22Tend to disagree5%-5%4%-----5%---5%17%-----5%5%
2-21-----2---2------22Strongly disagree5%-11%4%-----5%---10%------5%5%
1-1------1---1------11Don't know3%-5%------3%---5%------3%3%
22-915-----23--9113----22123Agree58%-46%65%-----59%--75%52%50%----100%57%59%
4-32-----4---31-----44Disagree11%-16%9%-----10%---15%17%-----11%10%
180613000001900982000021719Net agree47%0%30%57%0%0%0%0%0%48%0%0%75%37%33%0%0%0%0%100%46%48%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 315Q.27 To what extent do you agree or disagree that the HTA takes into account the views of the human application (tissue for treatment) sector when making decisionsthat might affect the sector?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-536471441-338Unweighted total
38*-**5**3**6**4**8**1**4**4**1**-**3**39*Weighted total
3-----1-11---3Strongly agree8%-----13%-25%25%---8%
19-32334-121-120Tend to agree50%-60%67%50%75%48%-25%50%100%-33%51%
11-1-212111--211Neither agree nor29%-20%-33%25%26%100%25%25%--67%28%disagree
2-1-1--------2Tend to disagree5%-20%-17%--------5%
2--1--1------2Strongly disagree5%--33%--13%------5%
1-------1----1Don't know3%-------25%----3%
22-32335-231-123Agree58%-60%67%50%75%61%-50%75%100%-33%59%
4-111-1------4Disagree11%-20%33%17%-13%------10%
1802123402310119Net agree47%0%40%33%33%75%48%0%50%75%100%0%33%48%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 316Q.27 To what extent do you agree or disagree that the HTA takes into account the views of the human application (tissue for treatment) sector when making decisionsthat might affect the sector?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
38236181433438Unweighted total
38*24**6**18**15**3**35*39*Weighted total
33-3--33Strongly agree8%13%-17%--9%8%
19152106-2020Tend to agree50%62%33%56%39%-57%z51%
1142363811Neither agree nor29%17%33%17%41%100%23%28%cdisagree
2-1-2-22Tend to disagree5%-17%-14%-6%5%
21111-22Strongly disagree5%4%17%6%7%-6%5%
11-1---1Don't know3%4%-6%---3%
22182136-2323Agree58%75%33%72%39%-65%z59%
41213-44Disagree11%4%33%6%20%-12%10%
1817012301919Net agree47%70%0%67%18%0%54%48%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 317Q.27 To what extent do you agree or disagree that the HTA takes into account the views of the human application (tissue for treatment) sector when making decisionsthat might affect the sector?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-1823-----38--12206----13738Unweighted total
38*-**19**23**-**-**-**-**-**39*-**-**12**21**6**-**-**-**-**2**37*39*Weighted total
3--3-----3---3------33Strongly agree8%--13%-----8%---15%------8%8%
20-913-----21--6123----21921Tend to agree53%-46%57%-----53%--50%56%50%----100%51%53%
7-62-----7--412-----77Neither agree nor18%-32%9%-----18%--33%5%33%-----19%18%disagree
1--1-----1----1-----11Tend to disagree3%--4%-----3%----17%-----3%3%
2-2------2---2------22Strongly disagree5%-11%------5%---10%------5%5%
5-24-----5--23------55Don't know13%-11%17%-----13%--17%15%------14%13%
23-916-----24--6153----22224Agree61%-46%70%-----61%--50%71%50%----100%59%61%
3-21-----3---21-----33Disagree8%-11%4%-----8%---10%17%-----8%8%
2007150000021006132000021921Net agree53%0%36%65%0%0%0%0%0%53%0%0%50%61%33%0%0%0%0%100%51%53%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 318Q.28 To what extent do you agree or disagree that the HTA takes action following feedback from the human application (tissue for treatment) sector?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-536471441-338Unweighted total
38*-**5**3**6**4**8**1**4**4**1**-**3**39*Weighted total
3----1--11---3Strongly agree8%----25%--25%25%---8%
20-12336112--221Tend to agree53%-20%67%50%75%74%100%25%50%--67%53%
7-2-2---1-1-17Neither agree nor18%-40%-33%---25%-100%-33%18%disagree
1-1----------1Tend to disagree3%-20%----------3%
2---1-1------2Strongly disagree5%---17%-13%------5%
5-11--1-11---5Don't know13%-20%33%--13%-25%25%---13%
23-12346123--224Agree61%-20%67%50%100%74%100%50%75%--67%61%
3-1-1-1------3Disagree8%-20%-17%-13%------8%
2000224512300221Net agree53%0%0%67%33%100%61%100%50%75%0%0%67%53%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 319Q.28 To what extent do you agree or disagree that the HTA takes action following feedback from the human application (tissue for treatment) sector?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
38236181433438Unweighted total
38*24**6**18**15**3**35*39*Weighted total
33-3--33Strongly agree8%13%-17%--9%8%
20152108-2121Tend to agree53%62%33%56%52%-60%z53%
72123257Neither agree nor18%8%17%11%20%67%14%18%disagree
1-1-1-11Tend to disagree3%-17%-7%-3%3%
21-11-22Strongly disagree5%4%-6%7%-6%5%
53222135Don't know13%13%33%11%14%33%9%13%c
23182138-2424Agree61%75%33%72%52%-68%z61%
31112-33Disagree8%4%17%6%14%-9%8%
2017112602121Net agree53%70%17%67%39%0%60%53%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 320Q.28 To what extent do you agree or disagree that the HTA takes action following feedback from the human application (tissue for treatment) sector?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-1823-----38--12206----13738Unweighted total
38*-**19**23**-**-**-**-**-**39*-**-**12**21**6**-**-**-**-**2**37*39*Weighted total
9-55-----9--432-----99Very well24%-27%22%-----23%--33%15%33%-----24%23%
6-15-----6--321-----66Fairly well16%-5%22%-----16%--25%10%17%-----16%16%
7-53-----8--251----268Not very well18%-25%13%-----20%--17%23%17%----100%16%20%a
6-44-----6--231-----66Not at all well16%-21%17%-----16%--17%15%17%-----16%16%
6-33-----6---6------66Don't know16%-16%13%-----16%---29%------16%16%
4-13-----4--121-----44The PPD procedure is not11%-5%13%-----10%--8%10%17%-----11%10%applicable to my role
15-610-----15--753-----1515Well39%-32%43%-----39%--58%24%50%-----41%39%
13-97-----14--482----21214Not well34%-46%30%-----35%--33%37%33%----100%32%35%a
20-33000001003-310000-231Net5%0%-14%13%0%0%0%0%0%3%0%0%25%-13%17%0%0%0%0%-100%8%3%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 321Q.29 How well would you say that you understand the Preparation Process Dossier (PPD) procedure?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
38-536471441-338Unweighted total
38*-**5**3**6**4**8**1**4**4**1**-**3**39*Weighted total
9-112-3--11--9Very well24%-20%33%33%-39%--25%100%--23%
6-1-111-1---16Fairly well16%-20%-17%25%13%-25%---33%16%
7-11112-11---8Not very well18%-20%33%17%25%22%-25%25%---20%
6-2111------16Not at all well16%-40%33%17%25%------33%16%
6---1-212----6Don't know16%---17%-26%100%50%----16%
4----1---2--14The PPD procedure is not11%----25%---50%--33%10%applicable to my role
15-21314-111-115Well39%-40%33%50%25%52%-25%25%100%-33%39%
13-32222-11--114Not well34%-60%67%33%50%22%-25%25%--33%35%
20-1-11-120001001Net5%0%-20%-33%17%-25%31%0%0%0%100%0%0%3%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 322Q.29 How well would you say that you understand the Preparation Process Dossier (PPD) procedure?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
38236181433438Unweighted total
38*24**6**18**15**3**35*39*Weighted total
97172-99Very well24%30%17%39%14%-26%23%
63114-66Fairly well16%13%17%6%27%-17%16%
75124-88Not very well18%20%17%11%25%-22%20%
63132156Not at all well16%13%17%17%14%33%14%16%
64142146Don't know16%17%17%22%14%33%12%16%c
42111134The PPD procedure is not11%8%17%6%7%33%9%10%applicable to my role
1510286-1515Well39%42%33%44%41%-43%39%
13825611314Not well34%32%33%28%39%33%37%35%
2203*-121Net5%10%0%17%2%-33%7%3%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 323Q.29 How well would you say that you understand the Preparation Process Dossier (PPD) procedure?
Base : All in the human application sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
28-1417-----28--11125----12728Unweighted total
28*-**15**17**-**-**-**-**-**29**-**-**11**13**5**-**-**-**-**2**27**29**Weighted total
4-31-----4--22------44Strongly agree14%-20%6%-----14%--18%16%------15%14%
8-36-----8--323-----88Tend to agree29%-20%35%-----28%--27%16%60%-----30%28%
8-54-----9--342----279Neither agree nor29%-32%24%-----30%--27%29%40%----100%26%30%disagree
1--1-----1--1-------11Tend to disagree4%--6%-----3%--9%-------4%3%
1--1-----1---1------11Strongly disagree4%--6%-----3%---8%------4%3%
6-44-----6--24------66Don't know21%-27%24%-----21%--18%32%------22%21%
12-67-----12--543-----1212Agree43%-41%41%-----42%--45%32%60%-----44%42%
2--2-----2--11------22Disagree7%--12%-----7%--9%8%------7%7%
10065000001000433000001010Net agree36%0%41%29%0%0%0%0%0%35%0%0%36%24%60%0%0%0%0%0%37%35%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 324Q.30 To what extent do you agree or disagree that the HTA's approach to implementing the PPD procedure improves the quality and safety of your processes?
Base : All in the human application sector to whose role the PPD procedure is applicable
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
28-53535-221-228Unweighted total
28*-**5**3**5**3**6**-**2**2**1**-**2**29**Weighted total
4--11-1--1---4Strongly agree14%--33%20%-18%--50%---14%
8-31--2--11--8Tend to agree29%-60%33%--35%--50%100%--28%
8---223-2----9Neither agree nor29%---40%67%47%-100%----30%disagree
1---1--------1Tend to disagree4%---20%--------3%
1-----------11Strongly disagree4%-----------50%3%
6-2111------16Don't know21%-40%33%20%33%------50%21%
12-321-3--21--12Agree43%-60%67%20%-53%--100%100%--42%
2---1-------12Disagree7%---20%-------50%7%
1003200300210-110Net agree36%0%60%67%0%0%53%0%0%100%100%0%-50%35%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 325Q.30 To what extent do you agree or disagree that the HTA's approach to implementing the PPD procedure improves the quality and safety of your processes?
Base : All in the human application sector to whose role the PPD procedure is applicable
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
28174131112728Unweighted total
28*18**4**13**12**1**28**29**Weighted total
43-31-44Strongly agree14%17%-23%9%-14%14%
84343-88Tend to agree29%23%75%31%26%-29%28%
87-25-99Neither agree nor29%38%-15%40%-31%30%disagree
11-1--11Tend to disagree4%6%-8%--4%3%
11-1--11Strongly disagree4%6%-8%--4%3%
62123156Don't know21%11%25%15%26%100%18%21%
127374-1212Agree43%40%75%54%34%-43%42%
22-2--22Disagree7%11%-15%--7%7%
10535401010Net agree36%28%75%38%34%0%36%35%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 326Q.30 To what extent do you agree or disagree that the HTA's approach to implementing the PPD procedure improves the quality and safety of your processes?
Base : All in the human application sector to whose role the PPD procedure is applicable
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
18-117--18-----972-----1818Unweighted total
18*-**1**12**-**-**12**-**-**-**-**-**6**5**1**-**-**-**-**-**12**12**Weighted total
6--3--4-----121-----44Very easy33%--29%--33%-----22%43%50%-----33%33%
9--6--6-----321-----66Fairly easy50%--53%--50%-----56%43%50%-----50%50%
3-12--2-----11------22Neither easy nor17%-100%18%--17%-----22%14%------17%17%difficult
----------------------Fairly difficult----------------------
----------------------Very difficult----------------------
----------------------No opinion----------------------
----------------------Don't know----------------------
15--10--10-----541-----1010Easy83%--82%--83%-----78%86%100%-----83%83%
----------------------Difficult----------------------
150010001000000541000001010Net83%0%0%82%0%0%83%0%0%0%0%0%78%86%100%0%0%0%0%0%83%83%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 327Q.31 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the anatomy sector?
Base : All in the anatomy sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
1812-1232-122218Unweighted total
18*1**1**-**1**1**2**1**-**1**1**1**1**12**Weighted total
611---1---1114Very easy33%100%50%---33%---50%50%50%33%
9-1-1111---116Fairly easy50%-50%-100%100%67%50%---50%50%50%
3------1-11--2Neither easy nor17%------50%-100%50%--17%difficult
--------------Fairly difficult--------------
--------------Very difficult--------------
--------------No opinion--------------
--------------Don't know--------------
1511-1121--11110Easy83%100%100%-100%100%100%50%--50%100%100%83%
--------------Difficult--------------
1511011210011110Net83%100%100%0%100%100%100%50%0%0%50%100%100%83%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 328Q.31 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the anatomy sector?
Base : All in the anatomy sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
1815111431518Unweighted total
18*10**1**8**3**2**10**12**Weighted total
63112224Very easy33%27%100%18%75%100%20%33%
96-61-66Fairly easy50%60%-73%25%-60%50%
31-1--22Neither easy nor17%13%-9%--20%17%difficult
--------Fairly difficult--------
--------Very difficult--------
--------No opinion--------
--------Don't know--------
1591732810Easy83%87%100%91%100%100%80%83%
--------Difficult--------
1591732810Net83%87%100%91%100%100%80%83%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 329Q.31 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the anatomy sector?
Base : All in the anatomy sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
18-117--18-----972-----1818Unweighted total
18*-**1**12**-**-**12**-**-**-**-**-**6**5**1**-**-**-**-**-**12**12**Weighted total
2--1--1-----1-1-----11Strongly agree11%--12%--11%-----11%-50%-----11%11%
9--6--6-----321-----66Tend to agree50%--47%--50%-----56%43%50%-----50%50%
4-13--3-----21------33Neither agree nor22%-100%24%--22%-----33%14%------22%22%disagree
1--1--1------1------11Tend to disagree6%--6%--6%------14%------6%6%
----------------------Strongly disagree----------------------
2--1--1------1------11Don't know11%--12%--11%------29%------11%11%
11--7--8-----421-----88Agree61%--59%--61%-----67%43%100%-----61%61%
1--1--1------1------11Disagree6%--6%--6%------14%------6%6%
10006007000004110000077Net agree56%0%0%53%0%0%56%0%0%0%0%0%67%29%100%0%0%0%0%0%56%56%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 330Q.32 To what extent do you agree or disagree that the HTA takes into account the views of the anatomy sector when making decisions that might affect the sector?
Base : All in the anatomy sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
1812-1232-122218Unweighted total
18*1**1**-**1**1**2**1**-**1**1**1**1**12**Weighted total
2---1--1-----1Strongly agree11%---100%--50%-----11%
9-1--121---116Tend to agree50%-50%--100%100%50%---50%50%50%
4-1-------11-3Neither agree nor22%-50%-------100%50%-22%disagree
11-----------1Tend to disagree6%100%-----------6%
--------------Strongly disagree--------------
2--------1--11Don't know11%--------100%--50%11%
11-1-1121---118Agree61%-50%-100%100%100%100%---50%50%61%
11-----------1Disagree6%100%-----------6%
10-1101121000117Net agree56%-100%50%0%100%100%100%100%0%0%0%50%50%56%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 331Q.32 To what extent do you agree or disagree that the HTA takes into account the views of the anatomy sector when making decisions that might affect the sector?
Base : All in the anatomy sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
1815111431518Unweighted total
18*10**1**8**3**2**10**12**Weighted total
21-1--11Strongly agree11%7%-9%--13%11%
96151156Tend to agree50%53%100%64%50%67%47%50%
42-11-33Neither agree nor22%20%-9%25%-27%22%disagree
11-1--11Tend to disagree6%7%-9%--7%6%
--------Strongly disagree--------
21-11111Don't know11%13%-9%25%33%7%11%
116161168Agree61%60%100%73%50%67%60%61%
11-1--11Disagree6%7%-9%--7%6%
106151167Net agree56%53%100%64%50%67%53%56%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 332Q.32 To what extent do you agree or disagree that the HTA takes into account the views of the anatomy sector when making decisions that might affect the sector?
Base : All in the anatomy sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
18-117--18-----972-----1818Unweighted total
18*-**1**12**-**-**12**-**-**-**-**-**6**5**1**-**-**-**-**-**12**12**Weighted total
2--1--1-----1-1-----11Strongly agree11%--12%--11%-----11%-50%-----11%11%
11-17--8-----431-----88Tend to agree61%-100%59%--61%-----67%57%50%-----61%61%
1--1--1-----1-------11Neither agree nor6%--6%--6%-----11%-------6%6%disagree
----------------------Tend to disagree----------------------
----------------------Strongly disagree----------------------
4--3--3-----12------33Don't know22%--24%--22%-----11%43%------22%22%
13-18--9-----531-----99Agree72%-100%71%--72%-----78%57%100%-----72%72%
----------------------Disagree----------------------
13018009000005310000099Net agree72%0%100%71%0%0%72%0%0%0%0%0%78%57%100%0%0%0%0%0%72%72%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 333Q.33 To what extent do you agree or disagree that the HTA takes action following feedback from the anatomy sector?
Base : All in the anatomy sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
1812-1232-122218Unweighted total
18*1**1**-**1**1**2**1**-**1**1**1**1**12**Weighted total
2---1--1-----1Strongly agree11%---100%--50%-----11%
11-1--111--1118Tend to agree61%-100%--100%67%50%--100%50%50%61%
1-----1------1Neither agree nor6%-----33%------6%disagree
--------------Tend to disagree--------------
--------------Strongly disagree--------------
41-------1-113Don't know22%100%-------100%-50%50%22%
13-1-1111--1119Agree72%-100%-100%100%67%100%--100%50%50%72%
--------------Disagree--------------
130101111001119Net agree72%0%100%0%100%100%67%100%0%0%100%50%50%72%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 334Q.33 To what extent do you agree or disagree that the HTA takes action following feedback from the anatomy sector?
Base : All in the anatomy sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
1815111431518Unweighted total
18*10**1**8**3**2**10**12**Weighted total
21-1--11Strongly agree11%7%-9%--13%11%
117152168Tend to agree61%67%100%64%75%67%60%61%
11-1--11Neither agree nor6%7%-9%--7%6%disagree
--------Tend to disagree--------
--------Strongly disagree--------
42-11123Don't know22%20%-18%25%33%20%22%
138162189Agree72%73%100%73%75%67%73%72%
--------Disagree--------
138162189Net agree72%73%100%73%75%67%73%72%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 335Q.33 To what extent do you agree or disagree that the HTA takes action following feedback from the anatomy sector?
Base : All in the anatomy sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3--3---3-----21-----33Unweighted total
3*-**-**3**-**-**-**3**-**-**-**-**-**2**1**-**-**-**-**-**3**3**Weighted total
----------------------Very easy----------------------
2--2---2-----11-----22Fairly easy67%--67%---67%-----50%100%-----67%67%
1--1---1-----1------11Neither easy nor33%--33%---33%-----50%------33%33%difficult
----------------------Fairly difficult----------------------
----------------------Very difficult----------------------
----------------------No opinion----------------------
----------------------Don't know----------------------
2--2---2-----11-----22Easy67%--67%---67%-----50%100%-----67%67%
----------------------Difficult----------------------
2002000200000110000022Net67%0%0%67%0%0%0%67%0%0%0%0%0%50%100%0%0%0%0%0%67%67%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 336Q.34 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the public display sector?
Base : All in the public display sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3---1-1-1----3Unweighted total
3*-**-**-**1**-**1**-**1**-**-**-**-**3**Weighted total
--------------Very easy--------------
2-----1-1----2Fairly easy67%-----100%-100%----67%
1---1--------1Neither easy nor33%---100%--------33%difficult
--------------Fairly difficult--------------
--------------Very difficult--------------
--------------No opinion--------------
--------------Don't know--------------
2-----1-1----2Easy67%-----100%-100%----67%
--------------Difficult--------------
20000010100002Net67%0%0%0%0%0%100%0%100%0%0%0%0%67%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 337Q.34 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the public display sector?
Base : All in the public display sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
32-2--33Unweighted total
3*2**-**2**-**-**3**3**Weighted total
--------Very easy--------
21-1--22Fairly easy67%50%-50%--67%67%
11-1--11Neither easy nor33%50%-50%--33%33%difficult
--------Fairly difficult--------
--------Very difficult--------
--------No opinion--------
--------Don't know--------
21-1--22Easy67%50%-50%--67%67%
--------Difficult--------
21010022Net67%50%0%50%0%0%67%67%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 338Q.34 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the public display sector?
Base : All in the public display sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3--3---3-----21-----33Unweighted total
3*-**-**3**-**-**-**3**-**-**-**-**-**2**1**-**-**-**-**-**3**3**Weighted total
----------------------Strongly agree----------------------
1--1---1------1-----11Tend to agree33%--33%---33%------100%-----33%33%
----------------------Neither agree nor----------------------disagree
1--1---1-----1------11Tend to disagree33%--33%---33%-----50%------33%33%
----------------------Strongly disagree----------------------
1--1---1-----1------11Don't know33%--33%---33%-----50%------33%33%
1--1---1------1-----11Agree33%--33%---33%------100%-----33%33%
1--1---1-----1------11Disagree33%--33%---33%-----50%------33%33%
0000000000000-110000000Net agree0%0%0%0%0%0%0%0%0%0%0%0%0%-50%100%0%0%0%0%0%0%0%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 339Q.35 To what extent do you agree or disagree that the HTA takes into account the views of the public display sector when making decisions that might affect the sector?
Base : All in the public display sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3---1-1-1----3Unweighted total
3*-**-**-**1**-**1**-**1**-**-**-**-**3**Weighted total
--------------Strongly agree--------------
1-------1----1Tend to agree33%-------100%----33%
--------------Neither agree nor--------------disagree
1-----1------1Tend to disagree33%-----100%------33%
--------------Strongly disagree--------------
1---1--------1Don't know33%---100%--------33%
1-------1----1Agree33%-------100%----33%
1-----1------1Disagree33%-----100%------33%
000000-10100000Net agree0%0%0%0%0%0%-100%0%100%0%0%0%0%0%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 340Q.35 To what extent do you agree or disagree that the HTA takes into account the views of the public display sector when making decisions that might affect the sector?
Base : All in the public display sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
32-2--33Unweighted total
3*2**-**2**-**-**3**3**Weighted total
--------Strongly agree--------
1-----11Tend to agree33%-----33%33%
--------Neither agree nor--------disagree
11-1--11Tend to disagree33%50%-50%--33%33%
--------Strongly disagree--------
11-1--11Don't know33%50%-50%--33%33%
1-----11Agree33%-----33%33%
11-1--11Disagree33%50%-50%--33%33%
0-10-10000Net agree0%-50%0%-50%0%0%0%0%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 341Q.35 To what extent do you agree or disagree that the HTA takes into account the views of the public display sector when making decisions that might affect the sector?
Base : All in the public display sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3--3---3-----21-----33Unweighted total
3*-**-**3**-**-**-**3**-**-**-**-**-**2**1**-**-**-**-**-**3**3**Weighted total
----------------------Strongly agree----------------------
----------------------Tend to agree----------------------
1--1---1-----1------11Neither agree nor33%--33%---33%-----50%------33%33%disagree
----------------------Tend to disagree----------------------
----------------------Strongly disagree----------------------
2--2---2-----11-----22Don't know67%--67%---67%-----50%100%-----67%67%
----------------------Agree----------------------
----------------------Disagree----------------------
0000000000000000000000Net agree0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 342Q.36 To what extent do you agree or disagree that the HTA takes action following feedback from the public display sector?
Base : All in the public display sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3---1-1-1----3Unweighted total
3*-**-**-**1**-**1**-**1**-**-**-**-**3**Weighted total
--------------Strongly agree--------------
--------------Tend to agree--------------
1-----1------1Neither agree nor33%-----100%------33%disagree
--------------Tend to disagree--------------
--------------Strongly disagree--------------
2---1---1----2Don't know67%---100%---100%----67%
--------------Agree--------------
--------------Disagree--------------
00000000000000Net agree0%0%0%0%0%0%0%0%0%0%0%0%0%0%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 343Q.36 To what extent do you agree or disagree that the HTA takes action following feedback from the public display sector?
Base : All in the public display sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
32-2--33Unweighted total
3*2**-**2**-**-**3**3**Weighted total
--------Strongly agree--------
--------Tend to agree--------
11-1--11Neither agree nor33%50%-50%--33%33%disagree
--------Tend to disagree--------
--------Strongly disagree--------
21-1--22Don't know67%50%-50%--67%67%
--------Agree--------
--------Disagree--------
00000000Net agree0%0%0%0%0%0%0%0%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 344Q.36 To what extent do you agree or disagree that the HTA takes action following feedback from the public display sector?
Base : All in the public display sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
59-1544----59---21335--1--5859Unweighted total
59*-**12**35*-**-**-**-**47*-**-**-**17**26*4**-**-**1**-**-**46*47*Weighted total
10-35----8---35------88Very easy17%-27%14%----17%---19%18%------17%17%
35-820----28---10172--1--2728Fairly easy59%-67%57%----60%---58%64%40%--100%--59%60%
10--8----8---332-----88Neither easy nor17%--23%----17%---19%12%40%-----17%17%difficult
4-12----3---121-----33Fairly difficult7%-7%7%----7%---5%6%20%-----7%7%
----------------------Very difficult----------------------
----------------------No opinion----------------------
----------------------Don't know----------------------
45-1125----36---13222--1--3536Easy76%-93%71%----76%---77%82%40%--100%--76%76%
4-12----3---121-----33Difficult7%-7%7%----7%---5%6%20%-----7%7%
410102300003300012201001003233Net69%0%87%64%0%0%0%0%70%0%0%0%72%76%20%0%0%100%0%0%69%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 345Q.37 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the research sector?
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
5922-10512523521159Unweighted total
59*2**2**-**8**4**10**4**2**2**4**2**9**47*Weighted total
10-1-1111-1--38Very easy17%-50%-10%20%8%20%-33%--36%17%
3521-62631131428Fairly easy59%100%50%-70%60%58%80%50%33%63%50%45%60%
10---212-1-1128Neither easy nor17%---20%20%17%-50%-18%50%18%17%difficult
4-----2--11--3Fairly difficult7%-----17%--33%18%--7%
--------------Very difficult--------------
--------------No opinion--------------
--------------Don't know--------------
4522-63641231736Easy76%100%100%-80%80%67%100%50%67%63%50%82%76%
4-----2--11--3Difficult7%-----17%--33%18%--7%
4122063541121733Net69%100%100%0%80%80%50%100%50%33%45%50%82%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 346Q.37 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the research sector?
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
59358262074959Unweighted total
59*28*6**21**16**6**39*47*Weighted total
108-61-88Very easy17%29%z-27%5%-20%17%
35173141032528Fairly easy59%60%50%65%60%57%64%60%
102223158Neither easy nor17%9%37%8%20%14%12%17%chdifficult
411-2223Fairly difficult7%3%13%-15%29%4%7%
--------Very difficult--------
--------No opinion--------
--------Don't know--------
45253191033336Easy76%89%z50%92%65%57%84%z76%
411-2223Difficult7%3%13%-15%29%4%7%
4124219823133Net69%86%37%92%50%29%80%70%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 347Q.37 How easy, if at all, is it to know what you have to do to comply with the HTA's standards in the research sector?
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
59-1544----59---21335--1--5859Unweighted total
59*-**12**35*-**-**-**-**47*-**-**-**17**26*4**-**-**1**-**-**46*47*Weighted total
9-26----7---331-----77A significant positive15%-13%16%----15%---19%12%20%-----16%15%impact
25-515----20---5142-----2020A minor positive impact42%-40%43%----42%---28%52%40%-----43%42%
10-26----8---26------88No impact either way17%-20%16%----17%---14%21%------17%17%
3-21----2---12------22A minor negative impact5%-13%2%----5%---5%6%------5%5%
1--1----1----1------11A significant negative2%--2%----2%----3%------2%2%impact
10-27----8---522--1--78Don't know17%-13%19%----18%---30%6%40%--100%--16%18%ah
1--1----1---1-------11Not applicable to my2%--2%----2%---5%-------2%2%establishment
34-621----27---8172-----2727Positive impact58%-53%59%----57%---47%64%60%-----59%57%
4-22----3---12------33Negative impact7%-13%5%----7%---5%9%------7%7%
3005190000240007142000002424Net51%0%40%54%0%0%0%0%50%0%0%0%42%55%60%0%0%0%0%0%52%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 348Q.38a Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Collaborative work with other regulators or agencies (e.g. consolidated guidance and/or information sharing) -
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
5922-10512523521159Unweighted total
59*2**2**-**8**4**10**4**2**2**4**2**9**47*Weighted total
9---2--1--1127A significant positive15%---30%--20%--18%50%27%15%impact
2522-3172--21220A minor positive impact42%100%100%-40%20%75%40%--37%50%18%42%
10---1-21-2--38No impact either way17%---10%-17%20%-67%--36%17%
3---1--11----2A minor negative impact5%---10%--20%50%----5%
1----1-------1A significant negative2%----20%-------2%impact
10---12--112-28Don't know17%---10%60%--50%33%45%-18%18%
1-----1------1Not applicable to my2%-----8%------2%establishment
3422-6172--22427Positive impact58%100%100%-70%20%75%60%--55%100%45%57%
4---11-11----3Negative impact7%---10%20%-20%50%----7%
302205072-1022424Net51%100%100%0%60%0%75%40%-50%0%55%100%45%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 349Q.38a Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Collaborative work with other regulators or agencies (e.g. consolidated guidance and/or information sharing) -
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
59358262074959Unweighted total
59*28*6**21**16**6**39*47*Weighted total
95123-77A significant positive15%17%13%12%20%-18%15%impact
2511410931620A minor positive impact42%40%63%46%55%57%40%42%
105132268No impact either way17%17%13%15%15%43%14%17%
32-11-22A minor negative impact5%6%-4%5%-6%5%
11-1--11A significant negative2%3%-4%--2%2%impact
104131-78Don't know17%14%13%15%5%-17%18%
11-1--11Not applicable to my2%3%-4%--2%2%establishment
34165121232327Positive impact58%57%75%58%75%57%59%57%
42-21-33Negative impact7%9%-8%5%-8%7%
30145101132024Net51%49%75%50%70%57%51%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 350Q.38a Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Collaborative work with other regulators or agencies (e.g. consolidated guidance and/or information sharing) -
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
59-1544----59---21335--1--5859Unweighted total
59*-**12**35*-**-**-**-**47*-**-**-**17**26*4**-**-**1**-**-**46*47*Weighted total
4-12----3---12------33A significant positive7%-7%7%----7%---5%9%------7%7%impact
13-29----10---271-----1010A minor positive impact22%-13%25%----22%---14%27%20%-----22%22%
17-410----14---581-----1414No impact either way29%-33%27%----29%---28%30%20%-----29%29%
----------------------A minor negative impact----------------------
----------------------A significant negative----------------------impact
12-19----10---532--1--910Don't know20%-7%26%----21%---30%12%40%--100%--19%21%a
13-56----10---461-----1010Not applicable to my22%-40%16%----22%---23%21%20%-----22%22%restablishment
17-211----14---3101-----1414Positive impact29%-20%32%----29%---19%36%20%-----29%29%
----------------------Negative impact----------------------
1702110000140003101000001414Net29%0%20%32%0%0%0%0%29%0%0%0%19%36%20%0%0%0%0%0%29%29%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 351Q.38b Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Increased licensing options for the removal of tissue from deceased donors, introduced from May 2012 -
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
5922-10512523521159Unweighted total
59*2**2**-**8**4**10**4**2**2**4**2**9**47*Weighted total
41---1-1--1--3A significant positive7%50%---20%-20%--18%--7%impact
13-1-2141---1210A minor positive impact22%-50%-20%20%42%20%---50%18%22%
17-1-2142-21-214No impact either way29%-50%-20%20%42%40%-67%18%-27%29%
--------------A minor negative impact--------------
--------------A significant negative--------------impact
12---211-1-31210Don't know20%---30%20%8%-50%-63%50%18%21%
131--211111--310Not applicable to my22%50%--30%20%8%20%50%33%--36%22%establishment
1711-2242--11214Positive impact29%50%50%-20%40%42%40%--18%50%18%29%
--------------Negative impact--------------
1711022420011214Net29%50%50%0%20%40%42%40%0%0%18%50%18%29%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 352Q.38b Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Increased licensing options for the removal of tissue from deceased donors, introduced from May 2012 -
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
59358262074959Unweighted total
59*28*6**21**16**6**39*47*Weighted total
42222-23A significant positive7%6%25%8%10%-6%7%impact
1361362810A minor positive impact22%20%13%15%35%29%20%22%
17726531014No impact either way29%26%37%27%30%57%26%29%
--------A minor negative impact--------
--------A significant negative--------impact
1242321810Don't know20%14%25%15%15%14%21%21%
1310-72-1010Not applicable to my22%34%z-35%10%-26%22%establishment
17725721014Positive impact29%26%37%23%45%29%26%29%
--------Negative impact--------
17725721014Net29%26%37%23%45%29%26%29%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 353Q.38b Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Increased licensing options for the removal of tissue from deceased donors, introduced from May 2012 -
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
IncreasedlicensingCollaborative
options for thework with otherremoval ofregulators ortissue fromagencies (e.g.deceasedconsolidateddonors,guidance and/or
introduced frominformationMay 2012sharing)
5959Unweighted total
4747Weighted total
37A significant positive7%15%impact
1020A minor positive impact22%42%
148No impact either way29%17%
-2A minor negative impact-5%
-1A significant negative-2%impact
108Don't know21%18%
101Not applicable to my22%2%establishment
1427Positive impact29%57%
-3Negative impact-7%
1424Net29%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 354Q.38 Thinking about the following changes implemented by the HTA, what level of impact, if any, do you think they will have on your establishment?
- Summary -
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
59-1544----59---21335--1--5859Unweighted total
59*-**12**35*-**-**-**-**47*-**-**-**17**26*4**-**-**1**-**-**46*47*Weighted total
4-22----3---121-----33Strongly agree7%-13%5%----7%---5%6%20%-----7%7%
29-419----23---9141-----2323Tend to agree49%-33%54%----49%---51%52%20%-----50%49%
11-45----9---46---1--89Neither agree nor19%-33%14%----19%---21%21%---100%--17%19%adisagree
7-24----6---231-----66Tend to disagree12%-13%11%----12%---9%12%20%-----12%12%
----------------------Strongly disagree----------------------
8-16----6---222-----66Don't know14%-7%16%----13%---14%9%40%-----14%13%
33-621----26---10152-----2626Agree56%-47%59%----56%---56%58%40%-----57%56%
7-24----6---231-----66Disagree12%-13%11%----12%---9%12%20%-----12%12%
2604170000210008121000002121Net agree44%0%33%47%0%0%0%0%44%0%0%0%47%45%20%0%0%0%0%0%45%44%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 355Q.39 To what extent do you agree or disagree that the HTA takes takes into account the views of the research sector when making decisions that might affect the sector?
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
5922-10512523521159Unweighted total
59*2**2**-**8**4**10**4**2**2**4**2**9**47*Weighted total
4---1-11----13Strongly agree7%---10%-8%20%----9%7%
2912-62411112423Tend to agree49%50%100%-70%60%42%20%50%33%18%100%45%49%
11---2-22--2-29Neither agree nor19%---20%-25%40%--45%-18%19%disagree
7-----21-11-16Tend to disagree12%-----25%20%-33%18%-9%12%
--------------Strongly disagree--------------
81---2--111-26Don't know14%50%---40%--50%33%18%-18%13%
3312-62521112526Agree56%50%100%-80%60%50%40%50%33%18%100%55%56%
7-----21-11-16Disagree12%-----25%20%-33%18%-9%12%
2612062211002421Net agree44%50%100%0%80%60%25%20%50%0%0%100%45%44%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 356Q.39 To what extent do you agree or disagree that the HTA takes takes into account the views of the research sector when making decisions that might affect the sector?
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
59358262074959Unweighted total
59*28*6**21**16**6**39*47*Weighted total
42-2--33Strongly agree7%9%-8%--8%7%
2915211832023Tend to agree49%54%25%54%50%57%51%49%
117162189Neither agree nor19%26%13%31%10%14%21%19%disagree
7-3-4236Tend to disagree12%-50%-25%29%8%12%ch
--------Strongly disagree--------
83122-56Don't know14%11%13%8%15%-12%13%
3318213832326Agree56%63%25%62%50%57%59%56%
7-3-4236Disagree12%-50%-25%29%8%12%ch
2618-213422021Net agree44%63%-25%62%25%29%51%44%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 357Q.39 To what extent do you agree or disagree that the HTA takes takes into account the views of the research sector when making decisions that might affect the sector?
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
59-1544----59---21335--1--5859Unweighted total
59*-**12**35*-**-**-**-**47*-**-**-**17**26*4**-**-**1**-**-**46*47*Weighted total
3-12----2---12------22Strongly agree5%-7%5%----5%---5%6%------5%5%
25-416----20---7112-----2020Tend to agree42%-33%45%----42%---42%42%40%-----43%42%
15-48----12---561--1--1112Neither agree nor25%-33%23%----26%---30%24%20%--100%--24%26%adisagree
3-12----2---12------22Tend to disagree5%-7%5%----5%---5%6%------5%5%
----------------------Strongly disagree----------------------
13-28----10---362-----1010Don't know22%-20%23%----22%---19%21%40%-----22%22%
28-518----22---8132-----2222Agree47%-40%50%----47%---47%48%40%-----48%47%
3-12----2---12------22Disagree5%-7%5%----5%---5%6%------5%5%
2504160000200007112000002020Net agree42%0%33%45%0%0%0%0%42%0%0%0%42%42%40%0%0%0%0%0%43%42%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 358Q.40 To what extent do you agree or disagree that the HTA takes action following feedback from the research sector?
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
5922-10512523521159Unweighted total
59*2**2**-**8**4**10**4**2**2**4**2**9**47*Weighted total
3-----11----12Strongly agree5%-----8%20%----9%5%
2511-6241-1-2320Tend to agree42%50%50%-80%40%42%20%-33%-100%36%42%
15-1-2-31--4-212Neither agree nor25%-50%-20%-33%20%--82%-27%26%disagree
3-----1--1--12Tend to disagree5%-----8%--33%--9%5%
--------------Strongly disagree--------------
131---212211-210Don't know22%50%---60%8%40%100%33%18%-18%22%
2811-6252-1-2422Agree47%50%50%-80%40%50%40%-33%-100%45%47%
3-----1--1--12Disagree5%-----8%--33%--9%5%
2511062420002320Net agree42%50%50%0%80%40%42%40%0%0%0%100%36%42%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 359Q.40 To what extent do you agree or disagree that the HTA takes action following feedback from the research sector?
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
59358262074959Unweighted total
59*28*6**21**16**6**39*47*Weighted total
32-2--22Strongly agree5%9%-8%--6%5%
2514-10521820Tend to agree42%49%-50%30%29%47%42%
15736521012Neither agree nor25%26%50%31%30%29%25%26%disagree
3-1-1212Tend to disagree5%-13%-5%29%2%5%c
--------Strongly disagree--------
1352261810Don't know22%17%37%12%35%14%20%22%
2816-12522122Agree47%57%-58%30%29%53%47%
3-1-1212Disagree5%-13%-5%29%2%5%c
2516-112402020Net agree42%57%-13%58%25%0%51%42%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 360Q.40 To what extent do you agree or disagree that the HTA takes action following feedback from the research sector?
Base : All in the research sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-129-30------91011----30-30Unweighted total
30*-**2**48**-**50**-**-**-**-**-**-**15**16**18**-**-**-**-**50**-**50**Weighted total
7--12-12------255----12-12Very easy23%--24%-24%------11%31%27%----24%-24%
12--20-20------8102----20-20Fairly easy40%--41%-40%------56%59%9%----40%-40%
5--8-8------2-7----8-8Neither easy nor17%--17%-17%------11%-36%----17%-17%difficult
5--8-8------323----8-8Fairly difficult17%--17%-17%------22%10%18%----17%-17%
----------------------Very difficult----------------------
----------------------No opinion----------------------
1-2--2--------2----2-2Don't know3%-100%--3%--------9%----3%-3%
19--31-31------10157----31-31Easy63%--65%-63%------67%90%36%----63%-63%
5--8-8------323----8-8Difficult17%--17%-17%------22%10%18%----17%-17%
1400230230000007133000023023Net47%0%0%48%0%46%0%0%0%0%0%0%44%80%18%0%0%0%0%46%0%46%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 361Q.41 How easy, if at all, is it to know what you have to do to comply with the HTA's standards for ODT named contacts and corporate licence holder contacts in the solidorgan donor sector?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-331391322-330Unweighted total
30*-**5**5**2**5**15**2**5**3**3**-**5**50**Weighted total
7--222--222-212Very easy23%--33%100%33%--33%50%50%-33%24%
12-52-252-22-220Fairly easy40%-100%33%-33%32%100%-50%50%-33%40%
5----23-3----8Neither easy nor17%----33%23%-67%----17%difficult
5--2--5-----28Fairly difficult17%--33%--34%-----33%17%
--------------Very difficult--------------
--------------No opinion--------------
1-----2------2Don't know3%-----11%------3%
19-532352233-331Easy63%-100%67%100%67%32%100%33%100%100%-67%63%
5--2--5-----28Difficult17%--33%--34%-----33%17%
1405223*22330223Net47%0%100%33%100%67%-3%100%33%100%100%0%33%46%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 362Q.41 How easy, if at all, is it to know what you have to do to comply with the HTA's standards for ODT named contacts and corporate licence holder contacts in the solidorgan donor sector?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
30167121342530Unweighted total
30*26**12**20**22**7**41**50**Weighted total
78383-1212Very easy23%32%29%43%15%-28%24%
121328821820Fairly easy40%49%14%40%38%25%43%40%
5-335338Neither easy nor17%-29%17%23%50%8%17%difficult
553-5278Fairly difficult17%19%29%-23%25%16%17%
--------Very difficult--------
--------No opinion--------
1-----22Don't know3%-----4%3%
19215161223031Easy63%81%43%83%54%25%72%63%
553-5278Difficult17%19%29%-23%25%16%17%
1416216702323Net47%62%14%83%31%0%56%46%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 363Q.41 How easy, if at all, is it to know what you have to do to comply with the HTA's standards for ODT named contacts and corporate licence holder contacts in the solidorgan donor sector?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-129-30------91011----30-30Unweighted total
30*-**2**48**-**50**-**-**-**-**-**-**15**16**18**-**-**-**-**50**-**50**Weighted total
7--12-12------552----12-12A significant positive23%--24%-24%------33%31%9%----24%-24%impact
14--23-23------31010----23-23A minor positive impact47%--48%-46%------22%59%55%----46%-46%
4--7-7------3-3----7-7No impact either way13%--14%-13%------22%-18%----13%-13%
2--3-3------3------3-3A minor negative impact7%--7%-7%------22%------7%-7%
1--2-2-------2-----2-2A significant negative3%--3%-3%-------10%-----3%-3%impact
2-22-3--------3----3-3Don't know7%-100%3%-7%--------18%----7%-7%
----------------------Not applicable----------------------
21--35-35------81512----35-35Positive impact70%--72%-70%------56%90%64%----70%-70%
3--5-5------32-----5-5Negative impact10%--10%-10%------22%10%-----10%-10%
18003003000000051312000030030Net60%0%0%62%0%60%0%0%0%0%0%0%33%80%64%0%0%0%0%60%0%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 364Q.42 Thinking about the new documentary framework for the quality and safety of organs intended for transplantation, what level of impact, if any, do you think it willhave on your working practices?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-331391322-330Unweighted total
30*-**5**5**2**5**15**2**5**3**3**-**5**50**Weighted total
7--322----2-312A significant positive23%--67%100%33%----50%-67%24%impact
14-52--10-232--23A minor positive impact47%-100%33%--66%-33%100%50%--46%
4----32-2----7No impact either way13%----67%11%-33%----13%
2-----22-----3A minor negative impact7%-----11%100%-----7%
1-------2----2A significant negative3%-------33%----3%impact
2-----2-----23Don't know7%-----11%-----33%7%
--------------Not applicable--------------
21-552210-233-335Positive impact70%-100%100%100%33%66%-33%100%100%-67%70%
3-----222----5Negative impact10%-----11%100%33%----10%
18055228-20330330Net60%0%100%100%100%33%54%-100%0%100%100%0%67%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 365Q.42 Thinking about the new documentary framework for the quality and safety of organs intended for transplantation, what level of impact, if any, do you think it willhave on your working practices?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
30167121342530Unweighted total
30*26**12**20**22**7**41**50**Weighted total
710282-1212A significant positive23%38%14%43%8%-28%24%impact
1413381251823A minor positive impact47%49%29%40%54%75%43%46%
42325-57No impact either way13%6%29%9%23%-12%13%
2-2-2223A minor negative impact7%-14%-8%25%4%7%
1-2-2-22A significant negative3%-14%-8%-4%3%impact
22-2--33Don't know7%6%-9%--8%7%
--------Not applicable--------
21235161353035Positive impact70%87%43%83%62%75%72%70%
3-3-3235Negative impact10%-29%-15%25%8%10%
18232161032630Net60%87%14%83%46%50%64%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 366Q.42 Thinking about the new documentary framework for the quality and safety of organs intended for transplantation, what level of impact, if any, do you think it willhave on your working practices?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-129-30------91011----30-30Unweighted total
30*-**2**48**-**50**-**-**-**-**-**-**15**16**18**-**-**-**-**50**-**50**Weighted total
3--5-5------23-----5-5Strongly agree10%--10%-9%------11%18%-----9%-9%
19--32-32------101012----32-32Tend to agree63%--66%-64%------67%61%64%----64%-64%
2--3-3------2-2----3-3Neither agree nor7%--7%-7%------11%-9%----7%-7%disagree
3--5-5------222----5-5Tend to disagree10%--10%-10%------11%10%9%----10%-10%
----------------------Strongly disagree----------------------
3-23-5-------23----5-5Don't know10%-100%7%-10%-------10%18%----10%-10%
22--36-36------121312----36-36Agree73%--76%-73%------78%80%64%----73%-73%
3--5-5------222----5-5Disagree10%--10%-10%------11%10%9%----10%-10%
190031031000000101110000031031Net agree63%0%0%65%0%63%0%0%0%0%0%0%67%69%55%0%0%0%0%63%0%63%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 367Q.43 To what extent do you agree or disagree that the HTA takes into account the views of ODT named contacts and corporate licence holder contacts in the solid organ donationsector when making decisions that might affect the sector?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-331391322-330Unweighted total
30*-**5**5**2**5**15**2**5**3**3**-**5**50**Weighted total
3-2-2-1------5Strongly agree10%-33%-100%-9%------9%
19-32-3102322-532Tend to agree63%-67%33%-67%68%100%67%50%50%-100%64%
2----2----2--3Neither agree nor7%----33%----50%--7%disagree
3--2--2-2----5Tend to disagree10%--33%--11%-33%----10%
--------------Strongly disagree--------------
3--2--2--2---5Don't know10%--33%--11%--50%---10%
22-5223112322-536Agree73%-100%33%100%67%77%100%67%50%50%-100%73%
3--2--2-2----5Disagree10%--33%--11%-33%----10%
19050231022220531Net agree63%0%100%0%100%67%66%100%33%50%50%0%100%63%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 368Q.43 To what extent do you agree or disagree that the HTA takes into account the views of ODT named contacts and corporate licence holder contacts in the solid organ donationsector when making decisions that might affect the sector?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
30167121342530Unweighted total
30*26**12**20**22**7**41**50**Weighted total
35-32-55Strongly agree10%18%-15%8%-11%9%
19157121332832Tend to agree63%57%57%60%62%50%69%64%
222-3-23Neither agree nor7%6%14%-15%-4%7%disagree
32323235Tend to disagree10%6%29%9%15%25%8%10%
--------Strongly disagree--------
33-3-235Don't know10%13%-17%-25%8%10%
22207151533336Agree73%75%57%74%69%50%80%73%
32323235Disagree10%6%29%9%15%25%8%10%
19183131223031Net agree63%68%29%66%54%25%72%63%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 369Q.43 To what extent do you agree or disagree that the HTA takes into account the views of ODT named contacts and corporate licence holder contacts in the solid organ donationsector when making decisions that might affect the sector?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-129-30------91011----30-30Unweighted total
30*-**2**48**-**50**-**-**-**-**-**-**15**16**18**-**-**-**-**50**-**50**Weighted total
3--5-5-------5-----5-5Strongly agree10%--10%-9%-------28%-----9%-9%
16--27-27------1088----27-27Tend to agree53%--56%-54%------67%51%45%----54%-54%
5--8-8------3-5----8-8Neither agree nor17%--17%-17%------22%-27%----17%-17%disagree
1--2-2-------2-----2-2Tend to disagree3%--3%-3%-------10%-----3%-3%
----------------------Strongly disagree----------------------
5-27-8------225----8-8Don't know17%-100%14%-17%------11%10%27%----17%-17%
19--31-31------10138----31-31Agree63%--65%-63%------67%80%45%----63%-63%
1--2-2-------2-----2-2Disagree3%--3%-3%-------10%-----3%-3%
18003003000000010118000030030Net agree60%0%0%62%0%60%0%0%0%0%0%0%67%69%45%0%0%0%0%60%0%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 370Q.44 To what extent do you agree or disagree that the HTA takes action following feedback from ODT named contacts and corporate licence holder contacts in the solid organ donation sector?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30-331391322-330Unweighted total
30*-**5**5**2**5**15**2**5**3**3**-**5**50**Weighted total
3-2-2-1------5Strongly agree10%-33%-100%-9%------9%
16-32-38222--527Tend to agree53%-67%33%-67%57%100%33%50%--100%54%
5----23-2-2--8Neither agree nor17%----33%23%-33%-50%--17%disagree
1-------2----2Tend to disagree3%-------33%----3%
--------------Strongly disagree--------------
5--3--2--22--8Don't know17%--67%--11%--50%50%--17%
19-522310222--531Agree63%-100%33%100%67%66%100%33%50%--100%63%
1-------2----2Disagree3%-------33%----3%
18052231020200530Net agree60%0%100%33%100%67%66%100%0%50%0%0%100%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 371Q.44 To what extent do you agree or disagree that the HTA takes action following feedback from ODT named contacts and corporate licence holder contacts in the solid organ donation sector?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
30167121342530Unweighted total
30*26**12**20**22**7**41**50**Weighted total
35-3--55Strongly agree10%18%-15%--11%9%
161351013-2727Tend to agree53%51%43%51%62%-65%54%
525-7528Neither agree nor17%6%43%-31%75%4%17%disagree
1-2-2-22Tend to disagree3%-14%-8%-4%3%
--------Strongly disagree--------
57-7-278Don't know17%25%-34%-25%16%17%
191851313-3131Agree63%68%43%66%62%-76%63%
1-2-2-22Disagree3%-14%-8%-4%3%
18183131203030Net agree60%68%29%66%54%0%72%60%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 372Q.44 To what extent do you agree or disagree that the HTA takes action following feedback from ODT named contacts and corporate licence holder contacts in the solid organ donation sector?
Base : All ODTs working in solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
896783-89-----10274210-37149-289Unweighted total
89*5**7**88*-**94*-**-**-**-**-**13**28**42*11**-**47*1**43*-**3**94*Weighted total
25-224-25-----1914--10-15--25Very easy28%-25%27%-26%-----10%34%33%--21%-35%--26%
513553-55-----1114247-32-22-255Fairly easy57%50%75%60%-59%-----81%51%55%68%-68%-51%-50%59%
72-6-8-----1123-3-3-28Neither easy nor8%33%-7%-8%-----10%5%4%32%-5%-8%-50%8%difficult
1--1-1------1---1----1Fairly difficult1%--1%-1%------5%---3%----1%
----------------------Very difficult----------------------
----------------------No opinion----------------------
51-4-5------23--113--5Don't know6%17%-4%-5%------6%7%--3%100%6%--5%
763777-80-----1224387-42-36-280Easy85%50%100%87%z-85%-----90%85%89%68%-89%-86%-50%85%
1--1-1------1---1----1Difficult1%--1%-1%------5%---3%----1%
7537760790000012223870410360279Net84%50%100%86%0%84%0%0%0%0%0%90%80%89%68%0%87%0%86%0%50%84%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 373Q.45 How easy, if at all, is it to know what you have to do to meet the HTA's requirements for solid organ donation?
Base : All non ODT specific contacts working in the solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
8934810718354951389Unweighted total
89*3**5**8**11**7**18**4**4**4**10**6**14**94*Weighted total
251116-411123325Very easy28%37%25%11%52%-24%33%20%33%21%47%25%26%
51235461432261855Fairly easy57%63%58%66%36%88%76%67%40%45%58%23%56%59%
7-12-----11218Neither easy nor8%-17%22%-----22%12%30%9%8%difficult
1-----------11Fairly difficult1%-----------9%1%
--------------Very difficult--------------
--------------No opinion--------------
5---11--2-1--5Don't know6%---12%12%--40%-9%--5%
763469618433841180Easy85%100%83%78%88%88%100%100%60%78%79%70%81%85%
1-----------11Difficult1%-----------9%1%
753469618433841079Net84%100%83%78%88%88%100%100%60%78%79%70%72%84%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 374Q.45 How easy, if at all, is it to know what you have to do to meet the HTA's requirements for solid organ donation?
Base : All non ODT specific contacts working in the solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
89468371458389Unweighted total
89*49*9**40*16**5**88*94*Weighted total
25191125-2425Very easy28%39%z9%30%30%-27%26%
5126624845155Fairly easy57%54%59%60%51%83%58%59%
72322178Neither easy nor8%4%31%5%11%17%8%8%difficult
1---1-11Fairly difficult1%---8%-1%1%
--------Very difficult--------
--------No opinion--------
52-2--55Don't know6%4%-4%--5%5%
76466361347580Easy85%93%z69%90%81%83%85%85%
1---1-11Difficult1%---8%-1%1%
75466361247479Net84%93%69%90%73%83%84%84%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 375Q.45 How easy, if at all, is it to know what you have to do to meet the HTA's requirements for solid organ donation?
Base : All non ODT specific contacts working in the solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
896783-89-----10274210-37149-289Unweighted total
89*5**7**88*-**94*-**-**-**-**-**13**28**42*11**-**47*1**43*-**3**94*Weighted total
10-19-10-----118--4-6--10Strongly agree11%-13%10%-11%-----10%3%18%z--8%-14%--11%
301133-34-----411172-22-10-234Tend to agree34%17%13%37%-36%-----29%40%39%20%-46%c-24%-50%36%c
203418-21-----6654-1318--21Neither agree nor22%67%62%21%-23%-----48%20%12%40%-27%100%18%--23%hdisagree
3--3-3------3---1-2--3Tend to disagree3%--3%-3%------11%---3%-4%--3%
----------------------Strongly disagree----------------------
261125-26-----27134-8-16-226Don't know29%17%13%29%-28%-----13%26%31%40%-17%-39%ze-50%28%e
401242-44-----512242-25-16-244Agree45%17%25%47%-46%-----39%43%57%20%-54%-39%-50%46%
3--3-3------3---1-2--3Disagree3%--3%-3%------11%---3%-4%--3%
37123904100000592420240150241Net agree42%17%25%44%0%43%0%0%0%0%0%39%32%57%20%0%51%0%35%0%50%43%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 376Q.46 To what extent do you agree or disagree that the HTA takes into account the views of the solid organ donation sector when making decisions that might affect the sector?
Base : All non ODT specific contacts working in the solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
8934810718354951389Unweighted total
89*3**5**8**11**7**18**4**4**4**10**6**14**94*Weighted total
10---113---11310Strongly agree11%---8%17%14%---12%16%22%11%
303235153-332434Tend to agree34%74%42%44%44%12%28%67%-78%33%39%28%36%
201-2325-1-51221Neither agree nor22%26%-22%28%29%28%-20%-46%16%16%23%disagree
3--1--1-----13Tend to disagree3%--11%--5%-----9%3%
--------------Strongly disagree--------------
26-3223513112326Don't know29%-58%22%20%41%26%33%80%22%9%30%25%28%
403236283-353744Agree45%74%42%44%52%29%42%67%-78%46%54%50%46%
3--1--1-----13Disagree3%--11%--5%-----9%3%
3732362730353641Net agree42%74%42%33%52%29%37%67%0%78%46%54%40%43%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 377Q.46 To what extent do you agree or disagree that the HTA takes into account the views of the solid organ donation sector when making decisions that might affect the sector?
Base : All non ODT specific contacts working in the solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
89468371458389Unweighted total
89*49*9**40*16**5**88*94*Weighted total
107-62-1010Strongly agree11%14%-14%11%-11%11%
3023216623134Tend to agree34%46%23%40%35%42%36%36%
20625512021Neither agree nor22%12%23%12%30%25%23%23%fhdisagree
3211--33Tend to disagree3%4%14%2%--3%3%
--------Strongly disagree--------
2612413422426Don't know29%24%41%32%24%34%27%28%
4029221724144Agree45%60%z23%54%46%42%47%46%
3211--33Disagree3%4%14%2%--3%3%
3728120723841Net agree42%56%9%51%46%42%44%43%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 378Q.46 To what extent do you agree or disagree that the HTA takes into account the views of the solid organ donation sector when making decisions that might affect the sector?
Base : All non ODT specific contacts working in the solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
896783-89-----10274210-37149-289Unweighted total
89*5**7**88*-**94*-**-**-**-**-**13**28**42*11**-**47*1**43*-**3**94*Weighted total
9--10-10-----334--6-3--10Strongly agree10%--11%-10%-----19%12%9%--13%-8%--10%
23-124-25-----38141-15-10--25Tend to agree26%-13%27%-26%-----19%28%32%8%-32%-22%--26%
203221-22-----6852-14-8--22Neither agree nor22%50%31%24%-23%-----48%29%12%20%-29%-18%--23%hdisagree
3-13-3------3---1-2--3Tend to disagree3%-13%3%-3%------11%---3%-4%--3%
----------------------Strongly disagree----------------------
343331-35-----26208-11120-335Don't know38%50%44%35%-37%-----13%20%47%72%-22%100%47%ze-100%37%e
32-134-35-----511181-22-13--35Agree36%-13%38%-37%-----39%40%41%8%-46%-31%--37%
3-13-3------3---1-2--3Disagree3%-13%3%-3%------11%---3%-4%--3%
29003103200000581810200110032Net agree33%0%0%35%0%34%0%0%0%0%0%39%29%41%8%0%43%0%27%0%0%34%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 379Q.47 To what extent do you agree or disagree that the HTA takes action following feedback from the solid organ donation sector?
Base : All non ODT specific contacts working in the solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
8934810718354951389Unweighted total
89*3**5**8**11**7**18**4**4**4**10**6**14**94*Weighted total
9---131---11310Strongly agree10%---12%35%5%---12%16%22%10%
231134-53-222125Tend to agree26%37%25%44%40%-26%67%-55%17%39%9%26%
202-32241--41322Neither agree nor22%63%-34%20%29%21%33%--37%16%22%23%disagree
3-----1-1---13Tend to disagree3%-----5%-20%---9%3%
--------------Strongly disagree--------------
34-42338-3232535Don't know38%-75%22%28%36%44%-80%45%33%30%38%37%
321136363-233435Agree36%37%25%44%52%35%30%67%-55%29%54%31%37%
3-----1-1---13Disagree3%-----5%-20%---9%3%
291136353-1233332Net agree33%37%25%44%52%35%26%67%-20%55%29%54%22%34%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 380Q.47 To what extent do you agree or disagree that the HTA takes action following feedback from the solid organ donation sector?
Base : All non ODT specific contacts working in the solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
89468371458389Unweighted total
89*49*9**40*16**5**88*94*Weighted total
96-62-1010Strongly agree10%13%-15%11%-11%10%
2315310622325Tend to agree26%31%36%25%38%42%26%26%
207154-2222Neither agree nor22%14%14%12%24%-25%23%fhdisagree
31211-33Tend to disagree3%2%23%2%6%-3%3%
--------Strongly disagree--------
3420318333135Don't know38%40%27%46%22%58%35%37%
3222316823235Agree36%44%36%40%49%42%37%37%
31211-33Disagree3%2%23%2%6%-3%3%
2921115722932Net agree33%43%14%37%43%42%33%34%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 381Q.47 To what extent do you agree or disagree that the HTA takes action following feedback from the solid organ donation sector?
Base : All non ODT specific contacts working in the solid organ donation sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30122830------181831-12--1730Unweighted total
30*1**2**30**32**-**-**-**-**-**-**1**8**19**3**1**-**13**-**-**17**32**Weighted total
7--77-------16---3--47Very easy23%--25%23%-------12%33%---25%--24%23%
121-1213------13531-4--713Fairly easy40%100%-40%40%------100%38%28%100%100%-33%--41%40%
6--66-------15---3--36Neither easy nor20%--21%20%-------12%27%---25%--17%20%difficult
4-234-------31---1--34Fairly difficult13%-100%11%13%-------38%5%---8%--18%13%
1--11--------1---1---1Very difficult3%--4%4%--------6%---8%---4%
----------------------No opinion----------------------
----------------------Don't know----------------------
191-1920------141231-8--1120Easy63%100%-65%64%------100%50%61%100%100%-58%--65%64%
5-245-------32---2--35Difficult17%-100%14%17%-------38%11%---17%--18%17%
141-215150000001110310600815Net47%100%-100%50%47%0%0%0%0%0%0%100%12%50%100%100%0%42%0%0%47%47%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 382Q.48 How easy, if at all, is it to know what you have to do to meet HTA's requirements for bone marrow and stem cell donation?
Base : All in bone marrow and peripheral blood stem cell sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30322-39-511-430Unweighted total
30*3**2**2**-**3**10**-**5**1**1**-**4**32**Weighted total
7--1--2-21--17Very easy23%--53%--21%-40%100%--27%23%
12311-25-1----13Fairly easy40%100%47%47%-68%47%-19%----40%
6-----2-2-1-16Neither easy nor20%-----22%-42%-100%-21%20%difficult
4-1--11-----14Fairly difficult13%-53%--32%10%-----24%13%
1-----------11Very difficult3%-----------27%4%
--------------No opinion--------------
--------------Don't know--------------
19312-27-31--120Easy63%100%47%100%-68%68%-58%100%--27%64%
5-1--11-----25Difficult17%-53%--32%10%-----52%17%
143*201603100-115Net47%100%-5%100%0%36%57%0%58%100%0%0%-24%47%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 383Q.48 How easy, if at all, is it to know what you have to do to meet HTA's requirements for bone marrow and stem cell donation?
Base : All in bone marrow and peripheral blood stem cell sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
3022-20642530Unweighted total
30*23**-**21**6**5**26**32**Weighted total
76-6--77Very easy23%27%-30%--28%23%
129-834913Fairly easy40%41%-40%53%78%36%40%
63-41146Neither easy nor20%14%-20%14%22%16%20%difficult
43-12-44Fairly difficult13%14%-5%33%-16%13%
11-1--11Very difficult3%5%-5%--4%4%
--------No opinion--------
--------Don't know--------
1916-15341720Easy63%68%-70%53%78%64%64%
54-22-55Difficult17%18%-10%33%-20%17%
1411013141115Net47%49%0%60%20%78%44%47%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 384Q.48 How easy, if at all, is it to know what you have to do to meet HTA's requirements for bone marrow and stem cell donation?
Base : All in bone marrow and peripheral blood stem cell sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30122830------181831-12--1730Unweighted total
30*1**2**30**32**-**-**-**-**-**-**1**8**19**3**1**-**13**-**-**17**32**Weighted total
3--33--------3---1--23Strongly agree10%--11%10%--------16%---8%--12%10%
16-11717------16721-6--1017Tend to agree53%-50%57%53%------100%76%39%67%100%-42%--59%53%
5-145-------14---3--25Neither agree nor17%-50%14%17%-------12%22%---25%--11%17%disagree
41-34-------121--1--34Tend to disagree13%100%-11%13%-------12%11%33%--8%--18%13%
----------------------Strongly disagree----------------------
2--22--------2---2---2Don't know7%--8%7%--------12%---17%---7%
19-12020------161121-7--1220Agree63%-50%68%63%------100%76%55%67%100%-50%--71%63%
41-34-------121--1--34Disagree13%100%-11%13%-------12%11%33%--8%--18%13%
15-111716000000158110600916Net agree50%-100%50%57%50%0%0%0%0%0%0%100%64%44%33%100%0%42%0%0%53%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 385Q.49 To what extent do you agree or disagree that the HTA takes into account the views of the bone marrow and stem cell donation sector when making decisions that might affect the sector?
Base : All in bone marrow and peripheral blood stem cell sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30322-39-511-430Unweighted total
30*3**2**2**-**3**10**-**5**1**1**-**4**32**Weighted total
3--1--1-1----3Strongly agree10%--53%--10%-19%----10%
16321-33-111-117Tend to agree53%100%100%47%-100%34%-21%100%100%-27%53%
5-----1-2---25Neither agree nor17%-----10%-42%---48%17%disagree
4-----2-1---14Tend to disagree13%-----22%-19%---24%13%
--------------Strongly disagree--------------
2-----2------2Don't know7%-----23%------7%
19322-34-211-120Agree63%100%100%100%-100%44%-40%100%100%-27%63%
4-----2-1---14Disagree13%-----22%-19%---24%13%
1532203201110*16Net agree50%100%100%100%0%100%22%0%21%100%100%0%3%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 386Q.49 To what extent do you agree or disagree that the HTA takes into account the views of the bone marrow and stem cell donation sector when making decisions that might affect the sector?
Base : All in bone marrow and peripheral blood stem cell sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
3022-20642530Unweighted total
30*23**-**21**6**5**26**32**Weighted total
33-3--33Strongly agree10%14%-15%--12%10%
1614-12221517Tend to agree53%59%-59%37%50%56%53%
52-22-45Neither agree nor17%9%-11%31%-16%17%disagree
42-12134Tend to disagree13%9%-5%33%25%12%13%
--------Strongly disagree--------
22-2-112Don't know7%10%-11%-25%4%7%
1917-16221820Agree63%72%-74%37%50%68%63%
42-12134Disagree13%9%-5%33%25%12%13%
1515015*11516Net agree50%64%0%69%4%25%57%50%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 387Q.49 To what extent do you agree or disagree that the HTA takes into account the views of the bone marrow and stem cell donation sector when making decisions that might affect the sector?
Base : All in bone marrow and peripheral blood stem cell sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30122830------181831-12--1730Unweighted total
30*1**2**30**32**-**-**-**-**-**-**1**8**19**3**1**-**13**-**-**17**32**Weighted total
1--11--------1------11Strongly agree3%--3%3%--------5%------6%3%
14--1515------16611-6--815Tend to agree47%--50%47%------100%76%33%33%100%-42%--47%47%
8-189-------18---6--39Neither agree nor27%-50%25%27%-------12%39%---42%--17%27%disagree
31-23-------111--1--23Tend to disagree10%100%-7%10%-------12%6%33%--8%--12%10%
----------------------Strongly disagree----------------------
4-144--------31--1--34Don't know13%-50%14%13%--------16%33%--8%--18%13%
15--1616------16711-6--916Agree50%--54%50%------100%76%39%33%100%-42%--53%50%
31-23-------111--1--23Disagree10%100%-7%10%-------12%6%33%--8%--12%10%
12-101413000000156010400713Net agree40%-100%0%46%40%0%0%0%0%0%0%100%64%33%0%100%0%33%0%0%41%40%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 388Q.50 To what extent do you agree or disagree that the HTA takes action following feedback from the bone marrow and stem cell donation sector?
Base : All in bone marrow and peripheral blood stem cell sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
30322-39-511-430Unweighted total
30*3**2**2**-**3**10**-**5**1**1**-**4**32**Weighted total
1-------1----1Strongly agree3%-------19%----3%
14122-14--11-215Tend to agree47%32%100%100%-36%44%--100%100%-54%47%
81----2-4---19Neither agree nor27%36%----22%-81%---21%27%disagree
3-----2-----13Tend to disagree10%-----22%-----24%10%
--------------Strongly disagree--------------
41---21------4Don't know13%32%---64%12%------13%
15122-14-111-216Agree50%32%100%100%-36%44%-19%100%100%-54%50%
3-----2-----13Disagree10%-----22%-----24%10%
1212201201110113Net agree40%32%100%100%0%36%22%0%19%100%100%0%30%40%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 389Q.50 To what extent do you agree or disagree that the HTA takes action following feedback from the bone marrow and stem cell donation sector?
Base : All in bone marrow and peripheral blood stem cell sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
3022-20642530Unweighted total
30*23**-**21**6**5**26**32**Weighted total
11-1--11Strongly agree3%4%-5%--4%3%
1414-13121315Tend to agree47%59%-60%20%50%49%47%
84-33-79Neither agree nor27%18%-16%47%-28%27%disagree
31-11123Tend to disagree10%4%-5%16%25%8%10%
--------Strongly disagree--------
43-31134Don't know13%14%-15%16%25%12%13%
1515-14121416Agree50%64%-64%20%50%52%50%
31-11123Disagree10%4%-5%16%25%8%10%
1214013*11213Net agree40%59%0%60%4%25%45%40%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 390Q.50 To what extent do you agree or disagree that the HTA takes action following feedback from the bone marrow and stem cell donation sector?
Base : All in bone marrow and peripheral blood stem cell sector
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
33-52765--595-1516--313-2431Standardize regulations/9%-10%9%19%4%--10%23%zkp8%-12%g9%g--5%6%7%-13%zb9%gpinspections across the
UK/between England/Scotland/sectors etc
2611266141-112110133-3585627Raise its profile/public7%11%2%8%17%9%11%-2%3%3%9%8%8%5%-5%28%16%za9%3%7%aawareness of the value
of organ donation (andassociated issues)
24-42138-154411473-12251424Clarify/simplify7%-9%7%10%6%-33%10%10%5%9%11%zh4%5%-3%12%4%9%7%7%hguidance/codes of
practices
221222315--2127593-7-53823Consent for tissue6%11%4%7%9%11%zk--5%3%3%47%4%5%5%-14%a-11%6%4%6%aresearch/organ donation/
port mortem research
17111629-12-3-314--4242517Better/more training5%10%2%5%7%6%-33%3%-4%-2%8%zgi--8%12%9%a3%3%5%adays/conferences/events
for IA's/DI's/PD's
14-311162--331482-1--5915Share good practice/4%-6%4%3%4%17%--8%m4%9%4%4%3%-3%--9%5%4%provide examples of
SOP's
13-11326---331310--3222614Better communication/4%-2%4%7%4%---8%m4%9%2%6%--5%12%4%3%3%4%contact
14-311-31-145-571---121113Controlling/reducing/4%-6%4%-2%6%-2%10%zp8%zp-4%4%2%---2%3%6%z4%licence fees/costs
141-12121-242-544---1-1213Reduce/avoid over4%11%-4%3%1%11%-5%10%zp3%-4%3%7%---2%-6%z4%burdensome regulations/
frequent inspections
9-2913---33117--1--2710Better inspectors/2%-4%3%3%2%---8%m4%9%1%4%--3%--3%3%3%trained/experienced HTA
staff
7-25-21--23-16----1337Ensuring compliance to2%-4%2%-1%6%--4%4%-1%4%----2%5%2%2%HTA standards
7--7-21--31-34--1-1-57Work closer with its2%--2%-1%6%--8%zmp1%-2%2%--3%-2%-2%2%stakeholders/those in
the profession (ieRCPath)
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 391Q.51 Thinking about the next few years, what two or three things do you think might be the most important for the HTA to focus on?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
7--7-3--21--412---1247Avoid overlap of2%--2%-2%--5%k3%--4%*3%---2%3%2%2%hregulations between
similar organisations/consider merging/linking/working withother bodies/streamlining regulations
7215-31--11-42----3-36Extend presumed consent2%19%2%2%-2%6%--3%1%-4%1%----7%za-1%2%rules to rest of UK
6--612--1-2-33--111-36Ethical considerations2%--2%4%1%--2%-3%-2%2%--3%6%2%-1%2%
4--5-3--11--3-2----325Raise standards/improve1%--2%-2%--2%3%--3%h-3%h----6%z1%1%practices/do more to
support stakeholders
5-141---111-221--1-135Nothing/happy with HTA1%-2%1%4%---2%3%1%-1%1%2%--6%-2%1%1%
5-331-1--21--41-----55Make the website more1%-6%zr1%3%-6%--5%zp1%--2%2%-----2%z1%ruser friendly
5-15111---1-23--1---35Tissue/organ retention/1%-1%1%3%1%11%---1%-1%2%--3%---2%1%storage/disposal
4--412--1-1-14---1-224Facilitate research/1%--1%4%1%--2%-1%-1%2%---6%-3%1%1%encourage innovation
3-13-3---1-111--3---14Responding promptly to1%-2%1%-2%---3%-9%1%1%--5%za---1%1%questions/requests
3--3-3-----1-11-1-2--3Concerns about1%--1%-2%-----9%-1%2%-3%a-4%za--1%trafficking
2--312-------3---1-2-3Focus on its remit/Human1%--1%4%1%-------2%---6%-3%a-1%Tissue Act
3--3------3-21------33Outsource/leave post1%--1%------4%zp-1%1%------1%1%mortem work to the CPA
(Clinical PathologyAssociation)
2--2-2--1---21-----212Transportation of organs1%--1%-1%--2%---1%*-----3%*1%/ tissue
2--22-------11------22Concerns about1%--1%6%-------1%1%------1%1%marketisation
2--2-11-----11--1---12Organ donations/tissue1%--1%-1%6%-----1%*--3%---*1%samples
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 391Q.51 Thinking about the next few years, what two or three things do you think might be the most important for the HTA to focus on?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
2--2------2--2------22Reduce paperwork/1%--1%------3%z--1%------1%*bureaucracy/reporting
2--2-1----1--2----1-12Consent training1%--1%-1%----1%--1%----2%-**
2--2----1-1-11------22Change its emphasis on1%--1%----2%-1%-1%*------1%*from threatening/
overbearing to asupportive/helpfulorganisation
1-111--------1------11Make the forms easier to*-2%z*3%--------1%------1%*fill out
1--1------1--1------11Improve the layout of*--*------1%--1%------**its newsletters/leaflets
6-141---211-222----146Other2%-2%1%3%---3%p3%1%-1%1%4%----2%2%2%
12511411074451218311445622-137132269123Nothing in particular35%10%29%34%23%31%39%33%44%l21%45%zlp9%36%33%40%-27%36%26%40%36%34%
64513514331-10211416281711421172965Don't know18%51%27%16%14%23%l11%-20%l5%15%27%13%16%31%zhi100%29%a12%23%12%15%18%lr
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 391Q.51 Thinking about the next few years, what two or three things do you think might be the most important for the HTA to focus on?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
3312253641111531Standardize regulations/9%10%8%12%12%8%8%19%3%6%3%7%11%9%inspections across the
UK/between England/Scotland/sectors etc
26-231382312-327Raise its profile/public7%-7%13%3%8%9%9%11%5%6%-7%7%awareness of the value
of organ donation (andassociated issues)
2421146313-1-424Clarify/simplify7%21%4%6%10%17%zg4%4%8%-3%-8%7%guidance/codes of
practices
22-21248--14-323Consent for tissue6%-7%4%6%11%9%--5%12%-6%6%research/organ donation/
port mortem research
171--323-1221317Better/more training5%9%--8%5%4%-4%9%7%7%6%5%days/conferences/events
for IA's/DI's/PD's
1415-213--12-115Share good practice/4%10%22%-6%3%3%--4%5%-2%4%provide examples of
SOP's
13-3-122---21314Better communication/4%-13%-2%6%3%---6%7%7%4%contact
14-31314-11---13Controlling/reducing/4%-13%5%7%2%5%-3%5%---4%licence fees/costs
14-2--24-1--2213Reduce/avoid over4%-8%--5%4%-3%--20%5%4%burdensome regulations/
frequent inspections
9-21232------10Better inspectors/2%-9%6%5%8%2%------3%trained/experienced HTA
staff
7----23--111-7Ensuring compliance to2%----5%4%--4%3%7%-2%HTA standards
7---122--11--7Work closer with its2%---3%5%2%--7%3%--2%stakeholders/those in
the profession (ieRCPath)
7--11-3-1-1-17Avoid overlap of2%--5%2%-3%-3%-3%-2%2%regulations between
similar organisations/consider merging/linking/working withother bodies/streamlining regulations
7-1--13-1----6Extend presumed consent2%-4%--3%4%-3%----2%rules to rest of UK
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 392Q.51 Thinking about the next few years, what two or three things do you think might be the most important for the HTA to focus on?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
6-1-113------6Ethical considerations2%-6%-2%2%4%------2%
4-2--21-1----5Raise standards/improve1%-7%--5%1%-3%----1%practices/do more to
support stakeholders
5--1----12--15Nothing/happy with HTA1%--6%----3%11%--2%1%
5-1-11---1-1-5Make the website more1%-4%-3%3%---4%-7%-1%user friendly
5-----11-21--5Tissue/organ retention/1%-----1%5%-11%2%--1%storage/disposal
4-----11-1--24Facilitate research/1%-----1%5%-4%--4%1%encourage innovation
3---1-1---1--4Responding promptly to1%---3%-2%---4%--1%questions/requests
3---2----1---3Concerns about1%---6%zg----5%---1%trafficking
2---2-1------3Focus on its remit/Human1%---5%z-1%------1%Tissue Act
3-------1-1-13Outsource/leave post1%-------3%-3%-2%1%mortem work to the CPA
(Clinical PathologyAssociation)
2-----1---2--2Transportation of organs1%-----1%---6%--1%/ tissue
2-----1-1----2Concerns about1%-----1%-3%----1%marketisation
2----1-1-----2Organ donations/tissue1%----4%z-4%-----1%samples
2-----1--1---2Reduce paperwork/1%-----1%--5%---*bureaucracy/reporting
2---1-------12Consent training1%---2%-------2%*
2----1------12Change its emphasis on1%----2%------2%*from threatening/
overbearing to asupportive/helpfulorganisation
1----1-------1Make the forms easier to*----3%z-------*fill out
1-----1------1Improve the layout of*-----1%------*its newsletters/leaflets
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 392Q.51 Thinking about the next few years, what two or three things do you think might be the most important for the HTA to focus on?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
6-----2111--16Other2%-----2%5%3%6%--2%2%
125549111320912512617123Nothing in particular35%52%19%45%30%37%25%48%38%30%38%51%38%34%
641229417474411065Don't know18%8%7%9%24%13%21%21%21%24%14%7%22%18%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 392Q.51 Thinking about the next few years, what two or three things do you think might be the most important for the HTA to focus on?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
332152011-3131Standardize regulations/9%10%9%12%z11%-10%9%inspections across the
UK/between England/Scotland/sectors etc
2619217742327Raise its profile/public7%9%3%10%7%11%7%7%awareness of the value
of organ donation (andassociated issues)
241181012-2224Clarify/simplify7%5%15%zh6%12%z-7%7%guidance/codes of
practices
2212591022123Consent for tissue6%6%10%5%10%5%7%6%research/organ donation/
port mortem research
17819221517Better/more training5%4%2%5%2%6%5%5%days/conferences/events
for IA's/DI's/PD's
14917611415Share good practice/4%4%2%4%6%2%5%4%provide examples of
SOP's
13827511314Better communication/4%4%4%4%5%2%4%4%contact
14555621213Controlling/reducing/4%3%10%zh3%5%5%4%4%licence fees/costs
141911131013Reduce/avoid over4%*17%zh1%11%zf9%3%4%fhburdensome regulations/
frequent inspections
933352810Better inspectors/2%1%6%2%5%6%2%3%trained/experienced HTA
staff
75-43-77Ensuring compliance to2%3%-2%3%-2%2%HTA standards
76131167Work closer with its2%3%2%2%1%2%2%2%stakeholders/those in
the profession (ieRCPath)
75225167Avoid overlap of2%2%3%1%5%z2%2%2%regulations between
similar organisations/consider merging/linking/working withother bodies/streamlining regulations
75-3-156Extend presumed consent2%3%-2%-2%2%2%rules to rest of UK
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 393Q.51 Thinking about the next few years, what two or three things do you think might be the most important for the HTA to focus on?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
36220552*163101*37*316362Weighted total
65151146Ethical considerations2%2%2%3%1%3%1%2%
42214-35Raise standards/improve1%1%3%*4%zf-1%1%practices/do more to
support stakeholders
54-1--55Nothing/happy with HTA1%2%-1%--2%1%
53-31145Make the website more1%1%-2%1%3%1%1%user friendly
55-3--55Tissue/organ retention/1%2%-2%--1%1%storage/disposal
4323--44Facilitate research/1%1%3%2%--1%1%encourage innovation
31112-44Responding promptly to1%1%2%1%2%-1%1%questions/requests
32121-33Concerns about1%1%2%1%1%-1%1%trafficking
23-3--33Focus on its remit/Human1%1%-2%--1%1%Tissue Act
3---2123Outsource/leave post1%---2%2%1%1%mortem work to the CPA
(Clinical PathologyAssociation)
22--2122Transportation of organs1%1%--2%2%1%1%/ tissue
22-11-22Concerns about1%1%-1%1%-1%1%marketisation
21--1-22Organ donations/tissue1%*--1%-1%1%samples
2-2-1112Reduce paperwork/1%-3%zh-1%2%**bureaucracy/reporting
22-11-22Consent training1%1%-1%1%-1%*
22-2--22Change its emphasis on1%1%-1%--1%*from threatening/
overbearing to asupportive/helpfulorganisation
1---1-11Make the forms easier to*---1%-**fill out
1-----11Improve the layout of*-----**its newsletters/leaflets
64-22156Other2%2%-1%2%2%1%2%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 393Q.51 Thinking about the next few years, what two or three things do you think might be the most important for the HTA to focus on?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
36220552*163101*37*316362Weighted total
125791261277114123Nothing in particular35%38%23%37%27%19%36%d34%d
642962511115065Don't know18%14%11%15%11%30%c16%18%ceh
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 393Q.51 Thinking about the next few years, what two or three things do you think might be the most important for the HTA to focus on?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
20-4192141-24-1795-6-151123Happy as it is/its fine/6%-8%6%6%10%k6%-5%k10%k-9%6%5%9%-13%c-2%9%6%6%knothing to improve/
continue as it is
18-315171-115-710--1152817More direct contact/5%-6%5%4%5%6%-2%3%8%-6%6%--3%6%11%z3%4%5%personal visits/meetings
15-11515--215-492---25915Improved communication/4%-2%5%3%4%--3%3%8%-4%5%3%---4%9%5%4%keep me in the loop/
more/better information/updates
13--1328----1365--435-113More/different teaching4%--4%7%6%----1%18%5%3%--8%a18%11%zab-*4%asessions/would like to
attend training events
7-2512--122-422--1-257Clearer/faster answers2%-4%2%4%1%--2%5%3%-3%1%3%--6%-3%2%2%to questions
6-16-41--2--232-1-1237Appoint a primary2%-2%2%-3%6%--5%--2%2%3%-3%-2%3%1%2%contact/dedicated
officer for queries/keyperson for each area
5-23-2--1-1-311-1-1125More accessibility of1%-4%1%-1%--2%-1%-2%1%2%-3%-2%2%1%1%workshops/meetings/
online assessments
4--4-1---211-21-1---34Improve/change1%--1%-1%---5%z1%9%-1%2%-3%---2%1%inspection process
3--3-2---1--12----1113Clarify what is1%--1%-1%---3%--1%1%----2%2%1%1%required/simplify
guidance
2-2------2--11------22Be less threatening/1%-4%zr------5%zp--1%1%------1%1%don't involve the
police/less heavy handedapproach
2--21--1-----2---1--12More knowledgeable/1%--1%4%--33%-----1%---6%--*1%experienced
pathologists/staff
2-11----1-1--2------22Improve website1%-2%*----2%-1%--1%------1%*
1--2-2--------2----2-2Be more friendly/polite/*--1%-1%--------3%zh----3%a-*would be nice to receive
a thank you
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 394Q.52 How, if at all, could the HTA improve its relationship with you?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
1-1------1---1------11Reduce/stop increasing*-2%zr------3%z---1%------1%*fees/charge less/more
value for money
1--1------1--1------11Be more supportive*--*------1%--1%------**
2--2------1-2-----1-12No answer1%--1%------1%-1%-----2%-**
21-11-----1--11-----22Other1%11%-*3%-----1%--1%2%-----1%1%
246530218229510236234898311635130123137133244Nothing in particular68%60%64%68%70%66%78%67%76%59%71%65%68%68%65%100%62%64%63%68%70%67%
2634212101-524-6136-42431226Don't know7%29%8%7%7%7%6%-10%5%5%-5%8%11%-8%12%9%6%6%7%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 394Q.52 How, if at all, could the HTA improve its relationship with you?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2011232235112223Happy as it is/its fine/6%10%6%9%8%5%2%13%15%6%3%14%4%6%nothing to improve/
continue as it is
18-3-2-41311-317More direct contact/5%-12%-6%-5%5%8%5%2%-7%5%personal visits/meetings
15-21215-2-1-315Improved communication/4%-7%5%5%3%6%-6%-3%-5%4%keep me in the loop/
more/better information/updates
131-1-23-21-1213More/different teaching4%13%-6%-6%4%-6%5%-7%4%4%sessions/would like to
attend training events
7---1-41----27Clearer/faster answers2%---3%-5%5%----4%2%to questions
6---231----1-7Appoint a primary2%---6%8%z1%----6%-2%contact/dedicated
officer for queries/keyperson for each area
51----11-1--15More accessibility of1%13%----1%5%-6%--2%1%workshops/meetings/
online assessments
4-1---111----4Improve/change1%-4%---2%5%3%----1%inspection process
3-----1-1-1--3Clarify what is1%-----2%-3%-3%--1%required/simplify
guidance
2-----1--1---2Be less threatening/1%-----1%--6%---1%don't involve the
police/less heavy handedapproach
2-----2------2More knowledgeable/1%-----2%------1%experienced
pathologists/staff
2----------112Improve website1%----------7%2%*
1-----2------2Be more friendly/polite/*-----2%------*would be nice to receive
a thank you
1---1--------1Reduce/stop increasing*---3%z--------*fees/charge less/more
value for money
1-----------11Be more supportive*-----------2%*
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 395Q.52 How, if at all, could the HTA improve its relationship with you?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
2-1---------12No answer1%-4%---------2%*
2-----2------2Other1%-----2%------1%
2467161523265211191126830244Nothing in particular68%68%71%75%62%76%64%58%62%60%87%66%65%67%
261113192131-426Don't know7%8%4%4%8%3%11%9%4%14%3%-8%7%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 395Q.52 How, if at all, could the HTA improve its relationship with you?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
20155164-2223Happy as it is/its fine/6%7%9%10%z4%-7%6%nothing to improve/
continue as it is
181037721517More direct contact/5%5%5%4%7%5%5%5%personal visits/meetings
15635721315Improved communication/4%3%5%3%7%5%4%4%keep me in the loop/
more/better information/updates
139173-1213More/different teaching4%5%2%4%3%-4%4%sessions/would like to
attend training events
73324357Clearer/faster answers2%1%5%1%4%8%zc1%2%cto questions
62424147Appoint a primary2%1%7%zh1%4%3%1%2%ccontact/dedicated
officer for queries/keyperson for each area
54-3--55More accessibility of1%2%-2%--2%1%workshops/meetings/
online assessments
41313134Improve/change1%*6%zh1%3%2%1%1%inspection process
31-11123Clarify what is1%1%-1%1%2%1%1%required/simplify
guidance
22-2--22Be less threatening/1%1%-1%--1%1%don't involve the
police/less heavy handedapproach
21-1-112More knowledgeable/1%*-1%-3%c*1%cexperienced
pathologists/staff
22-2--22Improve website1%1%-1%--1%*
1-2-22-2Be more friendly/polite/*-3%zh-2%5%zc-*would be nice to receive
a thank you
1---1-11Reduce/stop increasing*---1%-**fees/charge less/more
value for money
11-1--11Be more supportive**-1%--**
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 396Q.52 How, if at all, could the HTA improve its relationship with you?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
36220552*163101*37*316362Weighted total
21111-22No answer1%*2%1%1%-1%*
2-1-2112Other1%-2%-2%2%*1%
246150231136118223244Nothing in particular68%73%zg45%69%60%50%71%zd67%dg
26768691426Don't know7%4%12%h5%6%25%zc4%7%ch
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 396Q.52 How, if at all, could the HTA improve its relationship with you?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base
UnwtdtotalWork SectorSectorLength of time in roleRole/ Relationship with the HTA
OrganDonation
Human&applicatiTransplan
TransplanTransplanont (ODT)ts - bonets -(tissueAccredit-In-contactDesignate
marrow orsolidforBetween 6Between 1Stem cellLivingeddependentordstem cellorganPublictreatmentPostMore thanand 10and 5Less thanco-donor co-AssessorAssessorlicenceIndividua
VoluntaryPrivatePublicdonationdonationAnatomydisplayResearch)mortem10 yearsyearsyears1 yearordinatorordinator(AA)(IA)holderl (DI)Total(t)(s)(r)(q)(p)(o)(n)(m)(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
3621050316301191835938781112617649137175733217362Unweighted total
3629**47*31932**14412**3**47*39*69*14**12217155*1**47*19**49*54*191362Weighted total
26653223121109122372250118812539-3793737142263Feedback via e-73%59%68%72%65%76%l100%67%79%l57%73%73%72%73%70%-79%46%75%69%74%73%lnewsletter and website
199731171217492242436572903011682834110198Present results to key55%78%65%54%67%52%72%67%50%62%53%35%59%53%55%100%35%42%56%e63%e58%e55%estakeholders
1534191321653622320251597118-86252587150Inform HTA policy42%49%40%41%52%37%50%67%50%51%36%9%49%z41%34%-16%30%51%e46%e45%e41%edevelopment
78-1170532421214101293613-826184680Improve their22%-22%22%17%23%33%67%25%36%zk14%9%24%21%24%-16%12%12%33%c24%22%ckcommunications
5314469143-6610318264-54723351Issue media release15%10%9%15%30%10%22%-13%16%14%18%14%15%8%-11%24%14%3%17%zb14%b
11-48-3--133145--112-611Other (specify)3%-8%zr2%-2%--2%8%4%9%3%3%--3%6%4%-3%3%
2--3-3-------12---12-3None of these1%--1%-2%-------1%3%---2%3%a-1%
161-15-7--1-5-872-3132816Don't know4%12%-5%-5%--2%-8%-6%4%3%-5%6%5%3%4%4%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 397Q.53 How do you think the HTA should use the feedback from this evaluation?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f - z/g/h/i/j - z/k/l/m/n/o/p/q - z/r/s/tOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdtotalArea
NorthernYorkshire andIrelandWalesScotlandSouth EastSouth WestLondonEast of EnglandWest MidlandsEast MidlandsHumberNorth EastNorth WestTotal
(l)(k)(j)(i)(h)(g)(f)(e)(d)(c)(b)(a)(z)
362102117393580203118301348362Unweighted total
36210**23**20**37*35*82*19**31**18**30**12**47*362Weighted total
26681714262253172415221134263Feedback via e-73%78%73%73%71%64%65%90%76%84%72%93%73%73%newsletter and website
199812131923448181112623198Present results to key55%83%53%65%52%65%54%45%58%62%41%51%49%55%stakeholders
15371211131138511414419150Inform HTA policy42%70%52%56%35%32%47%28%37%25%47%33%40%41%development
7834512819363521080Improve their22%28%19%27%33%22%24%15%20%19%16%13%21%22%communications
53416241035263751Issue media release15%41%5%28%5%11%12%14%15%10%20%27%14%14%
11-2-2-4-21---11Other (specify)3%-8%-6%-5%-6%6%---3%
2----1----2--3None of these1%----2%----6%--1%
16-1113312-2-316Don't know4%-4%4%2%8%4%5%6%-6%-6%4%
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 398Q.53 How do you think the HTA should use the feedback from this evaluation?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/a/b/c/d/e/f/g/h/i/j/k/lOverlap formulae used. * small base; ** very small base (under 30) ineligible for sig testing
UnwtdHTA regulation an obstacle toHealth sector regulation antotalsuccessobstacle to successKept informed by HTA generally
DisagreeAgreeDisagreeAgreeNot informedInformedTotal(h)(g)(f)(e)(d)(c)(z)
362206501649837316362Unweighted total
36220552*163101*37*316362Weighted total
266156341286419239263Feedback via e-73%76%66%78%ze64%51%75%zd73%denewsletter and website
19911530905919176198Present results to key55%56%57%55%58%51%56%55%stakeholders
1539022664814136150Inform HTA policy42%44%43%41%48%38%43%41%development
785494123116780Improve their22%26%z17%25%23%31%21%22%communications
53339301034851Issue media release15%16%17%18%z10%9%15%14%
1163544611Other (specify)3%3%5%3%4%10%zc2%3%c
23-21-33None of these1%1%-1%1%-1%1%
16443751016Don't know4%2%8%h2%7%14%zc3%4%cfh
HTA Stakeholder Evaluation Project 2013 - Professional SurveyFinal
Table 399Q.53 How do you think the HTA should use the feedback from this evaluation?
Base : All
Respondent type : HTA StakeholdersFieldwork dates : 15 July - 1 August 2013Source : Ipsos MORI (JN13-031173-01)Proportions/Means: Columns Tested (5% risk level) - z/c/d - z/e/f - z/g/hOverlap formulae used. * small base